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1 Abstract 
Streptococcus pneumoniae is a genetically diverse organism that varies 
substantially in its genomic content from one strain to another. Current 
therapeutic strategies in the management of pneumococcal disease include 
treatment with antibiotics and prevention by vaccination. However, due to the 
highly competent nature of the bacterium the prevalence of antibiotic 
resistance and vaccine escape is increasing. The pneumococcus causes a wide 
range of diseases, and this can be attributed to both the succeptibility of the 
human host and the genetic background of the infecting strain. The study of the 
contribution of variations in the genome of S.pneumoniae is clearly important in 
understanding the behaviour of this organism, and managing the burden of 
disease relating to this organism. 
S.pneumoniae strains are able to acquire DNA from other strains, and also from 
other closely related species, who occupy the same niche in the human host. 
One region of genomic diversity in the pneumococcus encodes a large serine rich 
repeat protein, glycoysltransferases and secretion proteins, some of which are 
homologous to the Sec secretion pathway. Similar loci have been characterised 
and found to be important in the virulence of other gram positive bacteria, 
including S.gordonii and S.parasanguinis. 
The presence of this locus was investigated in a diverse population of 
pneumococcal isolates, and shown to be present in a wide variety of isolates. 
The RNA of genes in the locus was found to be expressed. Expression of the SRR 
protein, encoded by SP1772, was investigated; a role in biofilm formation was 
identified utilising an isogenic mutant in SP1772 of TIGR4. In addition, the gene 
encoding the SRR was found to be able to recombine within a single strain of 
S.pneumoniae, suggesting this region of the genome is not only variable in its 
presence in the pneumococcal population but also able to adapt to the 
environment it is in. 
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1 Introduction 
1.1 Streptococcus pnuemoniae 
Streptococcus pneumoniae (the pneumococcus) is responsible for the death of 
up to a million children under the age of five worldwide per year 
(http://www.who.int/immunization_delivery/new_vaccines/pneumo/en/). It 
causes a wide range of diseases, those it is commonly associated with that can 
be fatal are septicaemia (infection of the blood stream by bacteria), meningitis 
(infection of the brain and spinal chord) and pneumonia (infection of the lungs); 
more benign diseases commonly caused by S.pneumoniae  include otitis media 
(infection of the middle ear), sinusitis (infection of the paranasal sinuses) and 
bronchitis (infection of the bronchi) (Austrian, 1999). S.pneumoniae has also 
been associated with cases of arthritis (inflammation of the joints), 
osteomyelitis (infection of the bone or bone marrow), endocarditis 
(inflammation of the heart lining), endophthalmitis (inflammation of the eye), 
abscesses (formation of a cavity in the tissue) and necrotizing fasciitis (infection 
of subcutaneous tissue).  Contact of S.pneumoniae in most instances will not 
cause disease in humans and can simply be carried by the host. Carriage of the 
bacterium is, however, often believed to be the first step in the pathogenesis of 
this organism. The treatment of pneumococcal disease is usually with 
antibiotics, however the burden and mortality of the diseases caused by 
S.pneumoniae remains high (Hausdorff et al., 2005) and so together with the 
increasing prevalance of antibiotic resistant strains (Appelbaum, 2002; Jenkins 
et al., 2008), a strategy of prevention by vaccination is clearly more desirable 
than treatment to reduce the burden of pneumococcal disease. 
Current licensed vaccinations including Prevnar (Wyeth) and Pneumo 23 (Sanofi-
Aventis) are composed of the capsular polysaccharide that coats S.pneumoniae. 
However 90 different variations of this polysaccharide exist within the species 
(Henrichsen, 1995) and even the most effective vaccination only protects against 
7 of these (Black et al., 2000). Studies have shown that a 90-valent vaccine, 
aside from being cost-inefficient, would actually be impossible to create. 
The capsule of the pneumococcus is an indicator of the variation in the genome 
of this species. Vaccination strategies utilising other components of the 
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pneumococcal armoury are currently being developed, issues in developing these 
also include sequence variation, and in addition a lack of immunogenicity. 
1.1.1 History and classification of the pneumococcus 
S.pneumoniae is a gram positive facultative anaerobe. It was discovered 
simulataneously in 1880 by Chemist Louis Pasteur in France and Army physician 
George Sternberg in the US, and, since then several important scientific 
principles have been elucidated from the study of the pneumococcus. It is the 
organism in which genetic transformation was discovered (Griffith, 1928). It is 
also the organism in which the first non-protein antigen was found (Goebel and 
Adams, 1943) and in which DNA was shown to be the genetic material (Avery et 
al., 1944). 
1.1.2 MLST 
MLST (Multi Locus Sequence Typing) was pioneered due to the perceived 
limitation of the historical classification system of S.pneumoniae by capsular 
serotyping in being sufficiently sensitive to adequately reflect population 
diversity and the ability of the organism to cause disease. MLST classification is 
assessed by the sequencing of 7 housekeeping genes of the pneumococcus: aroE, 
gdh, gki, recP, spi, xpt and ddl (Enright and Spratt, 1998). House keeping genes 
are relatively conserved genes within an organism given that they are generally 
required for essential function for the viability of the organism. They also are 
cytoplasmic and as such subject to less host immune pressure than cell-surface 
exposed factors. Each variant allele of each gene is given a number. The number 
for each gene then assigns a ‘bar-code’ of the seven numbers which denotes an 
MLST type of a particular isolate, commonly referred to as a sequence type (ST). 
The limitations of MLST have become apparent by the proven difference in 
genetic content of S.pneumoniae isolates of the same ST type by whole genome 
microarray (Silva et al., 2006), which is a clear indicator of the massive genetic 
diversity extant within the species. Nonetheless MLST provides a more sensitive 
classification technique for the pneumococcus than capsular serotyping, and 
combined with an understanding of sequence diversity within virulence 
determinants of the bacterium could provide an extremely strong tool in 
understanding the implications of genetic diversity in the ability of a particular 
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species to cause disease (Hanage et al., 2005). As such, understanding the 
contribution of sequence diversity seen in virulence factors of the pneumococcus 
will strengthen the current understanding of the ability of the organism to cause 
a wide range of diseases.  
1.1.3 Comparative genomic hybridisation studies 
Comparative genomic hybridisation studies enable the comparison of genomic 
content of a strain to a reference strain. These studies can identify how much 
the genetic content of a test strain varies from the reference strain, but also 
how different test strains compare to one another versus the test strain. 
The pneumococcal genome is confirmed to be highly variable from isolate to 
isolate by these studies, one study found by comparative genomic hybridization 
of 19 strains, that 8 to 10% of genes were divergent from TIGR4, and that the 
nonconserved genes found across these strains was representative of 
approximately 20% of the TIGR4 genome (Hakenbeck et al., 2001). 
A comparative genomic hybridization study was carried out on pneumococcal 
strains of both the same serotype and sequence type. This identified that strains 
of serotype 14, ST124 do not have identical genomic content. This was 
consolidated by analysis of the virulence of these strains in an animal model of 
infection, with revealed that they behave differently (Silva et al., 2006). 
A further study sought to identify by comparative genomic hybridisation the 
genomic content of the pneumococcus which enables it to cause invasive 
disease. Strains that could be isolated from both invasive disease and carriage 
were selected, of serotypes 6A, 6B, and 14. The authors correlated the presence 
of certain regions of diversity within these serotypes with the ability of an 
isolate to cause disease (Obert et al., 2006). 
Comparative genomic hybridisation studies are valuable in understanding the 
variation that lies within genomes. However, this is by reference to a 
sequenced, reference strain. Whilst the study can confirm the presence of genes 
between a test and reference strain, the absence of genes could be due to a 
great divergence of that gene between test and reference strains, as opposed to 
its complete absence. In addition, these studies cannot characterise what is 
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present in the test strain and absent in the reference strain. Comparative 
genomic hybridisation studies of the pneumococcus have shown that there can 
be a high level of diversity within the population. Other studies have shown that 
genes within the pneumococcus can vary greatly in sequence and so the only way 
to completely characterise strains is by full sequencing. 
Three strains of S.pneumoniae have been fully sequenced: R6 is an 
unencapsulated avirulent laboratory strain, derived from D39, a serotypes 2 
invasive strain (Hoskins et al., 2001); TIGR4 is a serotype 4, ST strain isolated 
from the blood of a patient with invasive pneumococcal disease (Tettelin et al., 
2001); G54 is a serotype 19F, ST 63 strain isolated from a respiratory sample, 
and is resistant to macrolides and tetracylcine (unpublished data, 
http://cmr.tigr.org/cgi-bin/CMR/GenomePage.cgi?org=ntsp05). In addition, 
there are currently up to 30 pneumococcal genomes currently being sequenced 
around the world. 4 strains currently being sequenced at the Sanger Center are 
discussed in Chapter 3. 
1.2 Virulence factors of the pneumococcus 
The pneumococcus produces a wide range of virulence factors. Virulence factors 
in the bacterium have been identified classically by associating a factor with a 
function of the bacterium’s pathogenesis, however, in recent years whole 
genome sequencing has allowed the identification of putative virulence factors 
by homology to those identified in other species (Tettelin et al., 2001), and 
whole genome signature-tagged mutagenesis has allowed the identification of 
genes of entirely unknown function in the disease process (Hava and Camilli, 
2002; Lau et al., 2001; Polissi et al., 1998).  
Major virulence factors are presented in Table 1, and discussed in the following 
sections. 
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Table 1 – Major virulence factors of S.pneumoniae 
Virulence factor Function Reference 
CbpA - Choline 
binding protein A 
(PspC - 
Pneumococcal 
surface protein C) 
 
  
Binds secretory immunoglobulin 
 
Adhesion, virulence 
Adhesion to nasopharyngeal and 
lung epithelia 
Adhesion to brain microvascular 
endothelium 
Allow host cell invasion 
 
binds the secretory component of 
human secretory immunoglobulin 
A and human factor H 
enhances invasion of lungs in vivo 
involved in colonisation 
(Hammerschmidt et al., 
1997) 
(Rosenow et al., 1997) 
(Cundell and 
Tuomanen, 1994) 
(Ring et al., 1998; 
Rosenow et al., 1997) 
(Orihuela et al., 2004; 
Zhang et al., 2000) 
 
(Dave et al., 2004; Quin 
et al., 2005) 
(Quin et al., 2007) 
(LeMessurier et al., 
2006) 
CbpD – Choline 
binding protein 
D, CbpE (Pce - 
Phosphorylcholine 
esterase), CbpG 
CbpD and CbpE involved in 
colonisation, adherence 
CbpG is a protease and required 
for sepsis 
(Gosink et al., 2000) 
 
(Mann et al., 2006) 
ClpC 
(Caseinolytic 
protease C) 
Autolysis in some strains, pneumo 
growth in the lungs and 
bloodstream 
(Ibrahim et al., 2005) 
ClpP (Caseinolytic 
protease P) 
Thermotolerance, resistance to 
oxidative stress and virulence 
(Ibrahim et al., 2005) 
Cps (Capsule) Pivotal in allowing pneumococcus 
to cause disease 
Expression variable at different 
stages of disease 
Allows pneumococcus to be 
resistant to complement mediated 
opsonophagocytosis and allows 
systemic dissemination 
(Austrian, 1981) 
 
(Hammerschmidt et al., 
2005) 
 
(Winkelstein, 1984) 
Hyl 
(Hyaluronidase) 
Contributes to the effects seen 
with pneumolysin including 
damage to the respiratory 
epithelium 
Involvement in colonisation, tissue 
migration, produced by 90% 
isolates 
(Feldman et al., 2007; 
Paton et al., 1993) 
 
(Feldman et al., 2007; 
Paton et al., 1993) 
IgA  Cleaves human immunoglobulin A1 
(IgA1) 
(Bender and Weiser, 
2006) 
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LytA – Autolysin A Autolysin degrades the 
pneumococcal cell wall, resulting 
in lysis and release of intracellular 
and cell wall molecules 
Role in pneumonia and 
septicaemia 
Role in meninigitis 
 
(Lopez et al., 1997) 
 
(Berry and Paton, 2000) 
(Hirst et al., 2008) 
Lyt b – Autolysin 
b, Lytc- Autolysin 
c  
Reduced colonisation in their 
absence 
(Gosink et al., 2000) 
NanA – 
Neuraminidase A 
Cleaves N-acetyl neuramic acid 
and breaks down mucin from 
mammalian cells allowing 
exposure of pneumococci to 
mammalian receptors 
Colonisation and persistence of 
the nasopharynx and middle ear 
Involved in the spread of 
pneumococci from the 
nasopharynx to the lung 
(Tong et al., 2000) 
 
 
 
(Tong et al., 2000) 
 
(Orihuela et al., 2003) 
Ply – Pneumolysin Allows host invasion and spread of 
disease, required for survival and 
replication in the lungs 
Interferes with phagocyte function 
Slows ciliary beating and disrupts 
integrity of human respiratory 
epithelium 
Meningitis 
(Orihuela et al., 2004) 
 
(Houldsworth et al., 
1994) 
(Feldman et al., 1990) 
 
(Hirst et al., 2008) 
PotD – Polyamine 
transport protein 
D 
Polyamine transport protein D  
Recombinant PotD protects mice 
against systemic pneumococcal 
infections 
[Ware D 2006] 
[Shah p 2006] 
PsaA - 
Pneumococcal 
surface adhesin A 
Manganese ABC transporter 
required for competence and 
virulence  
Allows binding to host cells to 
protect pneumococci from 
oxidative damage 
Allows increased internalization of 
nasopharyngeal cells 
(Dintilhac et al., 1997) 
 
(Tseng et al., 2002) 
 
(Rajam et al., 2008) 
PspA – 
Pneumococcal 
surface protein A 
Cell surface, highly variable, in 
most strains,  
Role in complement receptor-
mediated clearance of 
pneumococci  
Prevents complement mediated 
(Briles et al., 1988; 
Crain et al., 1990) 
(Ren et al., 2004) 
 
(Tu et al., 1999) 
Chapter 1  Introduction 
19 
opsonization 
Binds to, and prevents killing by 
lactoferrin 
(Hammerschmidt et al., 
1999; Shaper et al., 
2004) 
RlrA, RgrA, RgrB Pilus involved in adhesion and 
invasion of host cells 
(Barocchi et al., 2006; 
LeMieux et al., 2006) 
SpxB 
(Streptococcal 
pyruvate oxidase 
B) 
Allows production of H2O2 which 
kills other bacteria in the upper 
respiratory tract 
Role in resistance to H2O2 
Involved in colonisation 
(Pericone et al., 2000) 
 
(Pericone et al., 2003) 
(Regev-Yochay et al., 
2007) 
ZmpB (Zinc 
metalloprotease 
B) 
Induces inflammation in the 
respiratory tract 
(Blue et al., 2003) 
 
1.2.1 The pneumococcal capsule 
The capsule of the pneumococcus is widely to be considered one of the most 
important factors in the ability of the pneumococcus to cause disease (Austrian, 
1981; Henrichsen, 1995). Two key supporting arguments are that unencapsulated 
pneumococci are rarely isolated from patients, and that unencapsulated strains 
of pneumococci are unable to cause disease in animal models (Morona et al., 
1999).  
The capsule is important in dissemination of the bacteria in the host, 
presumably mainly because it confers resistance on the bacterium to host 
complement mediated opsonophagocytosis (Winkelstein, 1984). Despite the fact 
that the ability of the pneumococcus is key in the ability of the organism to 
colonise and cause disease, high levels of capsule expression are not always 
desirable. It has been shown, for instance, that although capsular expression 
gives a considerable advantage in colonisation, less is required here than that 
required in invasive disease (Kim and Weiser, 1998; Magee and Yother, 2001; 
Ring et al., 1998; Weiser et al., 1994). So the capsule needs to be upregulated in 
instances where systemic dissemination is required, and down-regulated in the 
more intimate contact of the bacterium with host cells (Hammerschmidt et al., 
2005; Overweg et al., 2000). This is also true for other organisms including 
H.influenze (Weiser, 1993) and N.meningitidis (Hammerschmidt et al., 1996).  
Chapter 1  Introduction 
20 
As previously mentioned, there are over 90 different variants of capsular 
serotype, i.e. antibodies raised against one of these 90 will not cross react with 
any of the other 90 types. This variation is likely to have arisen from intense 
immune pressure from the host (Bentley et al., 2006) – in cases of systemic 
dissemination of the bacteria, the capsule may be one of the only virulence 
factors of the bacterium that is exposed to the host immune system, and as a 
highly immunogenic material it attracts a large immune response. Different 
serotypes, perhaps unsurprisingly, differ in their resistance to phagocytosis 
(Guckian et al., 1980). 
The rationale for capsular variation is clear. The mechanism by which this occurs 
has also been carefully studied. The majority of pneumococcal capsules are 
synthesised by a locus, cps, which lies between conserved genes dexB and aliA in 
the chromosome of pneumococcal strains (Garcia et al., 2000; Kolkman et al., 
1998). Serotypes 3 and 37 are the exceptions to this rule, their capsule types are 
synthesised by the synthase pathway (Arrecubieta et al., 1994; Cartee et al., 
2001; Dillard et al., 1995; Llull et al., 1999). Nonetheless, it is easy to imagine 
how both new capsule types are derived, since the recombination can occur 
between genes in the cps (Coffey et al., 1998; Waite et al., 2001; Waite et al., 
2003), but also how capsular switching – the ability of a strain to acquire an 
entirely different capsule type can occur (Brueggemann et al., 2007; Coffey et 
al., 1991). Capsular switching has already been observed in the post-vaccine era. 
The most common pneumococcal vaccine contains 7 capsular types conjugated 
to a protein. These 7 capsular types were the most common disease causing 
serotypes in the United States. It has now been observed that an ST type 
commonly associated with serotype 4 capsule has now been isolated from cases 
of invasive disease with a serotype 19A capsule, which is not included in the 
vaccine. Therefore, presumably this strain has maintained the genetic features 
allowing it to cause disease as a serotype 4 strain, but escapes the immunity 
afforded to the host by vaccination since it now has a 19A capsule. Presumably, 
capsule switching will increase over time and the effectiveness of the current 
vaccination will be diminished (Brueggemann et al., 2007). 
Capsule is important in determining the ability of an isolate to cause disease, 
however ST is also important (Brueggemann et al., 2003) as are other genetic 
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factors that have not yet been utilised in a classification system (Mizrachi 
Nebenzahl et al., 2004; Sandgren et al., 2004; Sandgren et al., 2005). 
1.2.2 Virulence factors on the cell surface of S.pneumoniae 
Many pneumococcal virulence factors are located on the cell surface. Their roles 
may be largely defined by capsule expression. When the capsule is upregulated, 
cell surface proteins may be ‘masked’ and may not carry out their function to 
the same extent as when the capsule is down-regulated (Hammerschmidt et al., 
2005). There is evidence that the capsule is up and down regulated at different 
stages of disease and in different disease types.  
PspA, a choline binding protein, for example, has been shown to be responsible 
for adhesion to nasopharyngeal epithelia, lung epithelia and brain microvascular 
endothelium (Cundell and Tuomanen, 1994; Ring et al., 1998; Rosenow et al., 
1997), and therefore allows the bacteria to invade host cells (Orihuela et al., 
2004a; Orihuela et al., 2004b; Zhang et al., 2000). This also correlates with 
where capsular expression is downregulated.  
There are other choline binding proteins which are cell surface exposed and 
have been shown to be required in virulence. Additional important cell surface 
proteins include PspA and the pneumococcal pilus (see Table 1). 
1.2.3 Other major virulence factors of S.pneumoniae 
Autolysin, encoded by LytA, has been shown to have a major role in the 
virulence of the pneumococcus, in pneumonia, septicaemia and meningitis 
(Berry and Paton, 2000; Hirst et al., 2008). It is responsible for the controlled 
lysis of the pneumococcal cell (Lopez et al., 1997), and has implications in the 
larger evolution of the bacterium. However, it is also upon the lysis of the cell 
that S.pneumoniae is able to release virulence factors that are intracellular 
throughout the duration of the cell’s viability. The best example of this is 
pneumolysin. Pnuemolysin is a pore-forming cytotoxin that is extremely 
important in the pathogenesis of all diseases caused by the pneumococcus 
(Feldman et al., 1990).  
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1.3 Pathogenesis of S.pneumoniae induced disease 
Large studies of serotype prevalence in invasive disease across Europe and the 
United states have revealed that most, if not all, serotypes are capable of 
causing disease (Nielsen and Henrichsen, 1992; Scott et al., 1996; Verhaegen et 
al., 1995), however, 85% of all invasive pneumococcal disease is caused by only 
20 serotypes (Kalin, 1998) and more recent studies have suggested that invasive 
disease is caused by only some types of S.pnuemoniae (Sandgren et al., 2004). 
Host factors clearly play a role in the succeptibility of the host, for instance in 
Alaskan and Australian natives, the incidence of invasive pneumococcal disease 
is 10–50 times higher than other populations (Cortese et al., 1992). 
S.pneumoniae is usually found as a commensal organism in the human host. It 
resides in the nasopharynx of healthy individuals, and will likely never cause 
disease. Biofilms are one way in which the bacterium resides in the human host, 
and this is discussed further in section 1.5. However, where disease does occur, 
the first step in the pathogenesis of disease is the dissemination of the organism 
from the nasopharynx to other parts of the host. The organism must cross tissue 
barriers and be able to adapt to different niches within the host. This, 
predictably is a complex process, involving many of the virulence factors 
discussed above, and the organism must be able to maintain tight control of 
these to be successful (Finlay and Falkow, 1989). See figure 1.1 for a schematic 
overview of the pathogenic routes by which S.pneumoniae causes infection. 
1.3.1 Carriage 
Nasopharyngeal carriage of S.pneumoniae is most common in young children. 
Adults can also carry the bacteria, and although the incidence decreases with 
age, there are many factors which increase the likelihood of a person being a 
carrier. Children can act as reservoirs of the bacterium, and it has been noted 
that the carriage rate of the pneumococcus is 6% in adults without children, but 
29% in those with children. Carriage of a strain usually lasts 3–4 months, but can 
last as long as 17 months (Gray et al., 1982). 
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Figure 1.1 – The pathogenic routes for pneumococcal infection 
 
 
 
 
 
Diagram illustrating the pathogenic routes for pneumococal infection. Organs 
infected through the airborne and haematogenic routes are depicted in blue and 
red, respectively. Figure from Boegart et al 2004a 
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Multiple serotypes of S.pneumoniae can be carried in the nasopharynx of healthy 
children and adults. The nasopharynx contains many bacterial species, including 
Haempophilus influenzae, Moraxella cattarrhalis, Neisseria meningitidis, 
Staphylococcus aureus and multiple streptococcal species (Bogaert et al., 
2004a), however the production of H2O2 by S.pneumoniae may confer a selective 
advantage on the organism, given that H2O2 can eliminate other bacteria 
(Pericone et al., 2000) and S.pneumoniae is elicited protection from H2O2 by the 
gene product responsible for its production, SpxB (Pericone et al., 2003). 
Nonetheless, it is of benefit to the pneumococcus to occupy this niche with 
other organisms, as a highly transformable bacterium it is within the 
nasopharynx that the organism acquires genes from other species, including 
penicillin resistance genes acquired from S.mitis (Dowson et al., 1994). The 
pneumococcus is able to acquire genes from other species due to the fact that it 
is naturally competent, and can uptake DNA from closely related organisms. This 
is explained further in section 1.4. Pneumococci in carriage do not necessarily 
cause disease, and it is believed that it is the introduction of a new serotype 
that often causes disease (Boulnois, 1992; Hardy et al., 2001). Carriage is clearly 
a desirable state for the bacterium, especially considering the ease of 
dissemination from this location between human hosts. The most common 
serotypes isolated from carriage are 6A, 6B, 9V, 14, 18C, 19F and 23F (Bogaert 
et al., 2004b) which are also those serotypes most commonly associated with 
invasive disease. However, S3 ST180, 6B, 19F and 23F are the isolates most 
strongly associated with carriage (Brueggemann et al., 2003). This, together 
with the observation that disease most likely occurs in the host by a serotype 
they were already colonised with (Lloyd-Evans et al., 1996) strongly suggests 
that carriage is the first step in the ability of the pneumococcus to cause 
invasive disease.  
1.3.2 Pneumonia 
Pneumonia is the infection of the lungs by bacteria. Following this, fluid 
accumulates in the lungs which prevents oxygen from easily transfusing to the 
bloodstream through the alveoli. There are 500,000 cases each year in the 
United States, with 50,000 resulting in deaths  (Bogaert et al., 2004a). In other 
developing countries the mortality rate has similarly been found to be 10-20%, 
seen particularly in infants, the elderly and immuno-comprimised patients 
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(Amdahl et al., 1995; Johnston, 1991). The serotype of a strain is likely to 
determine whether it can cause pneumonia in a particular host (Sjostrom et al., 
2006).  
Hava and Camilli identified in a STM screen that 1265 genes were involved in the 
ability of the pneumococcal strain TIGR4 to cause pneumonia (Hava and Camilli, 
2002). Interestingly, STM screens of other pneumococcal strains do not overlap, 
which suggests that different genes are required by different strains to cause 
pneumonia. Other studies have identified LytA (Orihuela et al., 2004a) CbpA 
(Rosenow et al., 1997; Zhang et al., 2000), NanA (Orihuela et al., 2003), ply 
(Feldman et al., 1990; Orihuela et al., 2004b) and the competence system 
(Oggioni et al., 2006) as contributing to the virulence of S.pneumoniae in 
pneumonia. 
1.3.3 Meningitis 
Meningitis is caused by the infection of the brain and spinal chord by a viral or 
bacterial pathogen. This infection causes fluid filled membranes to form around 
the brain and spinal chord. The mortality associated with this disease is high, 
and those that survive often present with learning disabilities and more extreme 
mental retardation, focal difficulties and hearing loss (Bohr et al., 1985). 
S.pneumoniae is now the leading cause of meningitis following the introduction 
of H.influenze type Ib conjugate vaccine (Bogaert et al., 2004a), and is 
responsible for up to 75% if all cases in the developing world 
(http://www.who.int/immunization_delivery/new_vaccines/pneumo/en/). 
Bacterial meningitis occurs following the translocation of bacteria across the 
blood-brain barrier (Ring et al., 1998). Once the bacteria have entered the 
cerebral-spinal fluid, it is thought to be the huge immune response by the host, 
particularly leukocyte recruitment, that causes the hallmarks of the disease 
(Hirst et al., 2004).  
The capsule of the pnuemococcus is thought to contribute to the massive 
immune response by the host to the invading bacteria (Engelhard et al., 1997), 
and the ability of a particular strain to cause meningitis can be attributed to 
their capsular type (Ribes et al., 2008). It is likely that known proinflammatory 
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cell wall components such as lipoteichoic and teichoic acids also contribute to 
this immune response (Schneider et al., 1999; Tuomanen et al., 1985). NanC has 
also been implicated in pneumococcal meningitis by the observation that it is 
found to be in strains recovered from the cerebral-spinal fluid significantly more 
than those isolated from carriage (Pettigrew et al., 2006). Pneumolysin has also 
been shown to have a role in meningitis (Hirst et al., 2008). 
1.3.4 Septicaemia 
Septicaemia is the infection of the blood stream by bacteria. Pneumococcal 
septicaemia can follow infection of another site of the body, e.g. pneumonia. 
When the bacteria disseminate into the blood stream, the chances of survival of 
the host diminish rapidly. 
One study identified that in 185 consecutive cases of invasive disease caused by 
S.pneumoniae in children, bacteraemia was present in 50% of cases, whilst 27% 
had pneumonia and 16% had meningitis (Myers and Gervaix, 2007). 
The capsule is greatly associated with ability of the pneumococcus to cause 
septicaemia, particularly since it confers resistance upon the bacterium to 
complement mediated opsonophagocytosis, which greatly aids in systemic 
dissemination (Winkelstein, 1984). PotD is a cell surface protein that has been 
shown to contribute to pneumococal septicaemia in a murine model of infection 
(Ware et al., 2006). In addition, mice immunised with PotD have a lower 
mortality mice than untreated mice (Shah and Swiatlo, 2006). A signature tagged 
mutagenesis screen carried out on S.pneumoniae identified the following 
virulence factors as contributing significantly to the ability of the organism to 
cause septicaemia: yha (hydrolysis of hylauronic acid), nanA, phoD (phosphate 
assimilation), msmK (sugar transport), mesD (unknown function) (Polissi et al., 
1998). LytA, ply, PspA and CbpG have also been shown to have a role in 
septicaemia (Berry and Paton, 2000; Mann et al., 2006; Oggioni et al., 2006). 
1.3.5 Otitis media 
Otitis media is a middle ear infection, which is in up to 50% cases caused by 
S.pneumoniae, by the passage of this organism to the Eustachian tube from the 
nasopharynx, where it resides in colonisation (Prellner et al., 1999). Otitis media 
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is usually diagnosed in children, and has a burden of disease of 7 million in the 
US each year 
(http://www.who.int/immunization_delivery/new_vaccines/pneumo/en/). 
Serotypes 3, 19 and 23 have been associated with otitis media in some studies 
(Hausdorff et al., 2000), however other studies have failed to associate 
particular pneumococcal serotypes or STs with otitis media (Hanage et al., 
2004). 
NanA, which encodes a neuraminidase, has been shown to contribute to the 
ability of the pneumococcus to cause otitis media (Tong et al., 2000). A recent 
signature-tagged mutagenesis screen also identified 169 genes of S.pnuemoniae 
that allow the bacterium to cause otitis media. Interestingly, a good proportion 
of these were found not to be required for nasopharyngeal colonisation, and had 
also not been identified in previous STM screens in pneumonia and bacteraemia 
models (Chen et al., 2007; Hava and Camilli, 2002; Lau et al., 2001; Polissi et 
al., 1998). 
1.4 Recombination in S.pneumoniae 
The variation seen in the genome of different isolates of S.pneumoniae is 
thought to arise largely from horizontal gene transfer, i.e. the transfer of 
genetic material from one cell to another. S.pneumoniae will usually reside in 
the nasopharynx of humans, along with other species of bacteria including 
H.influenze, M.cattarrhalis, N.meningitidis, S.aureus, S.mitis, S.oralis, and 
other streptococcal species. It is thought that much genetic exchange between 
the different species occurs here. An example of this is the acquisition of 
penicillin binding resistance, which confer resistance to penicillin on the host 
strain, thought to have been acquired by pneumococcal species from S.mitis 
(Dowson et al., 1993).  
S.pneumoniae is a naturally competent species, and so can take up DNA 
relatively easily. Incoming DNA is then incorporated into the genome of 
S.pneumoniae by the process of homologous recombination. This occurs when 
the incoming DNA bears similarity to DNA in the chromosome of the recipient 
strain. Two regions of the incoming DNA anneal to the recipient DNA and the 
genetic content between the two regions of the annealing DNA effectively flips. 
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S.pneumoniae sharing a niche with organisms that are similar genetically is 
clearly advantageous in the acquisition of new genetic material therefore, since 
it is more likely that incoming DNA will bear similarity to areas of the 
pneumococcal chromosome, and therefore it is more likely that recombination 
will occur. The ability of several different serotypes of S.pneumoniae to colonise 
the same host also allows intra-species genetic exchange which has allowed 
capsule switching. Capsule switching is a major advantage to the organism, given 
that current vaccine formulations target the capsule, and do not include all 
pneumococcal capsule types. 
The success of S.pneumoniae in changing to avoid host elimination by the 
immune system or elimination by antibiotics resides in its ability to acquire 
external DNA. Previously, it had been assumed that incoming DNA into 
pneumococcal cells was liberated from other cells by the lysis of other bacterial 
cells in its vicinity, however it has recently been shown that lysis is not required 
for the liberation of DNA from other species (Johnsborg et al., 2008).  
In 1995, Havarstein and colleagues identified a short peptide, released by 
pneumococci, which dramatically increased their ability to integrate DNA into 
the chromosome (Havarstein et al., 1995). This peptide, named competence 
stimulating peptide (CSP), has radically changed pneumococcal molecular 
biology, as it can now be synthesised, and utilised to induce competence in 
laboratory strains of S.pneumoniae to induce defined genetic changes in the 
genome of a particular strain. This allows relatively easy production of mutant 
strains and isogenic variants. Other streptococcal species also produce CSPs, and 
there are several different types of CSP, that are not restricted by species. 
Strains are able to communicate with other strains with the same CSP type, and 
therefore genetic exchange between strains and species with the same CSP type 
avoids the requirement of lysis.  
CSP is only one of many gene products involved in transformation. CSP is 
secreted from the cell via ComAB (Hui and Morrison, 1991). This is regulated by 
a two-component signal transduction system of ComD and ComE (Pestova et al., 
1996). The concentration of CSP external to the cell is detected by ComD, which 
is a membrane-bound receptor of CSP (Havarstein et al., 1996). Competence 
induction is reliant on sufficient saturation of ComD. It is assumed, although it 
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has not been shown, that the competence signal transduction system functions 
in the same way as other signal transduction systems, and therefore that CSP 
binding to ComD autophosphorylates ComD which in turn phosphorylates ComE. 
Phosphorylated ComE is then able to activate the transcription of many genes, 
including alternative sigma factor ComX (Claverys and Havarstein, 2002; Lee and 
Morrison, 1999). ComX then regulates the expression of the machinery required 
for the uptake and integration of DNA by the pneumococcus. A limited number 
of these genes have been shown to be essential for recombination to occur 
(Dagkessamanskaia et al., 2004; Peterson et al., 2004). Some other genes under 
the control of ComX have been shown to be involved in a process where 
pneumococci are able to induce lysis in non-competent cells (Claverys and 
Havarstein, 2007; Guiral et al., 2005; Moscoso and Claverys, 2004; Steinmoen et 
al., 2002; Steinmoen et al., 2003). LytA, LytC and CbpD have been implicated in 
the ability of competent cells to lyse their non-competent counterparts (Guiral 
et al., 2005; Kausmally et al., 2005; Steinmoen et al., 2002). Cells can be 
afforded protection against lysis by their competent counterparts by ComM and 
other immunity proteins (Havarstein et al., 2006). The ability of a cell to 
become competent has been shown to be under the same control as the ability 
of a cell to induce lysis to facilitate DNA release in another cell. It is therefore 
postulated that the systems evolved together to increase the ability of a cell to 
acquire exogenous DNA from bacteria of the same and closely related species 
(Claverys and Havarstein, 2007; Johnsborg et al., 2007; Johnsborg et al., 2008).  
1.5 Biofilm formation 
Microbiology, understandably given the huge diversity of species and the massive 
intra-species variation, has historically commonly involved the study of a single 
species, or strain of a species. However, this is thought to give us a distorted 
picture of the contribution of a strain’s own genetic background in its ability to 
successfully survive and proliferate, given that there is increasing evidence that 
a particular strain will rarely occupy a niche alone (Donlan and Costerton, 2002). 
A similar paradigm in human models of infection is that while the study of in 
vitro tissue culture models is informative, it cannot be entirely representative 
since the human host is a multi-tissue type, multi-organ system and therefore 
one cell type cannot be representative of the activity that could occur at that 
site in a ‘real’ situation. 
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Biofilms exist in many niches in the human host, and can confer an advantage to 
the host, as in the case of biofilm formation of the human intestine and female 
GU tract (Habash and Reid, 1999). However, it has been suggested that biofilms 
are involved in 60% of all human infection (Parsek and Singh, 2003) and are 
responsible for many chronic and persistent infections (Habash and Reid, 1999). 
Indeed biofilms have been shown to be associated with with dental caries, 
periodontitis, otitis media, musculoskeletal infections, cystic fibrosis 
pneumoniae, native valve endocarditis and bacterial prostatitis (Froeliger and 
Fives-Taylor, 2001). Furthermore, biofilm formation has been shown to actually 
be required for dental caries, periodontal disease and infective endocarditis to 
occur (Donlan and Costerton, 2002; Kolenbrander, 2000). It is not just human 
tissue that bacteria can form biofilms on during the pathogenesis of disease. 
Bacteria can form biofilms on any surface that contains naturally occurring 
materials. This includes medical devices implanted into the human body (Habash 
and Reid, 1999). When bacteria infect these devices they are well placed to 
replicate within the human host, and can disseminate from here to cause 
systemic disease.  
Biofilms can be comprised of one species, however, many biofilms require the 
presence of multiple species if they are to cause disease in the human host. A 
good example of this is the formation of dental plaque. The first step in the 
formation of dental plaque is the adhesion of ‘pioneer’ species of bacteria, for 
example S.gordonii, to the tooth (Gibbons and Houte, 1975; Kuboniwa et al., 
2006; Rosan and Lamont, 2000). Other bacterial species will then adhere to this 
biofilm, and later species can actually facilitate a disease causing process that 
earlier pioneer species were unable to facilitate. 
Biofilm formation confers several advantages to the bacteria involved in their 
formation. It has been noted the growth of bacteria in a biofilm is not identical 
to that of their planktonic counterparts (Donlan and Costerton, 2002; Oggioni et 
al., 2006; Stickler, 1999). Biofilms allow a secure and stable environment for 
cells involved, and can act as a pool of the bacteria for dissemination when 
appropriate circumstances arise (Hall-Stoodley and Stoodley, 2005). In biofilms, 
it is likely that bacteria are exposed to sub-lethal doses of antibiotics and the 
host immune devices, since the polysaccharide matrix is difficult to permeate 
(Stoodley et al 2004). In addition, some strains in biofilms are able to exist in a 
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sessile state, where they are not proliferating. Since many antibiotics target 
machinery involved in the replication of bacterial cells, sessile strains are 
afforded protection to these antibiotics when involved in biofilms. Due to this, a 
greater understanding of biofilm formation and ways to target it specifically and 
separately from planktonic growth is required (Donlan and Costerton, 2002; 
Oggioni et al., 2006; Stickler, 1999). 
Transposon mutagenesis has been useful in identifying virulence factors that are 
involved in biofilm formation in a variety of bacterial species. These studies 
have been carried out on the following bacteria: E.coli (Aanensen et al., 2007), 
V.cholerae (Watnick and Kolter, 1999), S.gordonii (Loo et al., 2000) and 
P.aeruginosa (O'Toole, 2004). 
1.5.1 Pneumococcal biofilm formation 
1.5.1.1 Genes involved in pneumococcal biofilm formation 
Pneumococcal biofilm formation has also recently been studied. Genes 
particularly associated with biofilm formation in the pneumococcus as found by 
gene expression studies in biofilm models include metalloproteases, 
neuraminidases, oxidative stress and competence genes (Oggioni et al., 2006).  
This correlates with the in vitro study of mutants in specific genes in a biofilm 
model. Moscoso and colleagues demonstrated that LytA, LytB, LytC, CbpA, PcpA, 
and PspA all have a role in biofilm development (Moscoso et al., 2006). 
Allegrucci and colleagues also noted that gene expression is variable in biofilm 
models from liquid culture. Interestingly, they also noted the number of types of 
proteins expressed increases greatly in pneumococcal biofilms (Allegrucci et al., 
2006). The authors suggest therefore that the ability of the pneumococcus to 
form biofilms is important to the proliferation of the species. A greater diversity 
and general upregulation of the proteome has been noted in other species in a 
biofilm mode of growth  (Bjarnsholt et al., 2005; Donlan and Costerton, 2002; 
Hassett et al., 1999; Yoon et al., 2002).  
This general proteomic upregulation presumably requires tightly controlled 
regulation of gene expression in response to changes in the environment of the 
bacterium, however the genetic content of a strain will also presumably dictate 
Chapter 1  Introduction 
32 
its ability to switch into biofilm growth mode, and this may determine its ability 
to be virulent (O'Toole, 2004). 
1.5.1.2 The role of capsule in pneumococcal biofilm formation 
Capsule has been shown not to be required by S.aureus for in vitro biofilm 
formation (Toledo-Arana et al., 2005). It has also been shown in some strains of 
the pneumococcus that biofilm development is inhibited in the presence of 
capsule by more than 60% (Moscoso et al., 2006).However, where capsule is 
present, studies have demonstrated that gene expression doesn’t vary in a 
biofilm model of growth (Oggioni et al., 2006), and also that the expression of a 
protein involved in capsular synthesis is upregulated (Allegrucci et al., 2006). It 
is worth noting that whilst invasion of host cells is far more efficient in the 
absence of capsule production, the bacteria needs to maintain the ability to 
produce capsule if it is to be successful following invasion of host cells 
(Hammerschmidt et al., 2005; Weiser and Kapoor, 1999). Indeed, capsule 
regulation is key to colonisation by the pneumococcus also, however not at high 
levels (Magee and Yother, 2001).  
However, its has been identified that single colony variants lacking capsule do 
arise in pneumococcal biofilms (Allegrucci and Sauer, 2007). These colonies, 
presumably, given the requirement for capsule in later stages of disease, will 
remain in the biofilm and can successfully compete here. The conditions within a 
biofilm such as availability of oxygen, are associated with less capsule 
production (Weiser et al., 1994). Also, increased H2O2 production increases 
mutations arising within the pneumococcal genome (Pericone et al., 2000).  
1.5.1.3 Association of the biofilm mode of growth with the 
pathogenesis of pneumococcal diseases 
One study by Oggioni and colleagues noted that gene expression in liquid culture 
was highly similar to gene expression in bacteria infecting the blood stream, and 
that gene expression in a biofilm model was highly similar to gene expression in 
tissue models of infection (Oggioni et al., 2006). They also showed that strains 
grown in liquid culture were more able to cause infection of the blood stream, 
and strains grown in a biofilm model were more able to cause infection of the 
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tissue. They note that when considering the pathogenesis of these diseases, the 
mode of growth associated with them seems logical. This therefore suggests that 
strains causing pneumonia and meningitis require the ability to form biofilms. 
1.6 Glycosylation 
Glycosylation is the process by which proteins are modified and greatly 
diversified by carbohydrate groups. In eukaryotes, where glycosylation has been 
more extensively studied, it has been shown to be involved in the molecule 
recognition – either between cells or between molecules of the same cell, 
changing the properties of a cell to suit its environment - such as solubility, 
viscosity and surface charge and control of proteolysis. 
In eukaryotes, there are five different types of linkages between carbohydrate 
groups and peptides: N-glycosides, O-glycosides, phosphorus-linked glycosides, S-
glycosides and C-glycosides. 
Two of these types of glycosylation have been observed in prokaryotes: (i) N-
linked: Glycans are attatched to the amide nitrogen of an Asn residue in a Asn-X-
Ser/Thr consensus sequence. (ii) O-linked: Glycans are attatched to the 
functional hydroxyl group of Ser/Thr residues.  
1.6.1 Bacterial glycosylation 
Prokaryotic glycosylation was believed not to occur until studies confirmed the 
existence of glycoproteins in the S-layer of halobacteria (Mescher and 
Strominger, 1976). However, the organisms containing the only known 
prokaryotic glycoproteins were of little medical importance, and prokaryotic 
glycobiology remained obscure until the discovery and characterisation of a 
glycoenzyme in pathogenic bacterium Streptococcus faecium that contributed to 
its virulence (Kawamura and Shockman, 1983). Since then, various prokaryotic 
glycoproteins have been studied, many of which have been implicated in the 
virulence of important pathogens.  
Due to the limited study of prokaryotic glycoproteins, much of what is known 
about eukaryotic glycoproteins has been extrapolated in theories relating to the 
function of the former, however, although bacteria carry out the 
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aforementioned types of glycosylation, they do so in a much altered way and 
thus this practice is fast diminishing. This has led to the discovery of many types 
of glycosylation that are unique to the prokaryotic kingdom (Inga Benz, 2002; 
Messner, 2004; Raj K. Upreti, 2003; Szymanski and Wren, 2005). Prokaryotic 
glycoproteins can be classified according to their cellular location (Raj K. Upreti, 
2003)  and examples are given to illustrate the role of glycosylation in each of 
the following sections. 
1.6.1.1 S-layer glycoproteins 
Surface layer glycoproteins are found present on the outer layer of the cell. In 
archea, most S-layer proteins are glycosylated, and this aids the organisms in 
surviving extreme environments (Schaffer et al., 2001). 
1.6.1.2 Membrane associated glycoproteins 
Chlamydia trachomatis, which causes blindness and sexually-transmitted 
diseases, expresses an abundant membrane protein which when unglycosylated 
prevents the bacteria being able to cause disease (Kuo et al., 1996). 
1.6.1.3 Cell-surface glycoproteins  
Some Campylobacter jejeuni and Campylobacter coli strains have been found to 
have glycosylated flagella, which are essential virulence factors to both species 
(Szymanski et al., 2003; Young et al., 2002). Flagella are proteinacious elements 
that extend beyond the surface of the cell, comprised of multiple subunits. They 
allow the motility of organisms within the host. Their glycosylation may aid 
immune evasion, or may endow the flagellum with a more suitable charge for 
the host environment.  
1.6.1.4 Secreted glycoproteins and exo-enzymes 
In Mycobacterium tuberculosis three secreted proteins that are glycosylated 
have been shown to illicit an impaired immune response when deglycosylated 
(Horn et al., 1999). In the absence of glycosylation, the ability of M.tuberculosis 
to stimulate T-lymphocyte production of the host is severely limited, and this is 
thought to be due to glycosylation interfering with recognition of glycosylated 
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peptides by the MHC recognition molecules which are recognised by T-
lymphocytes (Romain et al., 1999). 
1.6.1.5 Cellular glycoproteins  
Bacillus thuringiensis produces sporangia whose glycosylation protects them 
from degradation by proteases through the inability of the protease to interact 
fully with its target (Garcia-Patrone and Tandecarz, 1995). Two glycoproteins 
(205 and 72 kDa) were found in Bacillus thuringiensis sporangia.  
1.7 Bacterial secretion pathways 
Secretion is clearly a vital part of the pathogenesis of any disease causing 
organism. The majority of bacterial factors that are important in causing disease 
are either secreted or located on the cell surface, which is logical given that the 
host cell is external to the bacterial cell. The systems bacteria utilise to export 
factors required for their virulence, are themselves thererfore, unsurprisingly, 
required for the virulence of any organism (Finlay and Falkow, 1989).  
Much of the research into secretion systems in bacteria has taken place in 
Escherichia coli, but these findings are believed to be relevant to all bacteria 
due to the proteins involved being well conserved throughout the kingdom.  In a 
bacterial cell, all proteins are synthesised in the cytoplasm, however some are 
also needed in other parts of the cell, and often these proteins are important in 
virulence. They are therefore made in a precursor form containing a signal that 
directs the protein to its required location in the cell through interactions with a 
number of secretion proteins. This sequence is the protein to be exported varies 
dependent on the proteins required to secrete it. This sequence is then cleaved 
off to give a mature form of the protein (von Heijne et al., 1991).  
1.7.1 The Sec pathway 
The Sec-dependent protein export pathway is conserved throughout bacteria and 
it is responsible for translocating precursor proteins containing classical amino-
terminal signal sequences across the cytoplasmic membrane (Danese and 
Silhavy, 1998) 
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Pathogenic and non-pathogenic bacteria utilize this pathway to localize proteins 
to the cell surface or as the first step in secreting proteins out of the cell. Many 
bacterial pathogens also possess specialized protein export systems dedicated to 
the secretion of virulence factors (Hoskins et al., 2001).  
A protein involved in secretion in E.coli, SecB (Secretion protein B), was 
discovered by fusion of specific signal sequences with reporter genes (Kumamoto 
and Beckwith, 1985). Its function was deduced to be the most common 
chaperone of periplasmic and outer membrane proteins to the inner membrane 
to prepare for their export, since mutational studies of certain fusion proteins 
suggested that SecB interacts with their immature forms, and in its absence they 
quickly adopt their mature form (Collier et al., 1990). It is believed to 
chaperone them to the inner membrane because it can interact with the C-
terminal of another secretion protein, SecA (Secretion protein A), when SecA is 
found on the inner membrane (Bayer, 1994). Sec A is a homodimer, found in the 
cytoplasm and inner membrane, and each subunit contains a low and a high 
affinity ATP binding. In the cytoplasm, SecA functions as its own transcriptional 
regulator (Schmidt and Oliver, 1989) and also as a minor chaperone of proteins 
for export to the inner membrane (Fekkes et al., 1997). In the inner membrane, 
SecA binds to a complex of other secretory proteins, Sec E, G and Y (Secretion 
proteins E, G and Y) (Eichler et al., 1997). Upon binding of ATP to the high-
affinty site on SecA, both SecA and the molecule it is chaperoning, the protein 
for export, are taken up into the membrane due to a conformational change in 
SecA and they are protected from the hydrophobic environment a complex of 
Sec E, G and Y. However, the signal sequence of the protein for export remains 
in the cytoplasm where it is cleaved off. When the ATP is hydrolysed, SecA is 
released from the membrane, leaving the protein for export behind. The more 
ATP available for the translocation, the further the protein for export is 
translocated by SecA (Danese and Silhavy, 1998). SecE and Y have been shown to 
be essential for secretion, and the absence of SecG has been shown to 
significantly reduce secretion levels of secreted proteins (Ito et al., 1983; 
Nishiyama et al., 1994). SecY, the largest protein in the complex, requires the 
presence of SecE, in its absence, SecY is destroyed by a membrane protease 
(Kihara et al., 1995). Electron microscopy studies have identified a eukaryotic 
homologue of SecY that forms a hollow cylinder in the membrane, and thus this 
is postulated for SecY also (Hanein et al., 1996; Joly and Wickner, 1993). SecY 
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has also been shown to check the signal sequences of the proteins for export 
presented to the SecE/G/Y complex by SecA and reject proteins with incorrect 
sequences (Osborne and Silhavy, 1993). Three further proteins have been 
implicated in protein translocation across the inner membrane, SecD, F 
(Secretion protein D, F) and YajC (Preprotein translocase subunit). Although they 
have been shown to be non-essential, their presence does improve efficiency of 
the process, and it is speculated to stabilize the inner-membrane form of SecA 
(Danese and Silhavy, 1998) or be involved in clearing the secretion system 
channel (Veenendaal et al., 2004), or regulate SecA (Duong and Wickner, 1997). 
All of the secretory proteins above are required for efficient secretion of most of 
the proteins in the bacterial cell, however, recently it has emerged that several 
species of gram-positive bacteria contain additional homologues of some of the 
essential secretory proteins in their genome that are non-essential, but often 
required for virulence. See figure 1.2 for an overview of the Sec pathway. 
1.7.2 Alternative secretion pathways 
It has recently been found that some bacteria possess two copies of genes 
involved in the sec secretion system. It appears that there is a complete set of 
genes dedicated to the ordinary secretion of factors from the cytoplasm that is 
essential for the viability of the cell, and that the second, often incomplete set, 
is dedicated to the export of unusual proteins, usually required for the full 
virulence of the bacterium but not essential for survival. The most studied of 
alternative secretion systems contributing to the virulence of an organism are 
outlined below, however it is worth noting that in Corynebacterium glutamicum, 
which encodes two secA homologues, both have been found to be essential for 
the survival of the cell (Caspers and Freudl, 2008).  
There are two main types of alternative secretion systems that have been 
characterised in the prokaryotic kingdom thus far. Figure 1.3, from (Rigel and 
Braunstein, 2008) outlines the two most characterised types of alternative 
secretion. One contains a SecA2 homologue which is presumably capable of 
interacting with the main Sec pathway of the cell. This system has been shown 
of being capable of transporting a variety of products from the cell, it is 
chromosomally associated with one of these products. The other type of 
alternative secretion system has been shown to contain homologues of both SecA  
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Figure 1.2 – Protein translocation through the SecYEG complex 
 
 
 
 
Figure from (Robson and Collinson, 2006). Schematic overview of protein 
translocation and membrane protein insertion through the SecY complex in 
bacteria. Nascent chains having a signal sequence (red) emerge from the 
ribosomes (grey) and are localized to the SecY complex (green) co-
translationally by the signal recognition particle (SRP) and FtsY/SRP receptor 
(SR; left). Alternatively, they can be presented post-translationally through SecA 
or SecB (right). 
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Figure 1.3 – Models for SecA2 dependent transport 
 
 
 
 
 
Figure from (Rigel and Braunstein, 2008). A secA2 protein may be exported 
through either the canonical Sec system of the cell (right hand side), for 
example in M.tuberculosis. Alternatively, the genome may encode an entirely 
separate novel translocon (left hand side), for example in S.gordonii. 
this contributes to the bacterium being able to avoid elimination in the human  
Chapter 1  Introduction 
40 
and SecY (named SecA2 and SecY2, respectively), and is chromosomally 
associated with a variety of other alternative secretion genes. These systems 
have been found to be associated with large serine-rich repeat proteins and 
glycosyl-transferases. 
1.7.2.1 M.tuberculosis 
Mycobacterium tuberculosis causes tuberculosis. There were 9.2 million new 
incidences of tuberculosis in the world in 2006, and 1.7 million deaths from 
tuberculosis 
(http://www.who.int/tb/publications/global_report/2008/pdf/fullreport.pdf). 
The bacterium is able to survive and replicate within human macrophages, and 
host, even in the presence of antibiotics. The secretion of virulence and other 
factors is postulated to allow the survival of M.tuberculosis in the human 
macrophage, and as such, many studies have focussed on elucidating the 
essential secretion systems of the bacterium (Braunstein et al., 2003).  
M.tuberculosis has been found to contain a homologue of SecA in its genome, 
denoted SecA2. While its SecA is essential to the viability of the cell, SecA2 has 
been shown to be required for full virulence, probably due to its function as an 
exporter of superoxide dismutase A, used by M.tuberculosis to protect against 
attack from host macrophages (Braunstein et al., 2003). 
1.7.2.2 L.monocytogenes 
Listeria monocytogenes is a gram positive bacterium that is able to colonise a 
multitude of surfaces and survive in circumstances that many other non-spore 
forming organisms cannot. L.monocytogenes colonises the human host without 
causing disease, however it has also been shown to be involved in highly invasive 
disease, and is acquired through ingestion of contaminated food (Cossart, 1998). 
L.monocytogenes contains a homologue of SecA alongside its essential copy, 
again denoted SecA2, which has been implicated in virulence and the phenotypic 
variation of the bacteria. Mutants of SecA2 in L.monocytogenes are unable to 
secrete 17 proteins. Interestingly, only some of these proteins have been shown 
to have unusual signal sequences (Lenz and Portnoy, 2002).  
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1.7.2.3 S.gordonii 
S.gordonii contains homologues of SecA and SecY, and chromosomally associated 
with these genes are five additional genes, asp1-5 which have also been shown 
to be involved in secretion (Bensing and Sullam, 2002; Takamatsu et al., 2004, , 
2005b). All seven gene products have been shown to be exclusively involved in 
the export of GspB, a serine rich repeat protein that is involved in the adhesion 
of S.gordonii to platelets, an essential step in the ability of the organism to 
cause infective endocarditis. GspB and its associated pathway are further 
discussed in section 1.8.1. Other alternative secretion systems that are 
associated with the export of serine rich repeat (SRR) proteins are also discussed 
in section 1.8. 
1.8 Serine rich repeat proteins 
Various serine rich repeat (SRR) proteins that have been characterised in gram 
positive bacteria are detailed below. See Figure 1.4 for a diagram of the loci 
harbouring these SRRs.  
1.8.1 GspB 
Bensing and colleagues identified GspB, a SRR in Streptococcus gordonii in a 
study with the intent of identifying what allowed the organism to bind to 
platelets, which is thought to be an essential step in the ability of the organism 
to cause infective endocarditis (Bensing and Sullam, 2002). Infective 
endocarditis, which is the infection of the cardiac valves by bacteria, occurs 
when endocardial lesions occur in the human host. Under normal circumstances 
bacteria are unable to infect normal vascular endothelia (Alanee et al., 2007). 
Following  the appearance of lesions in the endocardium platelets accumulate at 
the site (Durack, 1975). S.gordonii is normally found in the mouth and is 
associated with dental plaque. However, the bacterium is also frequently 
isolated in cases of infective endocarditis. As a group, viridans streptococci are 
associated with 50% of all cases of infective endocarditis (Douglas et al., 1993) 
and S.gordonii is the streptoccal species isolated most frequently (Rosenow et 
al., 1997). The bacteria are believed to be able to bind to the platelets that 
have accumulated on the endocardial surface and form colonies there. When the  
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Figure 1.4 – Comparison of the ASL in different species of gram positive 
bacteria 
 
 
 
 
Figure from (Takamatsu et al., 2004a). ASLs in several species of gram positive 
bacteria are annotated. Purple indicates the SRR, blue indicates a glycosyl-
transferase, green are SecA2 and SecY2 homologues, orange indicate alternative 
secretion genes and yellow indicates essential glycosyl-transferases. 
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population reaches a critical mass, fibrin and platelets cover the colonies and as 
such a bacterial community is secured on the surface (Sullam et al., 1985). 
These infections are difficult to treat and the morbidity and mortality of the 
disease remains high in spite of treatment with antibiotics and surgery (Durack, 
1995). 
 Multiple proteins which mediate interactions between the human and bacterial 
cell have been identified in S.gordonii, however none had been implicated in 
platelet binding. Bensing and colleagues therefore sought to determine what 
allowed the organism to bind platelets by generating a library of mutants using 
an integrative vector (Bensing and Sullam, 2002) and assessing their ability to 
bind platelets. The mutant strain that was most severely attenuated in its ability 
to bind platelets was compared to the parent wild type strain and found to have 
an 8kb deletion, containing nine genes encoding glycosyl-transferases, 
homologues of SecA and SecY and several genes of unknown function. SecA and 
SecY have been shown to be involved in secretion out of the cell (Danese and 
Silhavy, 1998), and thus cell surface extracts of the mutant and wild type were 
compared and a protein far larger than the highest molecular weight marker of 
215 kDa was identified. A gene encoding 3072 amino acids giving a product of 
286 kDa was found to be present immediately upstream from the genes deleted 
in the mutant strain. Analysis of the sequence revealed it encoded a large serine 
rich repeat protein, and it was named GspB (Bensing and Sullam, 2002). 
GspB binds to sialic acid residues on the O-linked carbohydrates of a receptor on 
platelets, Ibα (Bensing et al., 2004). This binding is mediated by the central, 
basic region of GspB (Takamatsu et al., 2005a). GspB has also been shown to 
bind salivary mucin MG2 and salivary agglutinin (Takamatsu et al., 2006) 
Subsequent studies have been carried out to identify the functions of the genes 
adjacent to GspB (Gordonii surface protein B) in the chromosome. Asp1-5 
(alternative secretion proteins 1-5) were identified as required for the export of 
GspB, since strains deficient in these genes were unable to export GspB 
(Takamatsu et al., 2004, , 2005b). GtfA and GtfB mutants were found not to 
produce GspB at all, in these mutants GspB was transcribed but not expressed. 
Gly and nss were found to alter the lectin binding properties of GspB, but were 
not essential for the expression or secretion of GspB, cell surface levels of GspB 
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are only slightly diminished in the absence of either gly or nss. However the 
alteration in lectin binding does translate to a reduction in platelet binding 
ability by mutants in gly or nss (Takamatsu et al., 2004). 
1.8.2 Hsa (Human sialic acid binding protein) 
Hsa is a serine rich glycoprotein which has been idenitified in S.gordonii strain 
Challis (Kuo et al., 1996). It is able to recognise receptors on erythrocytes and 
polymorphonuclear leukocytes [Takahishi et al., 2004, 2006). Deletion of hsa 
reduces the ability of the bacteria to adhere to salivary agglutinin (Jakubovics et 
al., 2005) which is a highly glycosylated, cysteine-rich glycoprotein (Prakobphol 
et al., 2000). It has also been shown that Hsa binds salivary mucin MG2 and 
secretory immunoglobulin A (Takamatsu et al., 2006). 
1.8.3 Fap1 (Fimbral associated protein 1) 
S.parasanguinis colonise the oral cavity and are involved in the formation of 
dental plaque. Fimbriae have been shown to mediate the adhesion of 
S.parasnaguinis to teeth in a in vitro tooth model (Burnette-Curley et al., 1995; 
Quin et al., 2007). Fap1, a serine-rich glycoprotein, has been shown to be the 
major subunit of fimbriae (Quin et al., 2007). It is essential for fimbral formation 
and its deletion results in a reduced ability of S.parasanguinis to adhere to in 
vitro models (Quin et al., 2007). 
S.parasanguinis contains a locus that is dedicated to Fap1, which is fairly similar 
to that seen in S.gordonii, associated with GspB. The genes encoded here 
include alternative secretion genes, and glycosylation genes(Chen et al., 2004; 
Chen et al., 2006; Peng et al., 2008; Quin et al., 2007).  
1.8.4 SraP (Serine-rich adhesin for platelets) 
Staphylococcus aureus is able to cause infective endocarditis. Platelet binding, 
as in the case of S.gordonii, is assumed to be an important step in the 
pathogensis of the disease. S.aureus contains many factors which have been 
shown to allow it to bind to proteins on platelets. These are protein A (Chen et 
al., 2007; Nguyen et al., 2000), clumping factors A and B (Chen et al., 2007) and 
fibronectin-binding protein (Heilmann et al., 2004). Many of these are multi-
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functional and functionally redundant in the binding of human platelets (Siboo et 
al., 2005). 
SraP was originally identified in a study that characterized novel LPXTG proteins 
by analysing available genome sequences, and it was designated SasA (Roche et 
al., 2003). It is in the genomes of all S.aureus genomes published to date and is 
predicted to be 227 kDa without glycosylation. 
SraP and its associated genes vary from GspB and its associated genes in several 
important ways. Two genes that are required for optimal export of GspB in 
S.gordonii are absent in S.aureus (Siboo et al., 2005). These are gly and nss, 
which have been shown not to be essential for GspB expression, but the 
detectable levels of GspB on the cell surface of S.gordonii are reduced in their 
absence (Takamatsu et al., 2004). Asp4 and asp5 are also absent in S.aureus, 
suggesting a difference in the secretion of SraP compared to GspB (Siboo et al., 
2008). Indeed, disruption of SecA2 in S.aureus results in the near complete loss 
of SraP surface expression, but importantly does not completely abolish SraP 
export – the protein could no longer be detected by western blotting however it 
could be by a more sensitive technique of lectin blotting of the cell surface 
(Siboo et al., 2008). Examination of the sequence of SraP reveals some 
differences which may explain the slightly less stringent export requirements of 
the protein. The signal peptide of SraP is greatly altered from that of GspB, and 
also SraP only contains 2 glycine residues, which are in different positions from 
any of the 3 glycine residues in GspB that have been shown to be essential for its 
export by the alternative secretion system (Bensing et al., 2007). Interestingly, 
SraP has a pI that is acidic while GspB has a more basic pI. The combination of 
altered and possibly diminished glycosylation, absence of secretion machinery 
and changes in the SraP sequence by comparison to GspB suggest that the loci do 
not operate in an identical manner, and indeed SraP may, under certain 
circumstances, be suitable for export by the canonical Sec system of the cell 
(Siboo et al., 2008). The absence of genes encoding two glycosyl-transferases 
and two genes involved in alternative secretion could also suggest that the 
functions of products encoded by these genes are intertwined.  
The receptor for SraP has not been identified (Siboo et al., 2008). Deletion of 
SecA2 also resulted in less lipase and more amidase, but fluctuating transcripts 
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detected by microarray in the case of lipase suggest this is not due directly to 
the absence of SecA2 transport. There is no explanation for the additional 
amidase in the sample (Siboo et al., 2008).  
1.8.5 SrpA (Serine-rich protein A) 
S.cristatus is found in oral biofilms (Mouton et al., 1980). SrpA is a SRR in 
S.cristatus. SrpA disruption causes irregular fibrilar tuft morphology, and fibrilar 
tufts are required for interaction of S.cristatus with Corynebacterium 
matruchotii (Lancy et al., 1980) and Fusobacterium nucleatum (Lancy et al., 
1983) and human cells (Handley et al., 1991). SrpA disruption negates the ability 
of S.cristatus to interact with C.matruchotii and F.nucleatum (Handley et al., 
2005). This implies a role for SrpA in biofilm formation which is crucial in the 
formation of dental plaque. 
1.8.6 SrpA (Serine-rich protein A) 
Sanguis streptococci are primary colonizers of the tooth surface (Kolenbrander 
and London, 1993). They make up a major part of dental plaque and allow other 
plaque bacteria to adhere to them. These adhering bacteria cause caries and 
periodontal diseases (Gibbons and Houte, 1975). S.sanguinis is also able to cause 
infective endocarditis, the disease which GspB of S.gordonii is implicated as a 
major factor in. SrpA is a homologue of GspB and Plummer and colleagues have 
shown that SrpA mediates the adhesion of S.sanguinis to platelets by binding 
GPIb which presumably is also a primary step in the pathogenesis of the 
organism in causing infective endocarditis (Plummer et al., 2005). 
1.8.7 SP1772 
SP1772 was first identified when the genome of virulent isolate TIGR4 was 
sequenced (Tettelin et al., 2001). A signature tagged mutagenesis screen of 
TIGR4 identified SP1772 and 3 further genes in the locus SP1755-SP1773 as 
required for full virulence in a competitive model of lung infection (Hava and 
Camilli, 2002). Many studies have speculated as to the function of the SP1755-
SP1773 locus by comparison to work in other strains, discussed above (Bensing 
and Sullam, 2002; Quin et al., 2007). In addition, two comparative hybridisation 
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studies have identified this locus as a region of diversity of among pneumococcal 
strains (Obert et al., 2006; Silva et al., 2006). One of these studies found a 
correlation between the presence of this region of diversity and the propensity 
of a clone to cause invasive disease, and showed that SP1772 is required for full 
virulence in a pneumonia model of infection (Obert et al., 2006). 
SP1772 in the TIGR4 genome is 14.3kb. It has an LPXTG motif which presumably 
mediates its attachment to the cell surface by sortases, enzymes which allow 
the covalent attachment of proteins to the cell wall of the bacterium by 
interacting with the LPXTG motif of a protein when its hydrophobic domain and 
charged residues slow down its transport through the cell wall. Sortase cleaves 
the LPXTG motif and covalently bonds the protein to the cell wall (Paterson and 
Mitchell, 2004). SP1772 contains two serine rich repeat regions, SRR-1 and SRR-
2. SRR-1 is closer to the N-terminal of SP1772 and is much smaller than SRR-2 
which is closely followed by the C-terminal and LPXTG motif. A signal sequence 
is presumably encoded in the region upstream of SRR-1 in SP1772. See figure 1.5 
for a diagram of RD20 and figure 1.6 for a diagram of SP1772. 
Chapter 1  Introduction 
48 
Figure 1.5 – RD20 in TIGR4 
 
 
 
Each of the genes in RD20 of S.pneumoniae TIGR4 is annotated here.  
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Figure 1.6 – SP1772 in TIGR4 
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Annotation of SP1772 in TIGR4, with the SRRs and LPXTG motif highlighted. 
SP1772 is 14.3kb in TIGR4. 
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2 Materials and Methods 
2.1 Preparation of bacterial strains 
2.1.1 Streptococcus pneumoniae 
Strains were streaked on a BAB (Oxoid) agar plate, with antibiotic selection as 
appropriate. Plates were inverted and incubated statically o/n at 37˚C. One 
colony was selected from the plate and inoculated in 10 ml Bovine heart infusion 
(BHI), with antibiotic selection as appropriate, and incubated at 37˚C until OD600 
reached 0.6 (mid-log), determined on a spectrophotometer. 10% glycerol was 
then added to the culture and 1ml aliquots were taken and stored at -80˚C. A 
loop of the culture was taken simultaneously and streaked on a BAB plate, with 
antibiotic selection as appropriate, and incubated o/n at 37˚C with an optichin 
disc. Cultures were deemed S.pneumoniae if they had the correct morphology 
and were optichin sensitive. S.gordonii strains were prepared in the same 
fashion, but Bovine heart infusion plus 5% yeast (BHY) was used in place of BHY 
and strains were grown aerobically (in 10ml of culture in a 20ml universal). 
Additionally, strains were used if optichin resistant. 
2.1.2 Escherichia coli 
Strains were streaked on an Luria broth (LB, Oxoid) plate, with appropriate 
antibiotic selection. Plates were inverted and grown statically at 37˚C overnight. 
A colony was selected and inoculated into LB broth with antibiotic selection as 
appropriate. Cultures were incubated at 37˚C and shaking at 220 rpm until OD600 
reached 1.0. 10% glycerol was added to the cultures and aliquots of 1 ml were 
taken and stored at 80˚C. Simultaneously, a loop of the culture was taken and 
streaked on an LB plate with appropriate antibiotic selection to ensure the 
purity of the glycerol stocks. 
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Table 2.1 – Strains used in this study 
 
Name Species Genetic 
background 
Intentional mutation Study 
(chapters) 
TIGR4 S.pneumoniae S4, ST205  All 
Fp23a S.pneumoniae ST205 TIGR4Δcps 3,4,5 
TIGR4ΔSP1772 S.pneumoniae S4, ST205 TIGR4ΔSP1772 5 
TIGR4ΔcpsΔSP1772 S.pneumoniae ST205 TIGR4ΔcpsΔSP1772 5 
TIGR4ΔcpsΔsrt S.pneumoniae ST205 TIGR4ΔcpsΔsrt 3 
R6 S.pneumoniae ST128 D39Δcps 3,4,5 
Inv104b S.pneumoniae S1, ST227  3 
Inv200 S.pneumoniae S14, ST9  3,6 
OXC141 S.pneumoniae S3, ST180  3 
23F S.pneumoniae S23F, ST81  3 
SK120 S.gordonii   4 
BL21 E.coli   4 
Top-10 E.coli   4,5,6 
 
Table 2.2 – Plasmids used in this study 
Name Plasmid 
backbone 
Insertion Study 
(chapters) 
pET33bSP1772A pET33b(+) SP1772A 4 
pET33bSP1772B pET33b(+) SP1772B 4 
pET33bSP1772C pET33b(+) SP1772C 4 
pET33bSP1772D pET33b(+) SP1772D 4 (Figure 
4.7a) 
pET33bgatewayply pET33bgatewa
y 
Ply 4 (Figure 
4.7b 
pET33bplySP1772 pET33bgatewa
y 
SP1772 4 
pCR4-Topo-srtA pCR4-Topo srtA 4 
Topo-erm TopoTA Erm 5 
TopoΔSP1772 TopoTA Erm+ SP1772 flanking DNA 5 
TopoInv200SP1772-1 TopoTA Inv200 SP1772 clone 1 6 
TopoInv200SP1772-5 TopoTA Inv200 SP1772 clone 5 6 
TopoInv200SP1772-6 TopoTA Inv200 SP1772 clone 6 6 
TopoInv200SP1772-8 TopoTA Inv200 SP1772 clone 8 6 
TopoInv200SP1772-
16 
TopoTA Inv200 SP1772 clone 16 6 
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2.2 Isolating DNA 
2.2.1 Genomic DNA from S.pnuemoniae 
A loop of glycerol stocks of the strain from which genomic DNA was to be 
acquired was streaked onto a BAB plate and incubated o/n at 37°C. An optichin 
disk was placed in an area of high growth to ensure the strain was pure. 20ml 
BHI was then inoculated with 1 colony from the plate and grown o/n at 37°C. 
Cultures were centrifuged (4,000 rpm, 15 mins, 4°C) and the pellet was 
resuspended in 1ml lysis buffer (10mM Tris, 100mM EDTA, 0.5% SDS in sterile 
double distilled H2O), and incubated at 37°C for 1hr. 100μg/ml Proteinase K was 
added before incubating at 50°C for 3 hrs. Following this, 20μg/ml RnaseA was 
added before incubating at 37°C for 30 min. Then 1ml phenol:chloroform:IAA 
(25:24:1) was added and samples sharply inverted and centrifuged (13,000 rpm, 
3 min, RT). The upper phase was removed to a fresh tube and 0.2 volumes 10M 
ammonium acetate was added, followed by 600μl EtOH before centrifugation 
(13,000 rpm, 3 min, RT). The pellet was then air dried for 15min and 
resuspended in 200μl TE buffer (10mM Tris.HCl, 1mM EDTA). Samples were 
incubated at 65°C for 10min to encourage resuspension of DNA then stored at 
-20°C, in aliquots of 20µl. 
2.2.2 Plasmid DNA from E.coli 
Strains of E.coli harbouring the plasmid of interest were grown in 3ml LB with 
appropriate antibiotic selection, shaken at 220rpm o/n. Plasmid DNA was 
extracted from the culture using the QIAprep Spin Miniprep kit according to the 
manufacturer’s instructions. 
2.3 Transformation of S.pneumoniae 
BHI (1mM CaCl2) was aliquoted to give 10ml and inoculated with 100μl glycerol 
stock of S.pneumoniae (cells grown to OD600 0.6 in 15% glycerol and stored at -
80ºC). This was incubated statically at 37°C until OD600 reached 0.6. Two 1ml 
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aliquots were removed to sterile tubes and 100ng/ml CSP-2 (competence 
stimulating peptide-2) (Pozzi et al., 1996) was added to each. Competence 
stimulating peptides are naturally occurring and are able to induce competence 
in the pneumococcus. There are two major alleles, CSP-1 and CSP-2. Each allele 
will only induce competence in strains that are naturally sensitive to that allele. 
TIGR4 is naturally sensitive to CSP-2 and as such this allele is used in the 
transformation of TIGR4. Following the addition of CSP-2, cultures were 
incubated at 37°C for 15 min. No DNA was added to one whilst 1μg/ml plasmid 
DNA was added to the other. The tubes were incubated at 37°C for 1hr 15min. 
10μl, 50μl and 200μl of culture were then spread on the surface of both 
selective and non-selective BAB plates using a sterile spreader. 3 different 
volumes of culture were used to allow for differing transformation efficiencies, 
to allow single colonies to be isolated from one of the plates. The plates were 
incubated o/n at 37°C and then observed for transformants. 
 
2.4 Isolating RNA and creating cDNA 
RNA was extracted from 15ml TIGR4 grown to OD600 0.6 using RNeasy Mini Kit 
according to the standard protocol in the RNeasy Mini Handbook (3rd Edition, 
June 2001). Outwith the protocol,15mg/ml lysozyme was used in TE buffer, and 
initial incubation time was 15min at RT. 
cDNA was synthesised from RNA using Invitrogen ThermoScript RT-PCR System 
according to the standard protocol. 
2.4.1 Mapping the operon structure of SP1755-SP1773 
PCR using cDNA synthesised from RNA isolated from TIGR4 (2.4) was used to 
assess the operon structure of the ASL. The reaction volume was 25μl (200μM 
dNTPs, 2mM MgSO4, 2μM Primers, 0.1μl Invitrogen Platinum Taq Polymerase, 1μl 
cDNA/DNA, 2.5μl Invitrogen Platinum Taq 10x buffer; made up to 25μl with 
d.H2O) The conditions were: Initial denaturation 94°C, 2min; Cycle x 30 
(Denaturation 94°C, 30s; Annealing see appendix II for all primers 30s; Extension 
72°C 40s); Final extension 72°C 5min. Samples were diluted 5:1 sample:loading 
buffer and run on a 1% agarose gel. 
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2.5 Microarray analysis 
2.5.1 Microarray construction, DNA labelling and hybridization 
All microarray experiments were carried out by Dr. Donald Inverarity. 
Microarrays were constructed by robotic spotting of PCR amplicons onto poly-L-
lysine-coated glass microscope slides (MicroGrid II; BioRobotics, Huntingdon, 
United Kingdom). Amplicons were designed to represent each of the annotated 
open reading frames (ORFs) present in S.pneumoniae strain TIGR4 in addition to 
those unique to the other sequenced strain, R6. The process designed multiple 
amplicons using Primer3 for all TIGR4 ORFs, as determined by automated 
analysis of BLASTN comparisons. A single amplicon was selected to represent 
each ORF based on its lack of similarity to other ORFs on the array using BLASTN 
analysis to ensure minimal cross-hybridization. DNA was fluorescently labeled 
and hybridized to the microarray chips. Fluorchrome Cy3 or Cy5 dCTP 
(Amersham Pharmacia Biotech) was incorporated into whole-genomic DNA by a 
randomly primed polymerization reaction using large fragment DNA polymerase I 
(Invitrogen). Whole-genomic DNA comparisons were carried out by competing 
DNA from the test strains listed in Table 1 with a standard reference DNA from 
TIGR4. Microarray slides were prehybridized for 20 min at 65°C in a buffer 
containing 3.5x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 0.1% 
sodium dodecyl sulfate (SDS), and 10 mg/ml bovine serum albumin. Labeled 
DNAs from TIGR4 and the test strains were mixed and purified using a Mini-elute 
kit (QIAGEN), after which 4x SSC and 0.3% SDS were added. After denaturation at 
95°C for 2 min, the DNA mixture was applied to the microarray and hybridized 
during 18 h at 65°C. Before analysis, the slides were washed once in 1x SSC 
buffer with 0.06% SDS for 5 min at 65°C and twice in 0.06x SSC buffer at room 
temperature. Comparative hybridizations were performed between a Cy5-
labeled genomic DNA of the reference strain (TIGR4) in competition with Cy3-
labeled genomic DNA. Reciprocal dye swap experiments were performed to 
minimize labelling artefacts.  
2.5.2 Data generation and analysis.  
Hybridized slides were scanned using a ScanArray (Packard BioScience) according 
to the manufacturer's instructions, and the median pixel intensity values for 
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each element on the array were quantified using Quantarray (Packard 
BioScience). The data were further analyzed using Bluefuse. On the basis of 
preliminary PCR validations, the cutoff was determined for the normalized 
intensity ratio of >1.5 indicated the absence of a gene, unless the intensity was 
>1,500 in both channels (TIGR4 and test strain), in which case we decided that 
the gene is present. For intensities of <600 for both channels, the result was 
regarded as ambiguous and therefore was checked by PCR. Genes with a ratio of 
1.4 gave poor agreement between the array and PCR results, and so the 
presence or absence of all such genes was determined by PCR.  
2.6 Sequencing  
Sequencing of PCR products, specific regions of genomic DNA and plasmid DNA 
was carried out by a sequencing unit (MBSU, University of Glasgow or DBS 
genomics, University of Durham). Whole genome sequencing of S.pneumoniae 
was carried out at the Sanger Centre. 
2.7 Protein analysis in S.pneumoniae 
2.7.1 Preparation of S.pneumoniae cultures for protein analysis 
100μl glycerol stocks of pneumococcal strains were inoculated into 10ml BHI and 
grown to OD600 0.6. The bacterial growth was the recovered by centrifugion 
(4,200 rpm, 10 min, 4°C), followed by resuspension in 1ml PBS. The supernatant, 
containing culture medium was discarded at this point. The pellet was then 
sonicated (4 x 30s pulse, 30s hold) to break open the bacterial cells and 
centrifuged again (13,000rpm; 5 min, 4°C). Supernatant (containing the soluble 
fraction of cells) and pellet (containing the insoluble fraction of cells) were 
separated, pellets resuspended in 1ml PBS and stored at -20°C. To analyse, 15μl 
sample was added to 5μl sample buffer, boiled for 5 min and separated by SDS-
PAGE electrophoresis through 3%, 5% or 10% gels. The protocol was later 
modified as follows: a larger starting volume of culture was used (100ml, 1L); 
Sonication, resuspensions and centrifugations were modified accordingly; Amicon 
100,000mW cutoff centrifugation filters and Millipore 300,000mW cutoff 
ultrafiltration membranes were used to concentrate the sample. 
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2.7.2 SDS PAGE 
Samples for protein analysis (obtained as described in 2.7.1) were diluted 3:1 
with sample buffer and boiled for 5 min. Appropriate gels were used for the size 
of protein to be detected. Gels were run at 100 Volts for between 80 min to 16 
hours, dependant on the size of protein to be detected. Gels were then stained 
according to the manufacturer’s instructions using Commassie stain and destain, 
carbohydrate stain (Sigma), silver stain (Invitrogen) or transferred to Hybond-C 
nitrocellulose membranes for western blotting for protein visualisation, all 
according to standard protocols. Coomassie stain is used to visualise proteins, 
while easy to use, its detection limit is fairly high. Carbohydrate stain is used to 
visualise proteins that have carbohydrate associated with them, for the purposes 
of this study it was used to detect glycosylated proteins. Silver stain is used to 
visualise proteins that are in lower copy number since it is highly sensitive.  
2.7.3 Western blots 
In order to detect protein samples seaparated on SDS PAGE gels using specific 
antibodies, SDS PAGE gels were transferred to Hybond-C nitrocellulose 
membrane (Amersham Biosciences) and blotted for 90 min at 80 Volts. Blots 
were then blocked overnight at RT in 3% skimmed milk in Tris-NaCl pH 7.4 with 
shaking and incubated at 37˚C with shaking for 2h in 3% skimmed milk with an 
appropriate dilution of primary antibody. Membranes were washed in Tris-NaCl 
pH 7.4 x 4 and incubated for 1h with 1:1000 HRP-linked secondary antibody (a 
general antibody raised against the animal that the primary antibody was raised 
in; in this study that was mouse, rabbit or goat) in 3% skimmed milk, washed x 4 
and developed in developing solution (Amersham Bioscience). The reaction was 
stopped with distilled water. 
2.7.4 Dot blots 
50μl samples were pipetted onto Hybond-C nitrocellulose membrane (Amersham 
Biosciences) in 2μl drops, and dried. They were then blocked Blots were then 
blocked overnight at RT in 3% skimmed milk in Tris-NaCl pH 7.4 with shaking and 
incubated at 37˚C with shaking for 2h in 3% skimmed milk with an appropriate 
dilution of primary antibody. Membranes were washed in Tris-NaCl pH 7.4 x 4 
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Table 2.3 – Primary antibodies used in this study 
Antibody Immunogen Source Raised in 
α-ply S.pneumoniae ply Tim Mitchell Rabbits 
α-GspB GspB, raised by 
adsorption 
Paul Sullam Goats 
α-SP1772D SP1772D This study Mouse 
α-SP1772Dply SP1772Dply This study Mouse 
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and incubated for 1h with 1:1000 HRP-linked secondary antibody in 3% skimmed 
milk, washed x 4 and developed in developing solution. The reaction was 
stopped with distilled water. 
2.8 Raising antibodies against SP1772 
2.8.1 Cloning Fragments of SP1772 
Primers were designed (and made by Sigma Genosys) to clone selected 
fragments of SP1772 into plasmid pET33b(+) (Novagen) to be expressed in E.coli 
DE3 BL21 cells (Novagen). The reaction volume for the PCR was 100μl (400μM 
dNTPs, 2.5mM MgCl2, 2.4μM primers, 0.5μl Expand High Fidelity PCR system 
(Roche) Enzyme, 2μl 1μg/μl TIGR4Δcps genomic DNA, 10μl 10x buffer; made up 
to 100μl with d.H2O) The conditions were: Initial denaturation 94°C, 2min; Cycle 
x 30 (Denaturation 94°C, 30s; Annealing 50°C - 65°C, 30s; Extension 72°C, 1 min 
15 secs); Final extension 72°C 5min. The sample and loading buffer was run in a  
1:1 ratio on a 1% agarose gel. To isolate the piece of DNA to be cloned the 
remaining PCR amplified material was run on a 1% agarose gel 1:5 loading 
buffer:sample and the band excised from the gel. The DNA was purified using 
QIAquick gel extraction kit protocol. This purified DNA was then cut with 
restriction enzymes (50μl DNA, 20μl multicore buffer, 1μl SacI, 1μl BamHI, 128μl 
s.d.H2O. Incubated 1hr, 37°C) and then purified again using QIAquick gel 
extraction kit protocol. 3μl DNA was then ligated into the plasmid (1μl cut 
pET33b(+), 1μl 10x ligase buffer, 1μl ligase, 4μl sdH2O; incubated at RT for 4 
hrs). Plasmids were then electroporated into E.coli BL21s (Invitrogen). 1μl 
plasmid was added to 100μl competent BL21s thawed on ice and incubated on 
ice for 20min. The mixture was removed to a 0.1cm BioRad electroporation 
cuvette and electroporated using a GenePulser Eletroporator (Voltage 1.5kV, 
Capacito 25μF, Resistor 200Ω). 200μl LB was added and the mixture was 
removed to a fresh tube. Samples were incubated for 1hr at 37°C shaking. They 
were then plated out on selective plates (LBkan 50μg/ml) and incubated o/n at 
37°C. 5 colonies were then selected from each sample and grown o/n @ 37°C, 
shaking. Plasmids were then purified using QIAprep Spin Miniprep kit. PCR was 
carried out to confirm an insertion, using primers designed for the plasmid 
outside the cloning site. The reaction volume for the PCR was 25μl (400μM  
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Table 2.4 Designing fragments of SP1772 for cloning 
Fragment name Primer A Primer B Predicted Size 
(Kb/Kda) 
SP1772A 48L 48N 1.1 / 42.8 
SP1772B 48M 48N 0.09 / 7.5 
SP1772C 48L 48O 1.2 / 45.7 
SP1772D 48M 48O 0.16 / 10.4 
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dNTPs, 2.5mM MgCl2, 2.4μM Primers, 0.125μl Expand High Fidelity PCR system 
(Roche) Enzyme, 2μl plasmid DNA, 2.5μl 10x buffer; made up to 25μl with 
d.H2O) The conditions were: Initial denaturation 94°C, 2min; Cycle x 30 
(Denaturation 94°C, 30s; Annealing 50°C - 65°C, 30s; Extension 72°C, 1 min 15 
secs); Final extension 72°C 5min. 1:1 sample:loading buffer was run on a 1% 
agarose gel. The sample that gave the strongest signal on the agarose gel at the 
correct size was sent off for sequencing to MBSU, University of Glasgow. 
2.8.2 Creating SP1772ply in a Gateway system 
SP1772D was amplified from the TIGR4 chromosome using primers 56L and 56M 
(see appendix II), containing attB sites. The reaction volume was 50μl (200μM 
dNTPs, 2mM MgSO4, 2μM 56L and 56M, 0.2μl Invitrogen Platinum Taq 
Polymerase, 1.5μl TIGR4 DNA, 5μl Invitrogen Platinum Taq 10x buffer; made up 
to 50μl with d.H2O) The conditions were: Initial denaturation 94°C, 2min; Cycle x 
30 (Denaturation 94°C, 30s; Annealing 58ºC) 30s; Extension 72°C 3min); Final 
extension 72°C 8min. This PCR product was then used in a one-step LR-BP 
cloning reaction (Invitrogen), according to the manufacturer’s instructions and 
utilising the pET33bgatewayply vector as the entry vector (see figure 4.6). 
2.8.3 Protein expression 
Strains harbouring plasmids containing the constructs for expression were grown, 
shaking at 37˚C to OD600 0.4 in TB plus LBkan 50μg/ml. To induce expression of 
protein, IPTG was added to a final concentration of 1mM, cultures were then 
incubated shaking at 30˚C over time ranges of 4 – 8 hours to determine the 
optimal amount of time for incubation, which was determined by SDS PAGE 
analysis. Cultures were centrifuged at 13,000 rpm for 3 min. Pellets were 
resuspended in PBS plus Dnase I (Sigma) and Benxamidine, an inhibitor of serine 
proteases, (Sigma) and cells were sonicated (4 x 1 min pulse, 1 min hold). Cell 
lysates were centrifuged at 12,000 rpm at 4˚C for 30 min. Following 
confirmation by western blot that the desired protein was in the supernatant,  
supernatants were then purified using 0.2μm syringe filters.  
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2.8.4 FPLC purification of proteins 
All of the purified proteins utilised in this study were his-tagged, and were 
purified from crude extracts of the cell by FPLC on a Nickel-charged NTA colum 
(Qiagen Superflow resin). Proteins were eluted using a gradient of 0-300 mM 
imidazole in PBS on the FPLC. Resulting fractions were analysed by SDS page to 
determine which fractions contain the protein required. These fractions were 
then pooled for dialysis. 
2.8.5 Dialysis of FPLC purified proteins 
Fractions containing the relevant protein following FPLC were pooled and 
dialysed to remove salt. Dialysis tubing (Medicell International Ltd, UK) was 
boiled in 2% bicarbonate solution with 1mM EDTA for 10min, washed in distilled 
water and stored in ethanol at 4˚C. Tubing was then washed in distilled water, 
protein fractions added and the tubing sealed at both ends. The tubing was then 
placed in 1L phosphate buffer and placed on a magnetic stirrer overnight at 4˚C. 
The buffer was changed twice further. The resulting solution in the tubing was 
then concentrated using Amicon ultra-15 centrifugal tubes according to the 
manufacturer’s instructions (Millipore, UK) and stored at -20˚C.  
2.9 Construction of mutants 
2.9.1 Creating TIGR4ΔcpsΔsrt 
TIGR4ΔcpsΔsrt , a mutant with deleted capsule and sortase A genes was 
generated for experiments outlined in Chapter 5, was generated in the following 
manner: SrtA (spr1098) and flanking DNA in the R6 genome was amplified using 
primers 19H and 19I and cloned into pCR4-TOPO (Invitrogen) according to the 
manufacturer’s instructions. Primers 19W and 19X were then used to delete an 
internal fragment of srtA and introduce an AscI site between the 5’ and 3’ 
flanking sequences required for homologous recombination. Once confirmed by 
sequencing, the plasmid was digested using the AscI enzyme and an 
erythromycin cassette from pGhost5 (Biswas et al., 1993) was ligated into the 
plasmid. This plasmid was then transformed into unencapsulated TIGR4, since 
unencapsulated TIGR4 is both easier to transform and to utilise in protein 
Chapter 2 Materials and Methods 
63 
expression visualisation experiments given the lack of heavily expressed capsule, 
to give TIGR4ΔcpsΔsrtA.Transformants were analysed for presence of correct 
deletions by PCR of their extracted genomic DNA. The reaction volume was 25μl 
(200μM dNTPs, 2mM NEB Vent MgSO4, 2μM Primers, 0.15μl Promega Taq 
Polymerase, 2μl DNA, 2.5μl NEB Vent 10x buffer; made up to 25μl with d.H2O) 
The conditions were: Initial denaturation 95°C, 5min; Cycle x 32 (Denaturation 
95°C, 30s; Annealing 55°C 30s; Extension 72°C 2 min); Final extension 72°C 
10min. 5:1 sample:loading buffer was run on a 1% agarose gel. 
2.9.2 Creating TIGR4ΔSP1772 and TIGR4ΔcpsΔSP1772 
The left flank PCR for generating TIGR4ΔSP1772: The reaction volume was 50μl 
(200μM dNTPs, 2mM MgSO4, 2μM 50J and 49W, 0.2μl Invitrogen Platinum Taq 
Polymerase, 1.5μl T4 DNA, 5μl Invitrogen Platinum Taq 10x buffer; made up to 
50μl with d.H2O) The conditions were: Initial denaturation 94°C, 2min; Cycle x 
30 (Denaturation 94°C, 30s; Annealing 55ºC) 30s; Extension 72°C 1min10s); Final 
extension 72°C 5min. RF PCR: Conditions are identical to above, but primers 
used were 49X and 50K. Erm PCR: Conditions are identical to above, but primers 
used were 49Z and 50A, and template DNA was Topo erm (Created by amplifying 
erm cassette from TJMGL0496 using 49Z and 50A and cloning into Topo TA). 
Crossover PCR: The reaction volume was 50μl (200μM dNTPs, 2mM MgSO4, 2μM 
50J and 50K, 0.2μl Invitrogen Platinum Taq Polymerase, 1μl LF, 1μl RF, 1.5μl 
erm, 5μl Invitrogen Platinum Taq 10x buffer; made up to 50μl with d.H2O) The 
conditions were: Initial denaturation 94°C, 5min; Cycle x 30 (Denaturation 94°C, 
30s; Annealing 56.4ºC) 30s; Extension 72°C 3min10s); Final extension 72°C 
10min. Product is SP1772 P. This was cloned into TopoTA (Invitrogen) according 
to the manufacturer’s manual Version J. Colonies were grown and verified by 
PCR then selected for sequencing. Plasmids were then used to transform 
unencapsulated TIGR4, an unencapsulated derivative of TIGR4. Colonies were 
selected and genomic DNA isolated and used to transform TIGR4 to create 
T4ΔSP1772.  
Chapter 2 Materials and Methods 
64 
2.10 In vitro characterisation of strains 
2.10.1 Biofilm model 
The biofilm model used was developed by Moscoso and colleagues (Moscoso et 
al., 2006) and some experiments were carried by Dr. Patricia Romero-
Fernandez. Strains were grown in C+Y (a minimal, chemically predefined) 
medium until an A550 of 0.4 was reached. A volume of cells equivalent to A550 of 
0.6 was centrifuged and resuspended in 1 ml of prewarmed C+Y. The culture was 
then diluted and 200 μl were dispensed in a 96-well polystyrene plate. Plates 
were incubated at 34°C for 4 to 6 hours and bacterial growth was determined by 
measuring the A595 using a plate reader. Biofilm formation was measured by 
staining with 1% crystal violet (CV) at room temperature for 15 min, 
solubilization of the biofilm with 200 μl of 95% ethanol, and determination of the 
A595. 
2.11 In vivo experiments 
All in vivo experiments were carried out in accordance with the UK Animals 
(Scientific Procedures Act) 1986. All animal handling was carried out by Dr. Gill 
Douce, Dr. Gavin Paterson and Dr. Clare Blue. 
2.11.1 Preparation of standard innocula 
Strains for in vivo experiments were streaked onto blood agar plates. One colony 
was selected and grown to OD600 0.6 at 37˚C. FCS was added to give a final 
concentration of 20% and strains were stored at -80˚C. Viable counts were then 
carried out and aliquots of bacteria at 107CFU/ml (colony forming units/ml) 
were prepared. Viable counts were carried out again to ensure the correct 
concentration of bacteria. The relevant strain of mouse was then infected i.p 
with 100μl 107CFU/ml (to give a final dose of106CFU). The animals were then 
sacrificed at 20 h and blood was inoculated into 10 ml BHI and grown o/n at 
37˚C. Cultures were centrifuged at 3,000 rpm and re-suspended in 1ml BHI. 100 
ul was used to inoculate BHI plus 20% heat inactivated FBS (Gibco BRL, UK) and 
incubated at 37˚C until OD600 was 0.6. Aliquots of 1ml of the cultures were taken 
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and stored at -80˚C. Where appropriate, antibiotic selection was used to ensure 
the growth of mutant strains. 
2.11.2 Viable counting of bacteria 
A glycerol stock of 900μl of standard innocula were centrifuged at 13,000rpm. 
Cells were resuspended in 900μl sterile PBS (Sigma-Aldrich). Samples were then 
diluted 1/10 in a 96-well U-bottomed plate with sterile PBS in the range of 10-1 
to 10-6. 20μl of each dilution in triplicate was then plated on BAB plates, and 
each triplicate was also plated in duplicate and left to dry by a flame. Plates 
were then incubated o/n at 37˚C. Plates were examined and the sector where 
10-100 colonies per spot were then counted to give an average CFU/ml per 
strain. Strains were then diluted to an appropriate dilution for the latter 
infection studies in animals.  
2.11.3 Intraperitoneal model of infection 
Viable counts were carried out and aliquots of bacteria at 107CFU/ml were 
prepared. Viable counts were carried out again to ensure the correct 
concentration of bacteria. MF-1 mice were then infected i.p with 100μl 
107CFU/ml (to give 106CFU/dose). The animals were tail bled at 24h to get blood 
counts. They were then continued to be monitered for disease progression and 
survival. Viable counts were then carried out on the blood samples. 
2.11.4 Pneumonia model of infection 
Viable counts were carried out and aliquots of bacteria at 107CFU/ml were 
prepared. Viable counts were carried out again to ensure the correct 
concentration of bacteria. The relevant strain of mouse (MF-1 or Balb/c) was 
then infected i.n with 50μl 106CFU/dose (to give 5 x 105CFU/ml – MF-1) or 50μl 
107CFU/ml (to give 5 x 106CFU/ml – Balb/c). Bacterial counts were taken at 12h 
and 24h (MF-1) or 2 and 3 days post infection (dpi) (Balb/c) from the blood and 
lungs. Animals were then continued to be monitored for disease progression and 
survival. Viable counts of the harvested bacterium were then carried out on the 
blood and lung samples, as per the methodology of viable counting. 
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2.11.5 Colonisation model of infection 
Viable counts were carried out and aliquots of bacteria at 106CFU/ml were 
prepared. Viable counts were carried out again to ensure the correct 
concentration of bacteria. The relevant strain of mouse (MF-1) was then infected 
i.n with 10μl 106CFU/ml (to give 104 CFU/dose). Bacterial counts were taken at 5 
days from nasopharyngeal washes and tissue and viable counts of bacteria taken.  
2.11.6 Immunisation of mice 
4 female mice were injected subcutaneously at the base of the neck with 10μg 
of protein (Chapter 2) mixed with 7μl aluminium hydroxide and made up to 100μl 
with s.PBS. Initial immunisations were given on day 1. Sample bleeds were taken 
from the tail at days 13, 27 and 38. The sera were in all cases unreactive with 
SP1772 and hence repeat boosts were given on the day following the sample 
bleed.  
 
2.12 Inv200 SP1772 genomics 
2.12.1 Southern blotting 
Southern blotting was carried out using the DIG (Digoxigenin) DNA labelling and 
detection kit (Roche), according to the manufacturer’s instructions. gDNA was 
prepared (Section 2.2.1), and the probe utilised was amplified using primers 56O 
and 56N (See appendix II). The reaction volume was 50μl (200μM dNTPs, 2mM 
MgSO4, 2μM 56O and 56N, 0.2μl Invitrogen Platinum Taq Polymerase, 1.5μl DNA, 
5μl Invitrogen Platinum Taq 10x buffer; made up to 50μl with d.H2O) The 
conditions were: Initial denaturation 94°C, 2min; Cycle x 30 (Denaturation 94°C, 
30s; Annealing 56ºC) 30s; Extension 72°C 15min); Final extension 72°C 25min. 
2.12.2 Cloning  
Genomic DNA was extracted from Inv200 (Table 2.1). SP1772 in Inv200 was 
amplified: The reaction volume was 50μl (200μM dNTPs, 2mM MgSO4, 2μM 56F 
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and 56G, 0.2μl Invitrogen Platinum Taq Polymerase, 1.5μl Inv200 DNA, 5μl 
Invitrogen Platinum Taq 10x buffer; made up to 50μl with d.H2O) The conditions 
were: Initial denaturation 94°C, 2min; Cycle x 30 (Denaturation 94°C, 30s; 
Annealing 55ºC) 30s; Extension 72°C 4min); Final extension 72°C 10min. This 
entire pcr mix was cloned into Topo TA and electroporated into Top10 cells. 
Transformants were picked from the plates and colony pcr was carried out:  The 
reaction volume was 25μl (200μM dNTPs, 2mM MgSO4, 2μM 56F and 07F, 0.2μl 
Invitrogen Platinum Taq Polymerase, 2.5μl Invitrogen Platinum Taq 10x buffer; 
made up to 25μl with d.H2O) The conditions were: Initial denaturation 94°C, 
2min; Cycle x 30 (Denaturation 94°C, 30s; Annealing 55ºC) 30s; Extension 72°C 
4min); Final extension 72°C 10min. Plasmids were then extracted from each 
strain, and the above PCR was repeated using plasmid DNA as confirmation and 
in preparation for sequencing. 
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3 Investigating the Presence of the ASL in 
Pneumococcal Strains 
3.1 Introduction 
The pneumococcus is able to cause a wide range of diseases, and there are many 
reasons for this, including host factors. However, sequencing of pneumococcal 
genes and genomes has revealed that variations between pneumococcal genomes 
are substantial, and likely to be one of the most important contributory factors 
in the diversity seen in disease outcomes of pneumococcal infections. It is 
therefore of interest to study genes that are present or absent in different 
isolates of S.pneumoniae, since they may have a role in the different behaviours 
of strains. 
There have been several studies carried out to examine the diversity in the 
pneumococcus (Obert et al., 2006). One microarray analysis idenitified 22 
regions of diversity among 13 selected pneumococcal genomes (Silva et al., 
2006). In this analysis, one of the regions of diversity (RD), RD20, was found to 
be present in a minority of strains, including TIGR4 (Figure 3.1). Examination of 
the genome sequence of TIGR4 (Tettelin et al., 2001) revealed that RD20 
contained 18 genes, all of which are absent in R6, an unencapsulated avirulent 
sequenced strain of S.pneumoniae (Hoskins et al., 2001), (Figure 3.2). R6 does 
contain the genes flanking RD18 in TIGR4 at either end (SP1755, SP1774). 
Most of the genes in RD18 were found to have homologues in S.gordonii (See 
Figure 3.3). One of these genes, SP1772, encodes a serine rich repeat (SRR) 
protein. The other 17 genes fell into three categories (i) Glycosyl-transferases, 
(ii) Alternative secretion genes and (iii) Genes of unknown function (Figure 3.3). 
Work in S.gordonii has shown that the glycosyl-transferases glycosylate GspB, 
the SRR, whilst the alternative secretion genes secrete GspB via a pathway 
distinct from the main Sec system of the cell (Bensing and Sullam, 2002; 
Takamatsu et al., 2004). SecA2 and SecY2 are homologous to SecA and SecY, 
many of the other genes have no homologues in the main pathway (Bensing et 
al., 2005). Work in S.gordonii has also determined the functions of two of the  
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Figure 3.1 – Regions of diversity among pneumococcal strains 
 
 
 
Figure from (Silva et al., 2006). Comparative genomic hybridisation was carried 
out a panel of pneumococcal isolates. 22 regions of diversity were found 
amongst the 13 selected strains of varying serotypes. Red indicates the presence 
of a gene, and blue the absence. This study highlighted RD20 as a region that 
varies in its presence and absence between strains. The composition and size of 
each region of diversity is presented in Table 2. 
3 further RDs were characterised beyond this analysis, and are outlined in Table 
1. 
 
Strains 
Serotype 3 
Serotype 2 
Serotype 14 
Serotype 19A 
Serotype 6A 
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Table 3.1 – Regions of diversity among pneumococcal strains 
 
RD Approximate size 
(kb) 
SP no. of variable 
genes 
1 9 SP0067-074 
2 5.8 SP0109-0115 
3 5.6 SP0163-0168 
4 14.2 SP0346-0360 
5 3.3 SP0378-0380 
6 5.4 SP0394-0397 
7 12.6 SP0460-0468 
8 7.1 SP0473-0478 
9 5.6 SP0531-0544 
10 11 SP0643-0648 
11 8 SP0664-0666 
12 4.4 SP692-0700 
13 1.7 SP0888-0891 
14 7.9 SP0949-0954 
15 11.9 SP1050-1065 
16 9.2 SP1129-1147 
17 33.7 SP1315-1352 
18 12.1 SP1433-1444 
19 10.3 SP1612-1622 
20 34.8 SP1756-1773 
21 5.3 SP1793-1799 
22 3.2 SP1828-1830 
23 3.2 SP1911-1918 
24 9.4 SP1948-1955 
25 5.3 SP2159-2166 
 
 
Table taken from (Silva et al., 2006). Comparative genomic hybridisation was 
carried out a panel of pneumococcal isolates. 22 regions of diversity were found 
amongst the 13 selected strains of varying serotypes. The regions of diversity 
outlined in Figure 3.1 are detailed here. 
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Figure 3.2 – RD20 in R6 and TIGR4 
 
 
 
The homologues of TIGR4 SP1754 and SP1774 in R6 are spr1600 and spr1599, respectively. Annotation of the genetic region between 
spr1599 and spr1600 in R6, SP1754 and SP1774 in TIGR4 reveals RD20 is present in TIGR4, and absent from R6. The intergenic region 
between spr1599 and spr1600 in R6 is found to contain an insertion in TIGR4, which contains 18 genes: SP1755 – SP1773. 
R6 
TIGR4 
spr1600 spr1599 
SP1774 
37.8kb 
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Figure 3.3 – Functions of the genes in RD20 
 
 
Functions are assigned to the genes of RD20 according to their homology with genes from S.gordonii (established by BLAST analysis). Aside 
from the gene encoding the SRR protein, these genes were found to be homologous to characterised and uncharacterised 
glycosyltransferases and alternative secretion machinery.
Streptococcus gordonii 
Streptococcus pneumoniae TIGR4 
GspB 
SR
Glycosyl-transferase 
Secretion 
CHP 
Also in R6
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genes of unknown function as additional glycosyl-transferases (Takamatsu et al., 
2004). 
 
The work presented in this chapter was carried out to further determine the 
distribution of RD20 amongst pneumococcal isolates by sequencing and 
comparative genomic hybridisation, to determine the operon structure of RD20 
in TIGR4 and to investigate whether genes in RD20 of TIGR4 are transcribed. 
3.2 Results 
3.2.1 RD20 in strains currently being sequenced at the Sanger 
Centre 
The Wellcome Trust Sanger Institute, in collaboration with our laboratory, are 
currently sequencing the genomes of sixteen pneumococcal isolates 
(http://www.sanger.ac.uk/Projects/S_pneumoniae/). Four of these isolates are 
utilised in this study as they were available at the time the research was carried 
out (23F, Inv200, Inv104b and OXC141). Given the diversity seen in comparative 
genomic hybridisation studies and individual gene sequencing, the whole 
availability of genome sequences is invaluable of our understanding of the 
bacterium to give us a more complete picture of the genetic diversity of this 
species than serotyping, sequence typing and comparative genomic hybridisation 
studies can provide. 
The strains selected for sequencing were as follows: Inv104b is representative of 
the major clone of serotype 1, ST227, which is considered to be highly invasive. 
Inv200 is a serotype 14 ST9 clone, this clonal group is major disease causing 
group in children (Brueggemann et al., 2003). OXC141 is a serotype 3, ST180 
clone. This clonal group is associated with carriage in children (Brueggemann et 
al., 2003). 23F is a major multi-antibiotic resistant clone that is associated with 
carriage (Coffey et al., 1991; McDougal et al., 1992; Munoz et al., 1991).  
The full sequence of these strains therefore afforded an opportunity to establish 
not only whether the locus containing SP1772 was present, but also to look at 
the variation that exists in the locus between strains. Certainly, between 
different species of bacteria, the genomic organisation of the locus has been 
shown to differ, particularly in the truncation of the SRR and fewer numbers of 
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glycosyl-transferases (Takamatsu et al., 2004). In order to determine whether 
each strain contained a homologue of SP1772, the nucleic acid sequence of 
SP1772 was blasted against assembled contigs of each strain. Three strains, 23F, 
Inv104B and Inv200 were all found to contain homologues of SP1772. The specific 
contig of each strain was then aligned with the TIGR4 genome using Webact, a 
whole genome alignment tool available from the Sanger Centre 
(http://www.webact.org/WebACT/home). The locus in 23F and Inv104b appears 
to be similar to that in TIGR4, with minor differences arising presumably from 
divergent evolution since the locus was transferred (Figure 3.4). The 23F genome 
encodes an additional glycosyl-transferase. The locus in Inv200 was markedly 
different from that in the other genomes. Not only is the locus much smaller in 
size, but the genes are arranged differently. Inv200 was then directly compared 
to each strain individually to see if it was most disparate from TIGR4, but closer 
related to the other strains. This was found not to be the case (Figure 3.5).  
Loci were annoated using Vector NTI (Invitrogen) and BLAST. Initially, SP1754 
and SP1774 (ORFs at the beginning and end of RD20) were both blasted against 
the subject genome, and as such the location of the ASL within the genome was 
identified. All of the ORFs between SP1754 and SP1774 were then predicted. 
Each ORF was translated into its amino acid sequence, and the sequence was 
then blasted against the full NCBI database. Functions were assigned to genes on 
the basis of homology (Figure 3.6). Interestingly Inv200 was found to contain a 
truncated version of SP1772, and as such presented an opportunity to overcome 
some of the difficulties, as discussed in the next results chapter, of working with 
SP1772. This work is outlined in chapter 6. 
As previously mentioned, the ASLs identified in 23F and Inv104b were similar to 
that of TIGR4, however the sequence of the Inv200 ASL was divergent from 
these. The locus in Inv200 contains a truncated SRR, while SP1772 in TIGR4 is 
14.7kb, the SP1772 homologue in Inv200 is 3.3kb. The alternative secretion 
machinery associated with SP1772 is conserved between the two strains. 
However, while TIGR4 contains 8 different glycosyl-transferases associated with 
SP1772, Inv200 contains only 5. This is quite feasibly due to the truncated 
SP1772 in Inv200 requiring less glycosylation.  
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Figure 3.4 – Webact analysis of sequenced strains 
 
 
 
 
The region between the homologues of spr1599 and spr1600 in R6 in strains 
containing a homologue of SP1772 in TIGR4 were aligned using Webact (Sanger). 
Red lines represent areas of homology between the two strains, blue lines 
represent areas of inverted homology between the two strains and white areas 
represent areas of no homology. This analysis shows that the region (RD20 in 
TIGR4) is fairly well conserved between TIGR4, Inv104b and 23F but the 
sequence of the locus is somewhat divergent in Inv200. 
R6 
Inv200 
23F 
Inv 
104B 
TIGR4 
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Figure 3.5 – Webact comparison of Inv200 directly with other sequenced 
pneumococcal strains 
 
 
 
 
 
 
 
 
SP1772 and associated genes appear divergent from other sequenced 
pneumococcal ASLs in a multi-strain comparison. A direct comparison of Inv200 
with each strain is presented here, and shows that there is little similarity for 
the middle section in comparison with each ASL. 
Inv200 
23F 
Inv104B 
TIGR4 
Inv200 
Inv200 
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Figure 3.6 – Annotation of sequenced strains containing RD20 
 
 
 
 
RD20 in Inv104b, 23F and Inv200. Each ORF was predicted and the translated 
protein product was blasted against TIGR4. Functions were assigned to genes on 
the basis of homology (Cut-off utilised was 50%). 
inv104b 
37948 bp 
TIGR4
39168 bp 
inv200 
24046 bp 
23F 
39309 bp 
SRR 
Glycosyl-transferase
Secretion Machinery 
Unknown function 
Also in R6 
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This was interesting since the ASL is not found in all pneumococcal isolates, but 
is found in other bacteria, and supports the theory that the locus moves by 
horizontal gene transfer between different species of bacteria. The genomic 
organisation of the locus varies from species to species. A figure from Takamatsu 
and colleagues is presented in Figure 3.7. This figure shows that the number of 
genes associated with an SRR in any given species can vary significantly, mainly 
in the region between the SRR and the homologue of SecY. The Inv200 locus 
varied from other pneumococcal loci in this region, however, there were genes 
present in this region, unlike in S.gordonii, S.aureus or S.epidermidis. 
S.algalactiae similarly contained genes in this region, and to compare how 
related the locus in Inv200 and the locus in S.algalactiae were, an ACT 
comparison was done. This is presented in Figure 3.8. This revealed that the 
locus in Inv200 and S.algalactiae are also divergent, suggesting that a recent 
movement of the locus between these two species has not occurred. However, it 
does suggest that this location in the locus is able to vary significantly between 
strains and species. 
OXC141, a serotype ST180 strain isolated from the nasopharynx of a healthy 
child (Brueggemann et al., 2003), was found not to contain a homologue of 
SP1772. When SP1754 and SP1774 were blasted against oxc141 they were found,  
and the intergenic region examined it contained no predicted ORFs. Each 
additional gene in the ASL was blasted against the genome to verify that the ASL 
had inserted elsewhere in the genome, and the absence of these genes within 
OXC141 confirmed that this strain does not contain the ASL (Figure 3.9). 
3.2.2 Microarray analysis of Pneumococcal strains 
Previously, genomic hybridisation carried out in our laboratory identified the ASL 
as a region of diversity, RD20, which was found in a minority of strains (Silva et 
al., 2006). This study was therefore expanded by looking at more pneumococcal 
strains, and looking at large groups of the same ST to determine if MLST was a 
sufficiently sensitive classification for the pneumococcus. MLST is a system that 
classifies the pneumococcus according to variations in the sequence of 7 
housekeeping genes (Enright and Spratt, 1998), and it was sought to identify if in 
some instances these housekeeping genes can remain conserved while other 
parts of the genome can vary.  
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Figure 3.7 – Comparison of the ASL in different species of gram positive 
bacteria 
 
 
 
 
Figure from (Takamatsu et al., 2004a). ASLs in several species of gram positive 
bacteria are annotated. Purple indicates the SRR, blue indicates a glycosyl-
transferase, green are SecA2 and SecY2 homologues, orange indicate alternative 
secretion genes and yellow indicates essential glycosyl-transferases. 
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Figure 3.8 – Webact alignment of RD20 in Inv200 with homologous regions in 
other species 
 
 
 
The sequence of RD20 in Inv200 was aligned in RD20 to available loci from other 
bacteria using webact. This resulted in less homology found between inv200 and 
other bacteria than with other pneumococcal strains. This figure presents an 
example of an alignment with S.algalactiae.  
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Figure 3.9 – RD20 in OXC141 
 
(a) Webact alignment of RD20 in TIGR4 and OXC141 
 
 
 
(b) The genomic region between homologues of SP1754 and SP1774 in OXC141 
SP1754 SP1774
 
 
 
(a) The sequence of RD20 in TIGR4 was aligned to the region between 
homologues of SP1754 and SP1774 in OXC141. The locus does not appear to be 
present. (b) Annotation of the locus reveals the absence of the locus in OXC141.
TIGR4 
OXC141 
OXC141 
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Figure 3.10 – Microarray analysis of S.pneumoniae 
isolates
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Microarray analysis was carried out to determine the presence and absence of genes in RD20 in TIGR4. The ORFs are listed. Red indicates 
the presence of the gene, while blue indicates the absence of the gene. Generally the locus is present or absent in keeping with ST and 
serotype, for example all serotype 4 strains examined contain the locus, and all serotype 3 strains do not. 
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Figure 3.10 presents the microarray data, analysed using Blue fuse software. In 
most serotypes and MLSTs examined, there was consistency in whether RD20 was 
present or absent. In all serotype 4, MLST 256 strains examined, for example, 
the locus was always present. In all serotype 3 strains, ST180 strains most genes 
in the locus were always absent. Where some genes from the locus did appear to 
present in serotype 3, ST180 strains did appear to be present, it can be assumed 
this is due to homology to other genes in the pneumococcus. For example SP1768 
often appears to be present in serotype, ST180 strains. This is a gene of unknown 
function, and it is possible that the probe for this strain has homology to other 
genes in S.pneumoniae. There is no homology between this gene and any other 
in the OXC141 genome however, which shows there are differences at the 
genomic level between serotype 3, ST180 strains.  
3.2.2.1 Presence of the locus does not always correlate with 
serotype or ST 
In the previous section, the correlation between presence and absence of locus 
and the serotype and ST of the strain under examination was noted. However 
this study highlighted that there are exceptions to this rule. 
All ST9 strains, the majority were also serotype 14, evaluated in the study were 
found to contain the locus with the exception of an ST9 strain with capsule type 
19F. It is possible that capsule type 19F is not compatible with this locus, in that 
the cell is not able to produce both capsule and the product of this locus. This 
theory supported by the finding that a capsule type 19F ST 63 strain that also did 
not contain the locus (Figure 3.11). 19F is similar in capsule type to 19A, in fact 
the replacement of only 2 genes in the 19F capsular locus allows the locus to 
synthesis capsule of a 19A type (Morona et al., 1999). Examination of 19A strains 
included in the array (ST9, ST41) revealed that they did contain the ASL, and as 
such suggests that the absence of the ASL in 19F strains examined is either due 
to a very subtle difference in capsule biosynthesis or, alternatively, due to the 
requirements of the strains harbouring the locus. However, due to the limited 
number of 19F strains included in the study, conclusions cannot be drawn. 
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One of the ST9 strains containing the locus was of capsule type 23F. Examination 
of other 23F capsule types, showed that an ST81 strain did contain the locus 
(validated by the occurrence of the locus in the 23F ST81 strain being sequenced  
Chapter 3 Investigating the Presence of the ASL in Pneumococcal Strains 
86 
Figure 3.11 – Microarray analysis of specific S.pneumoniae isolates 
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Generally the presence of the locus is the same in keeping with ST or serotype. 
An ST9, 19F strain does not contain the locus. An ST63, 19F also does not contain 
most of the genes in the locus. This could possibly be because the capsule type 
of 19F is not compatible with the locus. 
Strains of the same capsule type can also vary in their presence of the locus. 
Strains with capsule type 23F and ST9 and ST81 on the array contain the locus. A 
23F ST37 does not contain the locus. This could signal capsule switching has 
occurred.  
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at the Sanger Centre), while a ST37 did not. This could indicate that capsule 
switching has occurred, and that the ST37 strain acquired the 23F locus in place 
of a capsule previously present. Capsular switching is able to occur due to the 
conserved location of the capsule across pneumococcal strains (Serotypes 3 and 
37 are the exceptions to this). The genes encoding capsule are located between 
dexB (glucan 1,6-alpha-glucosidase) and aliA (oligopeptide ABC transporter, 
oligopeptide-binding protein AliA), and as such, a highly competent species such 
as the pneumococcus is able to exchange this genetic material relatively easily. 
There is a pressure on the pneumococcus to switch capsule, it is highly 
immunogenic and has been used in vaccine formulations directed against the 
pneumococcus. This has created a pressure on the pneumococcus to acquire 
different capsular types (Bentley et al., 2006; Brueggemann et al., 2007).  
PCR confirmation of each gene in RD20 was carried out on two of the above 
mentioned strains, a 23F and 19F, both ST81 (Figure 3.12). These PCRs 
confirmed the results from the array, that the locus was present in the 23F 
strain and absent in the 19F strain. 
Interestingly, the ST9 strains included in the array contain many genes absent in 
TIGR4. Inv200, the ST9 strain sequenced at the Sanger Centre, contains a 
divergent locus from that of TIGR4. The results from the array suggest that this 
locus is highly divergent in the ST9 population, and there is the possibility that 
this is due to their other genomic content, or a requirement of the strain, its 
behaviour, or alternatively the compatibility between the locus and the serotype 
14 capsule type, since ST9 strains are predominantly serotype 14. 
3.2.3 RNA expression of genes in the ASL 
The DNA of the ASL is present in TIGR4, and so it was investigated whether the 
RNA of all of the genes within the locus is expressed. RNA was isolated from 
bacteria grown in BHI to midlog, and RT-PCR for each gene was carried out. 
Primers for each gene were designed against the TIGR4 genome, and each PCR 
was optimised using TIGR4 DNA. The experiments showed that mRNA from 17 of 
the 18 genes is expressed (Figure 3.13). The gene that was not shown to be 
expressed, SP1773 is a transposase. It was presumably involved in the 
translocation of this locus to TIGR4, but whose expression is no longer required.  
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Figure 3.12 – PCR validation of Microarray Data 
 
 
 
 
 
 
 
 
 
 
 
 
 
PCR confirmation of microarray analysis results. (a) All of the primers were 
designed against TIGR4 DNA and are validated (b) 04-1168, the 23F ST81 strain, 
contains most of the genes in the locus (c) 04-1548, the 19F ST81 strain, does 
not contain most of the genes in the locus. Ply was used as a positive control. 
The presence of genes is dentoed in bold. 
(a) TIGR4 DNA 
(b) 04-1168 DNA, 23F ST81 
(c) 04-1548 DNA, 19F ST81 
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Figure 3.13 – RT-PCR of genes in RD20 
 
 
 
 
 
 
 
 
 
 
 
 
RT PCR was carried out to determine if the genes in RD20 of TIGR4 are also 
expressed as RNA. (a) The primers are validated using TIGR4 DNA. (b) RT-PCR 
confirms that all of the genes in the locus are expressed, with the exception of 
SP1773. Ply was used as a positive control. The presence of genes is denoted in 
bold. 
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The operon structure of the locus was then determined. This was done by 
designing primers that flanked the start and end of each gene. RT-PCR was 
carried out on TIGR4 cDNA to determine how genes were co-expressed. Pairs of 
primer were used that gave a product of the end of one gene and the start of its  
adjacent gene and the intergenic region for each gene pair if the genes are 
transcribed together (Figure 3.14), (see appendix II for primers). The results for 
each gene pair allowed a map of the operon structure of RD20 to be drawn 
(Figure 3.15). This showed that three transcripts are expressed (The RNA of 
SP1773 is not expressed, as shown in Figure 3.13). Figure 3.15 also shows an 
analysis of the transcripts by putative functions of the genes, and membrane 
association (predicted using the GES – Goldman, Engelman and Steitz – 
hydrophobicity scale). 
The transcript containing SP1772 is 16kb and also contains SP1771, a putative 
glycosyl-transferase. Therefore levels of this glycosyl-transferase will 
presumably be controlled at the same level as SP1772. This glycosyl-transferase 
is not predicted to be membrane bound. 
SP1770 is predicted to be transcribed alone. It is possible that this glycosyl-
transferase is required in very high, low or variable levels depending on the 
niche of the bacteria. It may therefore be unsuitable to be co-transcribed with 
either the preceding or following transcript. In order to establish the levels of 
transcription, qRT-PCR could be carried out. 
The following transcript of genes SP1769-SP1759 is 15kb and contains the largest 
number of genes. SP1759-SP1763 are all predicted by homology to be genes 
involved in alternative secretion. Some are predicted to be membrane bound, 
and others not. SP1763-SP1767 and SP1769 are all predicted to be glycosyl-
transferases that are not membrane bound. SP1768 encodes a glycosyl-
transferase which is predicted to be membrane bound. SP1764-SP1769 encode 
glycosyl-transferases which are often absent in other species of bacteria with 
contain the locus (Figure 3.4). It is interesting that they are co-transcribed with 
genes that are commonly found associated with all SRRs. 
The next transcript is 3kb and is comprised of genes SP1755-SP1758, which 
encode two glycosyl-transferase and two alternative secretion proteins. All four 
products are predicted to be membrane associated. The two glycosyl-  
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Figure 3.14 – Mapping the Operon Structure of RD20 
 
 
 
Primers were designed to flank the end of one gene and the beginning of the 
next gene in the genome of TIGR4. The primers were validated using TIGR4 
genomic DNA. The primers were then used to amplify TIGR4 RNA. In the example 
above, Primers 1 and 2 give a product, and therefore gene A and B are expressed 
together. Primers 3 and 4 do not give a product, and therefore genes B and C are 
not expressed on the same transcript. 
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Figure 3.15 – The operon structure of RD20 in TIGR4 
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Primers were designed to map the operon structure of RD20 in TIGR4, and 
validated using TIGR4 DNA (Figure 3.12). The primers were then used to 
amplify TIGR4 RNA and the operon structure was found. Bold denotes the 
presence of the transcript (b) The operon structure was then correlated with 
the putative functions of genes in RD20, and the predicted membrane 
association.  
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transferases are found in all species containing the SRR, however, the two 
alternative secretion genes are not. 
 
3.3 Discussion 
RD20 was identified in TIGR4 and shown by comparative hybridisation studies to 
vary in its presence across the pneumococcal population (Silva et al., 2006). 
Analysis of a larger number of strains suggests that the locus is associated with 
strains that cause disease, and it is notably absent from all serotype 3, ST180 
strains which are strongly associated with carriage (Brueggemann et al., 2003). 
Another comparative genomic hybrdisation study has also noted a correlation 
between the presence of this locus and the ability of an isolate to cause invasive 
disease (Obert et al., 2006).  
Since the locus is large, and has been implicated in virulence this presents 
interesting questions about the function of the locus in the pathogenicity of 
S.pneumoniae. A study by Hava and Camilli identified SP1760, SP1770, SP1771 
and SP1772 as virulence factors (Hava and Camilli, 2002). Work to elucidate the 
function of the genes in the locus is presented in the following chapters. Further 
analysis in this chapter has also shown that the locus is not identical in each 
strain of S.pneumoniae where it is present. This divergence lies not only in the 
sequence of individual genes, but also in the presence and absence of particular 
genes. The most striking difference in the number of genes is found in the 
comparison of TIGR4 and Inv200. RD20 in Inv200 contains only 5 
glycosyltransferases, whilst in TIGR4 the locus contains 8 glycosyltransferases. 
The SRR in Inv200 is greatly truncated compared to that of SP1772. It is feasible 
therefore that the number of glycosyltransferases in the locus required by each 
strain is proportional to the size of the SRR. There could be some redundancy 
amongst the glycosyltransferases, however it could also be that the larger the 
SRR, the more variation in glycosylation is required, and thus it requires a 
greater number of diverse glycosyl-transferases to facilitate this. This could be 
to facilitate greater immune evasion, or alternatively to utitlise different sugars 
in the bacterial cell. The locus in S.gordonii also contains far fewer 
glycosyltransferases, and the SRR is much smaller (Bensing and Sullam, 2002). 
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However, S.algalactiae also contains a greatly truncated SRR, and yet encodes 
more glycosyl-transferases than S.gordonii, S.aureus  or S.epidermidis 
(Takamatsu et al., 2004). Where glycosyl-transferases are absent in Inv200 and 
other species, the function of these genes could be related, in part, to the size 
of the SRR. However, where these genes are present in Inv200, the function of 
the genes could be specific to the function of the locus in S.pneumoniae. This 
could be further investigated by sequencing of this locus in more strains, and 
comparing the number of glycosyltransferases with the size of the SRR. In 
addition, by elucidating the functions of the glycosyltransferases it could be 
determined what the function of variation in sequence and presence of these 
genes could be. 
The variation seen in the size of SRR and the locus harbouring it across 
pneumococci and other species, and its absence from all strains examined of 
closely related species Streptococcus pyogenes, Streptococcus mutans and 
Enterococcus faecalis suggest that the locus has not come from a common 
ancestor, but has been disseminated by horizontal transfer. This is feasible 
particularly when the natural competence of S.pneumoniae and S.gordonii is 
considered. The transposases present in S.pneumoniae and S.algalactiae also 
suggest a recent transfer of this locus to the species.  
The variation in genomic content of the locus also implies that the functions of 
the SRR can vary, not only between species but also between strains. Fap1 in 
S.parasanguinis, a member of the oral flora, has been shown to be responsible 
for biofilm formation and adhesion to teeth, both important in the formation of 
dental plaque (Froeliger and Fives-Taylor, 2001). SraP in S.aureus and GspB and 
Hsa of S.gordonii meanwhile have all been shown to aid in binding of bacteria to 
platelets, a first step in the organisms causing infective endocarditis (Bensing 
and Sullam, 2002; Siboo et al., 2005). However, while Hsa has also been shown 
to bind secretory immunoglobulin A, salivary mucin MG2 and salivary agglutinin 
(Jakubovics et al., 2005; Takamatsu et al., 2006), GspB only binds the latter 
two. The only major difference in the loci associated with GspB and Hsa is the 
size of the SRR (Hsa is smaller than GspB), and a variant glycosyl-transferase 
(Takamatsu et al., 2006). This implies that relatively small changes in the 
structure of the locus can alter the function of the resultant SRR, and as such, 
the diversity seen in the locus within the pneumococcal population could be due 
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to the differing behaviour of strains harbouring the strain, or alternatively due 
to the acquisition of the locus from different sources due to the occupation of 
differing niches by different strains. 
Comparative genomic hybridisation studies presented here demonstrate that the 
presence or absence of the locus can generally be correlated with the serotype 
and ST of a strain. However, there are exceptions to this. Strains of ST9 
generally were found to contain the locus, albeit with the absence of several 
genes. This could be expected when considering Inv200, the ST9 serotype 14 
strain, which contains a smaller version of the locus with a smaller SRR and 
fewer glycosyltransferases. 
However, one ST9 strain of serotype 19F was found not to contain the locus. 
Another 19F strain included in the study, of ST63, also did not contain the locus. 
SP1772 and capsular biosynthesis pathways are feasibly related in the cell of the 
pneumococcus. The full expression of both requires a large amount of sugars 
from the cell. It is possible that in some instances the cell either cannot afford 
the expenditure of all the sugars required to fully synthesize both, or 
alternatively that the pathways interfere with one another to the extent that 
they cannot co-exist within one strain. The idea that the 19F capsule and SP1772 
are incompatible is possible, but diminished somewhat by the observation that 
all strains of capsule type 19A contain the locus. Capsule type 19A is very closely 
related to 19F (Morona et al., 1999), and it is unlikely that the minor differences 
in both the synthesis and resultant capsule are enough to constitute a difference 
in the ability of a strain to host SP1772 and associated genes. 
When strains of different serotypes are the same ST type, it is proposed to be 
due to capsule switching (Coffey et al., 1998). However this study revealed that 
there are also other differences in the genomes of strains of the same ST. This 
could be because the locus is incompatible with certain capsule types, as 
discussed above, and so when the strain acquires a different capsule type, it 
cannot support the expression of the genes and so loses the locus. However, it is 
also possible that strains which are the same ST but different capsule types are 
not the result of capsule switching, but rather the result of genomic divergence. 
This can be further analysed by comparing the presence and absence of other 
genes these strains, or a more complete picture could be gained by sequencing 
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the strains and looking at sequence diversity at the gene level. In addition, by 
looking at expression of the locus under different conditions, the conditions 
under which expression of the locus in induced in nature may have been 
deduced, or indeed what has driven the presence or absence of the locus in 
natural selection could have been elucidated. 
The variation in the presence of SP1772 and associated genes in strains of 
S.pneumoniae, combined with the finding that several genes in the locus are 
virulence determinants demonstrates a role for this locus in the pathogenicity of 
S.pneumoniae. It has been shown here that the RNA for these genes is expressed 
in TIGR4, and we therefore sought to investigate if SP1772 is expressed by the 
cell, and what role the protein plays in the virulence of TIGR4. 
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4 Analysis of SP1772 Expression 
4.1 Introduction 
SP1772 has a homologue in Streptococus gordonii, GspB. GspB was identified in a 
transposon mutagensis screen, in which investigators attempted to identify the 
gene in S.gordonii responsible for binding platelets, an important step in the 
pathogenesis of the organism in causing infective endocarditis (Bensing and 
Sullam, 2002). Mutants significantly attenuated in their ability to bind platelets 
were sequenced around the insertion site of the transposon. It was found that 
the mutant most deficient in platelet binding had an 8 kb deletion in the 
chromosome of the parent strain. The 8 kb deletion was found by sequence 
analysis to contain nine contiguous genes which were found by homology to 
encode glycosyl-transferases, homologues of SecA and SecY, and genes of 
unknown function. SecA and SecY in E.coli have been shown to be essential to 
the survival of the cell as they have an essential role in protein secretion 
(Danese and Silhavy, 1998), and thus the investigators sought to determine the 
effect of this deletion on the proteome of the mutant strain. No differences 
were identified by SDS PAGE of cell extracts of the mutant compared to the wild 
type strain in the 8-200 kDa range, however above 216 kDa (the largest 
molecular weight marker) there was a band present in the wild type strain that 
was absent in the mutant strain. The investigators then sequenced upstream 
from the deletion in the mutant strain and found a gene encoding a product of 
286 kDa (Bensing and Sullam, 2002). In addition to the previous three 
glycosyl-transferases immediately downstream of this gene, one of the genes of 
unknown function was additionally identified as responsible for glycosylating this 
gene (Takamatsu et al., 2004a).  
The predicted protein product of the SP1772 gene, SP1772 (See Figure 4.2), is 
412kDa without glycosylation. There are 8 glycosyl-transferases adjacent to 
SP1772 in the TIGR4 chromosome. It is unknown what the molecular weight of 
the native protein product SP1772 is although, as in the case of GspB it could be 
assumed to be larger than 412kDa due to glycosylation by the adjacent 
glycosyltransferases in the chromosome (Takamatsu et al., 2004a). In addition, 
there are 8 glycosyl-transferases predicted to be adjacent to SP1772 in TIGR4 
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whilst only 4 have been identified in adjacent to GspB in S.gordonii (Takamatsu 
et al., 2004b). 
RT-PCR of all of the genes in the locus, presented in chapter 3 shows that the 
RNA of all of the genes in locus is expressed, with the exception of SP1773, a 
transposase. The work presented in this chapter was carried out to establish if 
the protein product of SP1772 RNA, SP1772, is expressed in TIGR4. 
4.2 Results 
4.2.1 Detection of SP1772 in TIGR4 cell extracts by SDS PAGE 
and Dot blot analysis 
Cell extracts of TIGR4 were sonicated, fractions separated by centrifugation and 
then analysed to determine whether SP1772 is expressed by TIGR4. Due to the 
LPXTG motif in SP1772 it is predicted to be anchored to the cell surface by 
sortase, and so it is likely to be present in the insoluble fraction of centrifuged 
cell extracts. Regardless, in all instances either the insoluble and soluble 
fraction, or else total cell protein (the two combined) were analysed. An 
unencapsulated derivative of TIGR4, TIGR4Δcps (Pearce et al., 2002) was used in 
all cases, to ensure that resulting bands did not  result from capsular protein 
aggregation. R6, an unencapsulated derivative of D39 (Hoskins et al., 2001) that 
has been sequenced was used as a negative control since it does not contain 
SP1772 or any of the other genes in the locus. SK120, a S.gordonii strain, was 
used as a positive control, since it contains GspB, the glycosylated homologue of 
SP1772. 
Cell extracts were prepared as described in 2.7.1 and analysed on a variety of 
SDS-PAGE gels as described in 2.7.2. The percentage of an SDS-PAGE gel is 
defined by the ratio of acrylamide to water. Lower percentage gels contain less 
acrylamide and therefore there is more space in the gel for large proteins to 
migrate through. Since SP1772 is predicted to be 412 kDa without glycosylation 
low percentage gels or gradient gels were used. Gradient gels contain a gradient 
of acrylamide through the gel and so smaller proteins can be resolved at the 
bottom of the gel while larger proteins can still be resolved further up the gel. 
SDS-PAGE was utilised to identify a band migrating above 250 kDa in TIGR4Δcps  
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Figure 4.1 – Sonicated cell extracts of bacteria, separated by SDS PAGE and 
blotted, and stained with different stains, to detect SP1772 
 
    (a) 4-12% Gradient Gel, Coomassie stain                 (b) 4-12% Gradient Gel, Glycoprotein stain 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   (c) 4% SDS PAGE, Silver stain                      (d) Dot blot, Glycoprotein stain 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sonicated cell extracts of S.pneumoniae, S.gordonii and S.aureus. SH – S.aureus SH100, SK – 
S.gordonii SK120. TCP – Total cell protein, Pel – Pellet, Sup – Supernatant. Extracts were 
separated by SDS PAGE or blotted onto nitrocellulose and stained with Coomassie blue, Silver 
stain or glycoprotein stain. 
Figure 4.1(a) is a 4-12% gradient gel, coomassie stained and run for 16 hours. There was not a 
band that could be detected above 250 kDa in the insoluble (cell wall associated, pel) or soluble 
(cytoplasmic, sup) fraction 
Figure 4.1 (b) is a 4-12% gradient gel, glycoprotein stained and run for 12 hours. The detection 
limit of the stain appears to be very low, and there was not a band detected above 250 kDa in 
any of the samples. 
Figure 4.1 (C) is a 4% gel, silver stained. Silver staining is a far more sensitive detection method 
for proteins. There were bands of above 250kDa present using this stain, however they were also 
present in R6, which does not contain the locus. 
Figure 4.1 (D) is a dot blot, glycoprotein stained. Each strain studied had duplicate samples. The 
stain reacted with all strains, indicating the presence of a glycoprotein in all strains, including 
R6, which does not contain SP1772. Therefore we could not confirm the presence of SP1772 since 
the reaction with TIGR4 may have been due to a reaction with the same glycoprotein as is 
present in R6. 
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extracts that was absent in R6, since SP1772 is not present in R6. Figure 4.1a is 
an example of a 4-12% gradient gel stained with coommassie blue, run for 16 
hours. There was not a band that fulfilled the criteria necessary to identify it as 
SP1772. The gel in figure 4.1b is an example of a gel stained with Glycoprotein 
detection kit (Sigma). This stain is more sensitive, and more specific, it will only 
react with glycoproteins. However, we could not identify a suitable band, even 
in cell extracts that had been concentrated using centrifugation filters (Amicon). 
There was a reaction with horse-radish peroxidase, the positive control for the 
stain, which shows the stain was working and so it appears that if glycol-proteins 
are present then they were not in high enough concentration to react with the 
stain. A highly sensitive silver stain (Silver Quest, Invitrogen) was then used on 
concentrated cell extracts (Figure 4.1c), on a 4% gel. This did not stain any high 
molecular weight bands that weren’t also present in the negative control strain, 
R6. It was decided that if SP1772 couldn’t be resolved on an SDS PAGE gel due to 
its size, whole cell extracts should be analysed by dot blot. A glycoprotein stain 
was used, and if SP1772 is the only glycosylated protein in TIGR4, then the stain 
would not react with R6. However, the stain did react with R6, showing that R6 
contains glycoprotein. We therefore could not conclude that the glycoprotein 
strain was reacting with TIGR4 due to the presence of SP1772 (Figure 4.1d). 
Therefore it was decided that a more specific reagent to recognise SP1772 was 
required. An antibody to GspB had been used in previous experiments with 
S.gordonii (Bensing and Sullam, 2002). In this study, antiserum was raised 
against wild type S.gordonii. This antisera was then adsorbed using heat killed 
cells of a mutant deficient in GspB. The resulting mixture was then filtered for 
use. This antiserum was then able to detect GspB because the majority of the 
antibodies in the mixture were against GspB, the one antigen that was present in 
the strain used to create the antiserum and not present in the strain used to 
adsorb the antiserum. Since SP1772 and GspB are homologues, it was possible 
that the anti-GspB antibody would therefore react with TIGR4 whole cell 
extracts containing SP1772. There was, however, no reaction of the antibody 
with TIGR4. GspB and SP1772 may be too divergent for an antibody raised 
against GspB to cross-react with SP1772 and therefore attempts were made to 
raise an antibody by cloning, expressing and purifying a suitable antigen and 
using it to raise antisera in a mouse.  
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4.2.2 Raising an antibody against SP1772 
In order to raise an antibody to SP1772 an attempt was made to clone the whole 
SP1772 by PCR. This initial step was unsuccessful, and it was deemed that should 
the PCR work, it would be unlikely to be expressed by E.coli, which is the 
organism commonly used to express proteins. This is due to the size and number 
of repeats of SP1772. Additionally, studies in S.gordonii have shown that the 
glycosyl-transferases adjacent to GspB in the chromosome are required for the 
stability of GspB. In their absence GspB can no longer be detected on the surface 
of S.gordonii cells, and instead the protein is found to aggregate in the 
cytoplasm (Takamatsu et al., 2004a). Whilst there are glycosyl-transferases 
present in E.coli, these are unlikely to be able to glycosylate pneumococcal 
proteins. It therefore seemed feasible to selected a part of SP1772 to clone, 
express and purify. 
There were several features of SP1772 that had to be taken into account in 
designing a suitable fragment of SP1772, against which to raise an antibody to 
SP1772. The features of SP1772 are outlined in Figure 4.2. SP1772 contains two 
serine-rich repeat regions. SRR-1 is a small repeat region near the N-terminal of 
the protein, and SRR-2 is a much larger domain, forming the bulk of the protein 
and spanning towards the C-terminal. There is an LPXTG motif downstream of 
SRR-2 which is predicted to allow SP1772 to be anchored to the cell surface by 
sortase. The N-terminal portion of the protein is predicted to contain a signal 
sequence which allows export to the cell surface from the cytoplasm through 
interacting with SecA2. It is unknown where this sequence falls in SP1772. It is 
unknown where the glycosylation sites on SP1772 are, however it is predicted 
that the repeat regions that are glycosylated, since truncates of GspB in the 
repeat region lead to a reduction in molecular weight of greater than predicted 
based upon the sequence (Bensing et al., 2004). Given that the repeat regions 
are incredibly expensive for the cell to produce but form such a large part of the 
protein, it is likely that these are important in the function of the protein. Due 
to all these factors, several fragments of SP1772 were cloned (Figure 4.3), to 
incorporate these considerations. SP1772A contains the entire N-terminal, and 
no repeat region. SP1772B contains none of the N-terminal, and no repeat 
region. SP1772C contains the entire N-terminal, and one repeat from SRR-2. 
SP1772D contains none of the N-terminal, and one repeat from SRR-2. 
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Figure 4.2 - Predicted features of SP1772 
 
LPXTGSRR-1 SRR-2
 
SP1772 protein predicted areas. SRR-1 and SRR-2 denote the serine rich repeat 
regions of the protein. The LPXTG denotes the motif recognised by sortase to 
attach proteins to the cell wall. It is therefore predicted that this end of the 
protein is attached to the cell surface and the sequence upstream of this is 
increasingly distant from the cell surface and therefore more exposed to the 
host environment. SP1772 will also contain a signal sequence allowing it to be 
recognised by SecA2 for export from the cytoplasm to the cell surface. This is 
predicted to be somewhere in A, most likely upstream of SRR-1.  
 
A 
Chapter 4  Analysis of SP1772 Expression 
104 
Figure 4.3 Raising an antibody against SP1772 
(a) Selection of fragments of SP1772 to clone, express and purify 
 
 
(a) Selection of fragments of SP1772 to clone in pET33b for expression and 
purification. (b) SP1772D was selected because it contained some of SRR-2, and 
very little of the N-terminal, which is predicted to be cleaved at an unknown 
site. 
 
pET33b(+) SP1772 D 
5563 bp 
Lac 
Kan 
SP1772 
N term His  
f1  
SRR-1 SRR-2 
SP1772 A 
SP1772 B 
SP1772 C 
SP1772 D 
 
(b) SP1772D in pET33b (2.8.1) 
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All four fragments were cloned into pET33b (Novagen) according to the 
manufacturer’s instructions. See appendix II for a list of the primers used to 
amplify each of the fragments for cloning into pET. The proteins were expressed 
in BL21 cells in Terrific broth (TB). Cells were then sonicated and centrifuged, 
and the supernatant was collected and filtered. Each fragment was then purified 
using FPLC. SP1772B was found not to express well, whilst SP1772A and SP1772C 
did not purify as effectively as SP1772D. Therefore SP1772D was selected for 
further use.  
BL21 cells harbouring the pET33bSP1772D plasmid were then grown on a larger 
scale, and protein was harvested in the above manner. Samples were then 
purified using FPLC and dialysed. 
The resulting protein from SP1772D cloning, expression and purification was 
analysed by mass-spec and determined to be the correct sequence, with no post-
translational modifications, showing that the section chosen was not 
glycosylated in E.coli. The protein also migrated at the correct size on a 15% SDS 
PAGE gel, to correspond to its predicted weight of 10.5 kDa (Figure 4.4). The 
protein was then used to raise an antibody. The protein was injected 
subcutaneously in mice. 
The antiserum was used in a western blot with purified SP1772D to determine if 
it would react with SP1772. The antisera did not react with SP1772D (Figure 
4.4), there was a non-specific reaction with some minor contaminating bands. 
This may have been due to a lack of immunogenicity of SP1772D. This is 
potentially due to the sequence of the protein, although analysis using MIF 
bioinformatics: Predicting Antigenic Peptides 
(http://bio.dfci.harvard.edu/Tools/antigenic.pl) suggests that there are two 
antigenic regions in this peptide fragment (see Figure 4.5). 
It appeared that this particular fragment of SP1772 was not sufficiently 
immunogenic alone to raise antibodies. 
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Figure 4.4 – Evaluation of Antisera raised against purified SP1772D 
 
 
    (a) SDS PAGE    (b) Western Blot 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) SDS PAGE and (b) western blot of purified SP1772D using antisera 
raised against SP1772. SP1772 is predicted to be 10.5kDa. The serum did 
not react with the protein, however it did react with minor contaminating 
bands just visible at the top of the SDS-PAGE gel. This suggests the 
immunisation was successful, however antibodies weren’t raised to 
SP1772D. 
250 kDa 
250 kDa 
250 kDa 
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Figure 4.5 Immunogenicity of SP1772D 
 
 
SP1772D sequence:  
VPITGTDTSFTFTPYAARTDRIGINYFNGGGKVVESSTTSQSLSQSKSLSVSASQSASAS 
 
SP1772D was analysed for immunogenicity using MIF bioinformatics: Predicting 
Antigenic Peptides (http://bio.dfci.harvard.edu/Tools/antigenic.pl). It is 
predicted that there are two antigenic regions in SP1772D. They are highlighted 
as 1 and 2 on the plot, and in red on the sequence of SP1772D below the plot.  
 
1 2 
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4.2.3 Raising an antibody to SP1772 using technology fusing an 
adjuvant to SP1772D 
Pneumolysin (ply) is a highly immunogenic virulence factor produced by 
S.pneumoniae (Feldman et al., 1990).The fusion of ply to other virulence factors 
of S.pneumoniae is predicted to make more efficient antisera against 
S.pneumoniae since ply is highly immunogenic, and the combination of two 
antigens from the ply will be more likely to elicit an immune response that 
would be effective against S.pneumoniae.  
Unpublished studies from our laboratory have shown that green jellyfish protein 
(GFP) is not immunogenic alone, however, when fused to ply, it can elicit an 
immune response in mice. By combining SP1772D to ply, the same response 
might be seen, and antibodies to SP1772 could be derived. Therefore, in order to 
raise antisera to SP1772, Gateway cloning technology (Invitrogen) was utilised to 
fuse SP1772D to ply. 
The Gateway technology is based on the bacteriophage lambda (λ) site-specific 
recombination system that facilitates the integration of bacteriophage λ into the 
chromosome of E. coli. Recombination occurs between specific attachment (att) 
sites on interacting DNA, which each possess a 15bp core region common to all, 
and differing flanking regions that provide binding sites for recombination 
proteins (Hartley et al., 2000). There are four different att sites designated 
attB, attP, attL and attR and it is these sites which are utilised by the Gateway 
technology. All vectors used in Gateway cloning contain a gateway cassette. The 
cassette contains a chloramphenicol resistance gene (CmR) and control of cell 
death gene (ccdB), flanked by att sites (Bernard et al., 1993).These are attP 
sites in the donor vector and attR sites in the destination vector. The presence 
of this cassette allows vectors with and without gene inserts to be distinguished 
as they only grow in DB3.1 E. coli cells which are resistant to the effects of the 
ccdB gene. The ‘BP’ and ‘LR’ recombination reactions constitute the Gateway 
technology and refer to the att sites being recombined in each. Figure 4.6 
outlines Gateway technology. 
The BP reaction allows genes of interest with flanking attB sites tagged on via 
specifically designed PCR primers, to be inserted into a donor vector. These  
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Figure 4.6 – Gateway technology 
 
(a) The gateway cassette 
 
(b) The BP and LR gateway reactions 
1772D
1772D
1772D1772D
 
 
(a) Features of a Gateway cassette. The cassette contains a chloramphenicol 
resistance gene (CmR) and control of cell death gene (ccdB), flanked by att 
sites. These are attP sites in the donor vector and attR sites in the destination 
vector. (b) The BP and LR reactions constituting gateway technology. The att 
sites allow recombination between the gene of interest, entry vectors and 
destination vectors to give expression vectors. Figures adapted from Gateway 
Cloning technology instruction manual (Invitrogen) 
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donor vectors possess attP sites to facilitate recombination and, between these, 
a gateway cassette. During recombination, with the aid of a BP Clonase enzyme 
mixture (Invitrogen), the gene of interest replaces the gateway cassette. 
Resulting vectors, referred to as entry vectors, contain attL sites and can be 
used for the LR reaction. 
The LR reaction allows recombination between the donor vector and a 
destination vector, which contains a gateway cassette and also a gene for the 
gene of interest to be fused to. The destination vector contains attR sites. 
During recombination, with the aid of a LR clonase enzyme mixture (Invitrogen), 
the gene of interest from the entry vector replaces the gateway cassette 
through the interaction of its attL sites and the destination vector’s attR sites. 
This creates an expression vector containing the gene of interest fused to the 
gene.  
The BP and LR reactions can be carried out in one step, by the addition of all 
vectors and the gene of interest amplified to contain attB sites to the reaction 
mixture.  
Primer 56L and primer 56M were used to amplify SP1772D from TIGR4 DNA. 
These primers were designed to contain the attB sites. An entry vector had 
previously been constructed. This vector, pET33bgatewayply (Figure 4.7) 
contained the pneumolysin gene fused to a gateway cassette. By amplifying 
SP1772D with appropriate primers, it could then be recombined into the 
pET33bgatewayply vector, to replace the gateway cassette giving 
pET33bSP1772Dply, the entry vector (Figure 4.7).  
This vector was then used to express and purify the plySP1772D fusion protein. 
The protein was then injected into mice intranasally at a molarity of 
pneumolysin known to produce antiserum (Table 1). The administration of 
protein was repeated on four occasions. The antiserum was then used in a 
western blot, and it was shown that the antiserum did not cross react with 
SP1772D, the fragment that it was raised against in fusion with ply (Figure 4.8). 
However, the antibody did react with the SP1772Dply, and therefore the 
immunisation was successful, but SP1772D appeared not to be immunogenic.  
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Figure 4.7 – Entry and Expression Vectors for Gateway technology 
 
(a) The entry vector 
 
 
(b) The expression vector 
 
 
 
 
(a) The entry vector utilised in gateway technology contains the gateway 
cassette and the pneumolysin gene. (b) Following BP and LR reactions, SP1772D 
is fused to ply in the expression clone. 
pET33bplySP1772D
6937 bp
LacI
KanR
PLY
SP1772D
N term His Tag
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T7 promoter
pBR322 ori
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pET33bGateway-PLY
8471 bp
LacI
KanR PLY
Gateway Casette
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Figure 4.8 – Evaluation of antisera raised against purified SP1772Dply 
 
 
 
 
 
 
 
 
 
 
Western blot evaluating antisera raised against purified SP1772Dply. Samples 
where there was a reaction with the antibody are denoted in bold. The serum 
reacts with purified ply and SP1772Dply, but does not react with SP1772D.  
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Table 1 – Calculating the amount of protein for intranasal vaccination with SP1772DPly 
 
Name of 
protein 
Molecular 
weight 
of 
protein 
Mass equivalent 
to 0.1 μg PLY 
Concentration 
of purified 
protein 
(μg/μl) 
Vol of prep containing  
mass of protein in 1 
dose (μl) 
Vol 
containing 
mass of 
protein in 
100 μl for 5 
doses (μl) 
      
WT Ply 
(non-His 
tagged) 53006.41 0.1 0.417   
SP1772D 90532.73 0.170795815 0.454 0.38 1.88 
      
Explanations  
MW of 
proteins 
(MW of 
protein/MW of 
Ply) x 0.1 ug  
(Mass equivalent to 
0.1 ug 
Ply/concentration) 
Vol of prep x 
5 
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4.2.4 Construction of a sortase mutant in the TIGR4 background 
SP1772 contains the LPXTG motif, and so is predicted to be cell-wall anchored 
by sortase. A mutant was constructed to knockout the sortase gene, to analyse 
whether a difference could be seen in the cellular localisation of SP1772 i.e. 
that SP1772 would be seen in the soluble fraction. The srtA gene was deleted by 
allelic replacement, as described below. 
SrtA (spr1098) and flanking DNA in the R6 genome was amplified using primers 
19H and 19I and cloned into pCR4-TOPO (Invitrogen) according to the 
manufacturer’s instructions. Primers 19W and 19X were then used to delete an 
internal fragment of srtA and introduce an AscI site between the 5’ and 3’ 
flanking sequences required for homologous recombination. Once confirmed by 
sequencing, the plasmid was digested using the AscI enzyme and an 
erythromycin cassette from pGhost5 (Biswas et al., 1993) was ligated into the 
plasmid. This plasmid was then transformed into unencapsulated TIGR4 to give 
TIGR4ΔcpsΔsrtA. 
Evaluation of the sortase mutant showed that many proteins which are in 
insoluble fraction of fp23a (unencapsulated TIGR4) are in the soluble fraction of 
TIGR4ΔcpsΔsrt (Figure 4.9), however there was no band could conclusively be 
identified as SP1772, due to the limitations of the visualisation methods used. It 
would have been useful to repeat this analysis using a glycoprotein stain, since 
coomassie stains do not always visualise glycoproteins. 
4.3 Discussion 
The RNA from each of the genes in this locus, including the SP1772 gene is 
expressed, as demonstrated by the RT-PCR presented in the previous chapter. 
The work presented here was carried out in order to show that the full protein 
product of the SP1772 gene is expressed, however this was not possible. There 
are several reasons why the protein is not able to be detected by conventional 
methods. One is that the protein too large to be resolved by SDS-PAGE, it is 
predicted to be 412kDa without glycosylation, and SDS-PAGE is typically only 
useful for separating proteins up to 500kda in size. Additionally, since the 
SP1772 and associated genes are so expensive for the cell to make, the protein is 
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predicted to be found in very low copy number in the cell, and thus present in 
concentrations below the limit of detection. To overcome this, more sensitive 
stains were used, however a band that was present in TIGR4 derivatives and not 
R6 could not be identified. A more specific glycoprotein stain could also not 
identify SP1772 by dot blot analysis since R6 reacted with the stain and thus 
probably also contains glycoproteins. Incidentally, in work with GspB it was 
noted that conventional stains were not ideal in resolving GspB, including 
glycoprotein stains (Takamatsu et al., 2004a). GspB also was not easily visualised 
using silver stain, the most successful methods used to identify GspB involved 
the use of a specific anti-GspB antibody (Bensing and Sullam, 2002). This 
antibody was raised by adsorbing antisera from a wild type strain against the  
Figure 4.9 – Evaluation of TIGR4ΔcpsΔsrt 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SDS PAGE analysis of TIGR4ΔcpsΔsrt (Fps). Cell extracts were diluted to 
contain the same amount of protein, determined by Bradford’s assay; 
then separated on a 4% SDS PAGE gel. Many proteins that are present in 
the pellet of TIGRΔcps are present in the supernatant of TIGR4ΔcpsΔsrt. 
This was predicted to be the case, since sortase anchors many proteins 
with an LPXTG motif to the cell membrane, and thus in the absence of 
sortase, proteins are no longer cell wall associated. SP1772, however, 
could not be identified. 
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proteome of a GspB mutant strain. Given the homology between GspB and 
SP1772 it was anticipated that this antibody may react with SP1772 strains. 
However, given that the glycosylation of these two serine rich repeat proteins is 
probably different, it is quite plausible that there would be no cross-reactivity. 
However, this was not the case. GspB is however, able to enter an SDS-PAGE gel 
and can be transferred by western blotting. As previously mentioned, the 
predicted size of SP1772 means that it is unlikely to even enter SDS-PAGE gels, 
and so dot blots of whole cell extracts were used with the antibody. 
It was therefore attempted to raise a specific antibody to SP1772. Given the size 
and number of repeats in SP1772, it was not able to be amplified by PCR. It was 
also deemed that without the associated glycosyl-transferases in the TIGR4 
chromosome, full SP1772 would not be stable in E.coli, as null mutants of GspB 
associated glycosyl-transferases result in either complete abolition of expression 
(GtfA and GtfB) or very limited expression (gly and nss) (Takamatsu et al., 
2004a). Therefore, selected parts of SP1772 were cloned, expressed and 
purified. A small fragment, entitled SP1772D encoding a portion of the N-
terminal and one repeat region from SRR-2 was selected as it expression and 
purification was efficient. When used to raise antisera, no specific antiserum to 
this fragment was obtained, but antibodies were raised to minor contaminating 
bands from the protein purification, demonstrating that the immunisation had 
been successful. Analysis of the fragment for immunogenicity suggested it should 
be antigenic, however it was not.  
A strategy was used to make SP1772D antigenic by gateway fusion to 
pneumolysin, a highly immunogenic pore-forming toxin encoded by 
S.pneumoniae. Previous unpublished studies had shown that green jelly fish 
protein, which is not immunogenic, could be made immunogenic by fusion to 
ply. SP1772D was therefore fused to ply and used to raise antisera. However, the 
resulting antiserum reacted with the SP1772D-ply fusion protein used to raise 
the antisera, but did not react with SP1772D alone. This strongly suggests that 
this portion of SP1772 is not immunogenic.  
Further work that could be carried out would be to evaluate other sections of 
SP1772 to raise antibodies, or alternatively to utilise the method used by Bensing 
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and colleagues to raise an anti-GspB antibody, in which specific anti-GspB 
antisera was raised by adsorption. 
One further strategy was utilised in an attempt to identify if SP1772 is expressed 
by TIGR4. A sortase mutant was constructed. Sortase has been shown to anchor 
proteins to the cell wall by their LPXTG motif. By constructing a strain of TIGR4 
without sortase, it was hoped that SP1772 would be released from the cell wall 
of the pneumococcus, and a band could be identified in the soluble fraction of 
cell lysates in the mutant that was in the insoluble fraction of cell lysates in wild 
type TIGR4. Due to the inability of SP1772 to be detected by western blot or 
SDS-PAGE, no band could be identified as SP1772, although the mutant was 
clearly successful in that a great deal of the proteome that was detectable in 
the insoluble fraction of TIGR4 was now detectable in the soluble fraction of the 
mutant strain. Further work with this mutant strain could entail concentrating 
the soluble fraction with a high molecular weight cut-off filter, and mass-
spectometry could be carried out to identifiy if SP1772 is present. The 
antibodies raised against SP1772D and SP1772Dply could also be evaluated using 
this strain, however given that they do not react with the proteins against which 
they were raised, it is unlikely that a reaction would occur. 
In order to determine if the protein is expressed in the cell, a strategy to 
determine the function of SP1772 in TIGR4 was devised by examining the 
phenotype of an SP1772 null mutant. This work is outlined in the following 
results chapter. 
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5 Construction and Analysis of SP1772 null 
Mutants 
5.1 Introduction 
In a chapter 3, it has been shown that SP1772 is present in many, but not all, 
pneumococcal strains and SP1772 RNA was shown to be expressed. Conventional 
methods were not able to determine if TIGR4 expresses SP1772, due to the 
highly unusual nature of the native gene product. We therefore sought to 
determine the function of SP1772 by constructing and examining the phenotypes 
of mutants of TIGR4 where the gene encoding SP1772 was knocked out. 
The function of SraP, a SRR protein in Staphylococcus aureus was determined by 
disrupting the gene by allelic replacement in its native strain. A mutant of 
S.aureus in this gene was compared to its parent strain for its ability to bind 
platelets, and it was found that it was deficient in its ability to do this. The 
mutant was also assessed in a rabbit model of endocarditis, and was found in 
significantly lower levels (7-fold) than its parent strain (Siboo et al., 2005). 
Many methods have been used to generate mutants in S.pneumoniae. The 
method selected for use in this instance was that used by Throup and colleagues 
to study the role of two-component signal transduction systems in the virulence 
of S.pneumoniae (Throup et al., 2000). In this method cross-over PCR is used to 
generate an insert for a plasmid which contains an antibiotic resistance cassette 
flanked by DNA which flanks the target gene in S.pneumoniae. Cross-over PCR is 
carried out by amplifying numerous fragments which are to be annealed to one 
another. Each fragment is amplified using primers with some sequence from the 
desired adjacent fragments in the final product. A PCR utilising the final 5’ and 
3’ primers and each fragment will then anneal all of the desired fragments to 
one another. The plasmid is then transformed into S.pneumoniae and 
transformants, selected on the basis of antibiotic resistance, should contain an 
antibiotic resistance cassette in place of the target gene. By careful design of 
the transforming plasmid, the gene can be cleanly replaced with an antibiotic 
resistance cassette, avoiding downstream polar affects. The absence of 
downstream polar affects can be assessed by RT-PCR of adjacent genes. 
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5.2 Results 
5.2.1 Constructing SP1772 deletion mutants in the TIGR4 
background 
5.2.1.1 Construction 
In order to delete SP1772 in TIGR4, a method of allelic replacement was used to 
replace SP1772 with an erythromycin resistance cassette (erm). This was based 
on a method developed to create a library of mutants deficient in two-
component signal transduction systems (Throup et al., 2000). 
Primers 50J, 50K, 49W and 49X were designed to amplify approximately 1kb up 
and downstream of SP1772 in the TIGR4 genome. The primers 49W and 49X 
(Figure 5.1) were designed to also contain regions homologous to an 
erythromycin cassette (Throup et al., 2000). PCRs were carried out to amplify up 
the left and right flank of SP1772, and then a crossover PCR was carried out 
using primers 50J and 50K, and the erythromycin cassette, and left and right 
flanking DNA of SP1772 as template DNA (Figure 5.2). This construct was ligated 
into Topo TA (Invitrogen), and the plasmid was transformed into E.coli Top10 
cells. The plasmid was sequenced and then used to transform an unencapsulated 
derivative of S.pneumoniae strain TIGR4. The genomic DNA of resulting 
transformants was checked by PCR and sequencing and then used to transform 
TIGR4. 
5.2.1.2 Confirmation of SP1772 deletion mutants 
Mutants were selected by the phenotype of erythromycin resistance. The 
homologous recombination replacement of SP1772 with the erythromycin 
cassette was confirmed by several PCRs. Primers 50X and 50Y were used to 
confirm the absence of SP1772, and primers were used to confirm the presence 
of genes adjacent to SP1772 in the chromosome that were not knocked out (51B 
and 51C – SP1771; 50V and 50W – SP1773). Specific primers were also used to  
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Figure 5.1 – Crossover strategy to replace SP1772 in the TIGR4 chromosome 
 
 
 
 
(a) Primers are designed 1kb up and downstream of SP1772 in TIGR4 (50J and 
50K). Primers 49W and 49X are designed to contain the sequence just up and 
downstream of SP1772, and also contain DNA homologous to the erythromycin 
cassette (marked in red). (b) Primers 49Z and 50A are used to amplify the 
erythromycin cassette from Topo erm. (c)  Left flank and Right flank of PCR 1 
and the erythromycin (erm) cassette are added to primers 50J and 50K. Tails on 
the LF and RF will anneal to the ery cassette and primers 50J and 50K will read 
through, making a PCR product that contains flanking DNA of SP1772 with the 
erm cassette in place of SP1772. This construct can then be used to transform 
TIGR4 to replace the erm cassette. 
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Figure 5.2 – Strategy to create TIGR4∆SP1772 
 
 
 
 
 
The strategy to knockout SP1772 from the TIGR4 chromosome was devised based 
on replacing SP1772 with an erythromycin resistance cassette by homologous 
recombination (Throup et al., 2000). A plasmid is created by crossover PCR that 
contains the erythromycin cassette flanked by SP1772 flanking DNA. SP1772 is 
then replaced by homologus recombination between the plasmid and the TIGR4 
genome. 
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verify that the erythromycin cassette had integrated into the chromosome of 
TIGR4 in the correct location, and that surrounding DNA had not been disrupted. 
Primers 49Z and 50A together amplify the erythromycin cassette and so primer 
50A was used with primer 50X (SP1773 end) and primer 49Z was used with primer 
51A (SP1771 start) to confirm the correct insertion. All primers are listed in 
(appendix II) and all PCRs are presented in Figure 5.3. 
5.2.2 Characterisation of SP1772 deletion mutants 
5.2.2.1 In vitro growth Curves 
In order to establish if the absence of SP1772 had an effect on the growth of 
TIGR4, the growth of the mutant was compared to WT. If the mutant strain did 
have aberrant growth from the wildtype, this has to be taken into account when 
looking at other phenotypes of the strain. Growth curves were carried out in BHI 
and by viable counting and it was confirmed that the deletion of SP1772 had no 
effect on the growth of TIGR4. BHI is a rich medium however, and to confirm the 
absence of SP1772 had no effect on growth of the strain, it would be desirable to 
also carry out a growth curve in a nutrient poor medium. 
5.2.3 Investigating the role of SP1772 in biofilm formation 
S.pneumoniae have been shown to produce biofilms in vitro. It has been noted 
that not only are many genes upregulated in a biofilm model of infection, but 
also that the number differing detectable proteins also differs significantly 
(Allegrucci et al., 2006; Moscoso et al., 2006; Oggioni et al., 2006).  
Homologues of SP1772 have been shown to be associated with biofilm formation. 
S.parasanguis contains a serine rich repeat protein, Fap1, that is required for 
biofilm formation (Froeliger and Fives-Taylor, 2001; Quin et al., 2007), essential 
in the ability of the organism to contribute to dental plaque formation.  
S.cristatus, also involved in plaque formation, also conatins a serine-rich repeat 
protein, SrpA which is involved in biofilm formation (P. S. Handley, 2005). 
SP1772 was therefore evaluated in a biofilm model, the discontinuous-culture 
model of biofilm growth developed by Moscoso and colleagues for S.pneumoniae  
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Figure 5.3 – Confirming TIGR4∆cps∆SP1772 
 
(a) Presence and absence of genes 
 
 
 
 
 
 
 
 
 
(b) Localisation and orientation of erythromycin cassette in T4∆cps∆SP1772  
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(a) Mutants were confirmed by PCRs looking for the presence and absence of 
SP1772 and surrounding genes. Present genes are denoted in bold. (b) The 
localisation and orientation of the erythromycin cassette in the TIGR4 genome 
was confirmed by PCRs using primers internal to the erythromycin cassette and 
external to the area of recombination in the TIGR4 genome. (c) RT-PCR was 
carried out on mutants. Present genes are denoted in bold. 
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(Moscoso et al., 2006). This assay utilises the ability of the bacteria to form 
biofilms of polystyrene plates.  
Strains are grown in media and then transferred to a 96-well plate. Plates are 
then incubated to allow growth and biofilm formation is determined by staining 
with 1% crystal violet at room temperature, solubilizing the biofilm with ethanol 
and determining the A595. 
Strains evaluated in this model were: T4, T4∆cps, T4∆SP1772, T4∆CPS∆SP1772 
and R6. All of the results are presented in Figure 5.4. Figure 5.5 presents the 
data anaylsed in pairs of strains.  
In the absence of capsule, compared to the wild type, the ability of TIGR4 to 
form biofilms is slightly reduced (Figure 5.5a). This is in disagreement with 
previous studies where capsule has been shown not to be required in a variety of 
pneumococcal strains, including TIGR4 and D39 (Oggioni et al., 2006) (Moscoso 
et al., 2006). However it has also been noted that capsular expression is the 
same across sessile and planktonic growth models(Oggioni et al., 2006) and that 
some capsular components expression is upregulated in biofilm models of growth 
(Allegrucci et al., 2006). It is worth noting that the observation regarding TIGR4 
was made in a different biofilm model and the observations of requirement of 
the capsule in this model was not in TIGR4 (Moscoso et al., 2006). 
In the absence of SP1772, the ability of TIGR4 to form biofilms is greatly reduced 
(Figure 5.5b). However, comparison of strains reveals that a mutant strain 
lacking both capsule and SP1772, TIGR4∆cps∆SP1772, is much more able to 
produce biofilms than TIGR4, TIGR4∆cps or TIG4∆cps∆SP1772 (Figure 5.5c). R6, 
an unencapsulated strain that does not contain SP1772, is better able to form 
biofilms than any of the TIGR4 derivatives, including TIGR4∆cps∆SP1772 (Figure 
5.4).  
5.2.4 In vivo characterisation of SP1772 deletion mutants 
Studies were carried out to determine if SP1772 plays a role in the virulence of 
S.pnuemoniae. A signature tagged mutagenesis screen of TIGR4 had previously 
demonstrated that in a competitive model of pneumonia infection in mice, 
SP1772 had a role in virulence (Hava and Camilli, 2002). We therefore sought to 
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Figure 5.4 – Evaluating SP1772 knockouts in a biofilm model 
 
(a) Biofilm growth and bacterial growth in a biofilm model 
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Summarized data of bacterial growth and biofilm formation of S.pneumoniae 
strains and mutants in a biofilm model. Strains studied were TIGR4, TIGR4∆cps, 
TIGR4∆SP1772, TIGR4∆cps∆SP1772 and R6. 
(a) The bacterial growth and biofilm formation of each strain studied. Filled and 
open bars indicate growth and biofilm formation, respectively. 
(b) The ability for each strain to form biofilms is illustrated. The values have 
been normalized for absorbance, and the percentages calculated in relation to 
R6.Direct strain comparisons are presented in Figure 5.5. 
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Figure 5.5 – Evaluating SP1772 knockouts in a biofilm model – comparison 
between strains 
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T4 ∆cps/T4 ∆cps ∆SP1772
0.000
0.500
1.000
1.500
2.000
2.500
3.000
3.500
T4 ∆cps T4 ∆cps ∆SP1772
Bacterial growth
Biofilm formation
 
 
Chapter 5 Construction and Analysis of SP1772 null Mutants 
129 
Comparison in pairs of biofilm generated in TIGR4 and mutants in the capsule 
region and SP1772. 
(a) Bacterial growth and biofilm formation of TIGR4 and TIGR4∆cps. TIGR4 is less 
able to form biofilms in the absence of capsule. 
(b) Bacterial growth and biofilm formation of TIGR4 and TIGR4∆SP1772. TIGR4 is 
less able to form biofilms in the absence of SP1772. 
(c) Bacterial growth and biofilm formation of TIGR4∆cps and TIGR4∆SP1772. In 
the absence of both capsule and SP1772, the TIGR4 is able to form more biofilm 
than either wt or TIGR4∆cps 
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compare the virulence of TIGR4 with TIGR4∆SP1772 to see if the latter was 
attenuated in various single strain models of infection in mice. The relationship 
between capsule and SP1772 could not be evaluated in in vivo models, since 
unencapsulated strains of TIGR4 are unable to cause disease in animal models. 
5.2.4.1 Intraperitoneal infection and generation of standard 
Innocula 
The mutant, TIGR4∆SP1772, and the parent wild type strain, TIGR4, were given 
intraperitoneally (i/p) to generate standard innocula for future experiments and 
to assess any difference in virulence by this route of infection. 100µl of 107 
CFU/ml (colony forming units/ml) was injected into 5 MF-1 (outbred) mice for 
each strain. After 20 h mouse number one from each strain was culled and bled 
to prepare standard innocula. The rest were tail bled at 24 h to measure 
bacterial levels in the blood and monitored for disease progression and survival.  
The following blood counts were calculated, and showed no difference by this 
route of infection: Mean+/- SEM TIGR4 5.47 +/- 0.44 log10 CFU/ml TIGR4∆SP1772 
5.58 +/- 0.37 log10 CFU/ml. There was no difference in survivalof animals 
treated with the different strains. These data are presented in Figure 5.6. 
5.2.4.2 Investigating the role of SP1772 in a pneumonia model of 
infection 
TIGR4∆SP1772 and TIGR4 were then given intranasally (i/n) to assess any 
difference in virulence in a pneumonia model of infection. 50 µl of 106 CFU/ml 
was injected into the nares of 5 anaesatized MF-1 (outbred) mice for each 
strain. Bacterial counts were taken at 24 h from the lungs and blood. Survival 
was then monitored. The following blood counts were calculated, and showed no 
difference by this route of infection: Mean+/- SEM TIGR4 6.10 +/- 1.81 log10 
CFU/ml; TIGR4∆SP1772 5.40 +/- 2.06 log10 CFU/ml. There was no difference in 
survival either. These data are presented in Figure 5.7. 
Data were then published by Obert et al in which a mutant in the TIGR4 
background of SP1772 was generated by insertion-duplication (Obert et al., 
2006). When evaluated in a pneumonia model of infection, it was found that 
SP1772 was required for the full virulence of TIGR4 in mice. The experiments  
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Figure 5.6 – Intraperitoneal passage of TIGR4 and TIGR4∆SP1772 
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(a) Log of counts of bacterial in the blood of MF-1 24 h post infection 
intraperitoneally with 106 CFU TIGR4 or TIGR4∆SP1772. Each animal is 
represented by a dot, with the mean represented by the horizontal line. (b) 
Survival curve from the experiment described above.  
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had been done using Balb/c (inbred) mice, using 107 CFU/ml in a 50 µl volume. 
We therefore sought to repeat this model of infection, to determine if we could 
see an attenuation in virulence with our mutant by this model. We also repeated 
our model of infection for pneumonia in parallel. Survival data and blood counts 
are presented in Figure 5.8 (MF-1) and Figure 5.9 (Balb/c). In both strains of 
mice no difference in virulence was seen between TIGR4 and TIGR4∆SP1772.  
5.2.4.3 Investigating the role of SP1772 in a colonisation model of 
infection 
S.pneumoniae is normally found in a commensal state in the human host. It will 
not, in most instances of human contact, cause disease. However when it does 
cause disease, the bacteria has usually colonised the human host prior to this. 
Given that we had not seen a role for SP1772 in invasive disease by our models, 
we sought to investigate whether SP1772 has a role in colonisation. 
TIGR4∆SP1772 and TIGR4 were given intranasally (i/n) to assess any difference in 
virulence in a colonisation model of infection. 10 µl of 106 CFU/ml was injected 
into the nares of 5 anaesatised MF-1 (outbred) mice for each strain. 
Nasopharyngeal washes (2 ml) and nospahryngeal tissue counts were taken at 
day 5. The following counts were calculated, and showed a difference in 
colonisation after 5 days, however this wasn’t significant. These data are 
presented in Figure 5.10.  
5.3 Discussion 
The work presented in this chapter shows SP1772 has an unusual role in biofilm 
formation, that is linked to the presence of capsule. Several studies have shown 
that capsule is not required for biofilm formation in vitro by examining the 
behaviour of isogenic mutants with the capsule knocked out (Donlan et al., 
2004; Moscoso et al., 2006). However, other studies have noted that capsular 
expression is not down-regulated in a biofilm model (Oggioni et al., 2006) and 
also that proteins involved in the synthesis of capsule are upregulated 
(Allegrucci et al., 2006). These observations taken together suggest that whilst 
capsule is not required for biofilms to form, that in its presence, biofilm 
formation is not inhibited. However, Moscoso and colleagues suggest that in fact  
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Figure 5.7 – Pneumonia intranasal infection model of TIGR4 and 
TIGR4∆SP1772 
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(c) Survival 
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(a) Log of counts of bacteria in the blood of MF-1 24 h post infection intransally 
with 106 CFU/ml TIGR4 or TIGR4∆SP1772. Each animal is represented by a 
symbol, with the mean represented by the horizontal line. (b) Log of counts of 
bacteria in the lungs of MF-1 mice from the experiment described above. (c) 
Survival curve from the experiment described above.  
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Figure 5.8 – MF-1 (CB) Pneumonia infection model of TIGR4 and 
TIGR4∆SP1772 
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(a) Log of counts of bacteria in the blood of MF-1 12 h and 24 h post infection 
intransally with 106 CFU TIGR4 or TIGR4∆SP1772. Each animal is represented by a 
symbol, with the mean represented by the horizontal line. (b) Survival curve 
from the experiment described above.  
 
Chapter 5 Construction and Analysis of SP1772 null Mutants 
136 
Figure 5.9 – Balb/c (CB) Pneumonia infection model of TIGR4 and 
TIGR4∆SP1772 
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(a) Log of counts of bacteria in the blood of balb/c 2 d and 3 d post infection 
intransally with 107 CFU TIGR4 (T4) or TIGR4∆SP1772 (T4∆S). Each animal is 
represented by a symbol, with the mean represented by the horizontal line. (b) 
Survival curve from the experiment described above.  
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Figure 5.10 – Colonisation model of TIGR4 and TIGR4∆SP1772 
 
(a) Nasopharyngeal wash 
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(a) Log of counts of bacteria from a nasopharyngeal wash of MF-1 mice 5 d post 
infection intransally with 106 CFU TIGR4 or TIGR4∆SP1772. Each animal is 
represented by a symbol, with the mean represented by the horizontal line. (b) 
Nasopharyngeal tissue counts from the experiment described above, also taken 5 
d post infection. 
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biofilm formation can be reduced by more than 60% in the presence of capsule 
by comparing unencapsulated and capsulated strains. Isogenic mutants with 
different capsule types similarly were less able to produce biofilms (Moscoso et 
al., 2006). However the authors also note that presumably, given that biofilms 
are composed predominantly of extracellular polysaccharides, it is premature to 
discount a role for the pneumococcal capsule in biofilm formation.  
Capsule production has been shown to be tightly regulated, and this is due to 
the importance in its levels in different settings of the pneumococcus. For 
instance, in attachment to human cells it has been shown that the capsule is 
down-regulated (Hammerschmidt et al., 2005) however the pneumococcus must 
maintain the ability to produce capsule, since it is unable to further cause 
disease without a capsule. 
A recent study has identified that some single colony variants arise in biofilms 
(Allegrucci and Sauer, 2007). This could be due to the conditions in biofilms such 
as less oxygen promoting less capsule production (Weiser et al., 1994) and also 
more H2O2 promoting a higher mutation rate (Pericone et al., 2000). However, it 
still suggests that it could be favourable, in some circumstances, to the 
pneumococcus for this to occur. This is interesting, since unencapsulated 
mutants will not be able to go on and cause invasive disease in the host. The 
biofilm therefore is perhaps a safe haven for the unencapsulated mutants. Since 
biofilms are ideal settings for the exchange of genetic material, it is also 
possibly that these single colony variants can reside here to act as a recipient or 
donor of genetic material. 
Nonetheless, the role of capsule in biofilm formation, if it does indeed have a 
role remains to be determined. Our studies suggest that biofilm formation in 
TIGR4 is slightly improved in the presence of the capsular locus. This is in 
disagreement with a study in which the TIGR4 capsule was shown not to have a 
role in biofilm development (Donlan et al., 2004), however this study utilised a 
different biofilm model. It is also in disagreement with the observation in this 
model that the presence of capsule limits biofilm formation (Moscoso et al., 
2006), however TIGR4 was not utilised in this study. This result is in agreement 
with the observation that capsular expression levels are similar in a biofilm 
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mode of growth as in liquid medium (Oggioni et al., 2006), and also that some 
capsule proteins are upregulated in biofilms (Allegrucci et al., 2006). 
The observation that encapsulated TIGR4 in the absence of SP1772 is impaired in 
its ability to form biofilms implies a role for SP1772 in biofilm formation. This 
difference in phenotype shows SP1772 must be produced by the cell, although a 
it does not define its role in S.pneumoniae. This would be in agreement with 
observations that homologues of SP1772 have been shown to be involved in 
biofilm development (Froeliger and Fives-Taylor, 2001; P. S. Handley, 2005; Quin 
et al., 2007). The size of SP1772 at 412kDa, and its putative location at the cell 
surface (due to the presence of the LPTXG motif and associated secretion 
machinery) suggest that SP1772 extends potentially beyond the capsule and 
could mediate contact with other cells. In its absence but in the presence of 
capsule, cells may be less likely to form biofilms. 
Several studies have noted the expense for the cell to switch from planktonic to 
sessile growth. It is feasible, given the expense to the cell of synthesising SP1772 
and all of the additional genes required for its full expression, that in its 
absence, cells have more energy to produce the components of a biofilm.  
There is no in vivo biofilm model at present however it has also recently been 
noted that the gene expression profile of pneumococci in a biofilm model is very 
similar to the expression of pneumococci in tissue models of infection (Oggioni 
et al., 2006). 
SP1772 null mutants were also evaluated in animal models of disease. 
Previously, SP1772 had been identified as involved in pneumococcal pneumonia 
in a STM screen of TIGR4 (Hava and Camilli, 2002). SP1772 was shown in a 
competitive model of infection to contribute to virulence. In our studies, which 
were single strain infection models, SP1772 deficient mutants were no less able 
to cause disease than the wild type, including a pneumonia model of infection. 
Future work with respect to this result would be to repeat the competitive 
model of infection, using the same dose and breed of mouse. 
Consequently, a study was published that showed that when SP1772 in TIGR4 is 
disrupted by a method of insertion-duplication, the mutant strain is severly 
impaired in its ability to cause pneumonia in a mouse model of infection 
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compared to the wild type strain (Obert et al., 2006). The model of infection 
differed from that which we had used previously, in that the strain of mouse 
differed, as did the innoculum.  
It has been noted in other studies that variation across studies is seen with the 
pneumococcus. For instance, in a gene expression study by Oggioni and 
colleagues (Oggioni et al., 2006) they note that while their data fit well with 
those described in another study in a sepsis model (Orihuela et al., 2004), the 
same two studies differ in their results from a meningitis model of infection. The 
authors attribute this to differences in host species, challenge dose and time of 
sampling in the two models. They further note that when compared to yet 
another study (LeMessurier et al., 2006), the tissue infection results concur, but 
there is a discrepancy in the results from the sepsis model (Oggioni et al., 2006). 
We therefore repeated the model of infection used in the study that had 
identified a role for SP1772 in virulence (Obert et al., 2006), however the 
mutant strain constructed in our laboratory was no less able to cause infection in 
this model than the wild type. Presumably the differences arising therefore in 
the behaviour of the strains is due to the differing approaches to constructing 
the mutants. Certainly the RNA expression patterns of the two mutants differ, in 
a later publication by the same group, the authors confirm that the mutant they 
have constructed by insertion duplication does not have polar affects on 
neighbouring genes in the chromosome of SP1772: SP1771 and SP1773 (Rose et 
al., 2008). This is demonstrated by northern blot. This is in disagreement with 
RT-PCR studies from our laboratory which show that SP1773 RNA is not expressed 
in either TIGR4 Chapter 3 or TIGR4∆SP1772 (This chapter, Figure 5.3). 
There’s also the possibility that mouse model isn’t suitable. This gene is clearly 
highly variable (chapter 1, chapter 4) and that could be a host response. 
Therefore it may not play a role in mice, like it does in humans, or the receptor 
in mice is different and it would take many serial passages through mice to see 
this. It would be interesting to Southern blot the DNA from the resulting culture 
to see if there was variation in size. It would also be interesting to do the same 
in the strain in human blood. 
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6 Analysis of SP1772 in Inv200  
6.1 Introduction 
In chapter 3, S.pneumoniae strains being sequenced at the Sanger Centre were 
annotated for genes in RD20 where they were present (Figure 6.1). It was noted 
that SP1772 in Inv200 was far smaller, at 3.3kb, than in any of the other strains. 
In TIGR4 SP1772 is 14.3 kb, in 23F 13.1 kb and in Inv104b it is 13.8 kb.  
There were many issues in working with a gene and predicted product of a large 
size, which were not seen in work describing other smaller SP1772 homologues 
(Bensing and Sullam, 2002; Siboo et al., 2005). Studies were therefore carried 
out with Inv200 SP1772, in the hope of overcoming some of the issues relating to 
the size of TIGR4 SP1772.  
Primarily, at 3.3 kb it was deemed possible to amplify SP1772 in Inv200. Upon 
amplification by PCR it was noted that there were many bands of several 
different sizes of the gene and therefore the studies in this chapter sought to 
characterise the heterogenous population resulting from PCR amplification of 
Inv200 SP1772. 
6.2 Results 
6.2.1 Southern blotting 
In order to confirm the size of Inv200 SP1772 a southern blot was devised to 
compare SP1772 in Inv200 with TIGR4 SP1772. A suitable enzyme which would 
digest the DNA whilst leaving SP1772 intact was using Vector NTI (Invitrogen). 
The enzyme was SspI (Figure 6.2a). A probe was then designed that would 
incorporate a non repeat region, and also repeat region of SP1772. Primers were 
designed using the TIGR4 genome (Tettelin et al., 2001). The 3’ primer (56O) 
sequenced through a repeat region, and thus allowed a heterogenous probe 
containing different amounts of repeat region to maximise the chance of the 
probe annealing to the DNA (Figure 6.2b, 6.3a). The 5’ primer (56N) sequenced 
through a non-repeat region upstream of the repeat 
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Figure 6.1 – Annotation of sequenced strains containing RD20 
 
(a) Table showing functions of genes in RD20 in sequenced strains 
 
 
(b) Annotated RD20 in sequenced strains 
 
 
(a) Genes grouped by function in RD20 in sequenced strains. (b) RD20 in Inv104b, 
23F and Inv200. Each ORF was predicted, and the translated protein product was 
blasted against TIGR4. Functions were assigned on the basis of homology. 
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Figure 6.2 – Designing a southern blot to detect SP1772 
 
(a) Selecting a suitable restriction enzyme 
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(b) Designing an appropriate probe 
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(a)A suitable restriction enzyme to digest TIGR4 DNA to get the whole SP1772 
gene was found by mapping all available restriction enzymes against the target 
sequence using Vector NTI. SSpI was chosen on the basis that it cut the genome 
at an appropriate point to obtain a suitably sized fragment containing SP1772. 
(b) A probe was designed to incorporate both repeat (SRR-1) and non-repeat 
region from SP1772. The reverse primer was designed to anneal to a repeat 
region, to give a probe heterogenous in size. 
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Figure 6.3 – Southern blotting to detect SP1772 
 
(a) Probe PCR 
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(b) Genomic DNA digestion for Southern blot 
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(a) PCR of the SP1772 probe. The 3’ primer was designed to anneal to a repeat 
region, and so the probe is heterogenous in size. (b) Genomic DNA was digested 
using SSpI, and run on a gel to confirm digestion. Digestion of DNA by specific 
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enzymes generally leads to a smear down the gel since there are many different 
sizes of DNA present. (c) A southern blot confirming the size of SP1772 in TIGR4 
is bigger than that of Inv200. 
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region in SP1772. The southern blot confirmed that SP1772 in TIGR4 is far larger 
than Inv200 SP1772 (Figure 6.3). Interestingly, the predominant band of SP1772 
in Inv200 appeared to be smaller than the 3.3kb size determined by whole 
genome sequencing at the Sanger Centre. Due to the confirmed smaller size of 
Inv200 SP1772, it was thought it would be possible to amplify the gene by PCR. 
6.2.2 PCR optimisation 
Genomic DNA was extracted from a culture grown from a single colony of 
S.pneumoniae strain Inv200. Primers 56F and 56G were then used to amplify the 
homologue of SP1772 from Inv200. Primers were designed against the sequence 
available from ongoing sequencing projects at the Sanger Centre. A variety of 
enzymes were used to do this, Invitrogen Taq Hi-Fi was the enzyme that was 
successful. The product was predicted to be 3.3kb. The resulting PCR mixture 
was run on a gel and it was noted that there was a mixture of products, of 
varying sizes, notably none of 3.3kb (Figure 6.4). This did not match with what 
had been observed in the southern blot of appropriately digested TIGR4 and 
Inv200 gDNA, where it appeared that there may be many forms of TIGR4 SP1772, 
but Inv200 SP1772 appeared to be only present in one form. The resulting PCR 
products were therefore analysed, in an attempt to determine if there were 
varying forms of Inv200 present in the cell, and the sequence of these different 
forms.  
6.2.3 Cloning 
The mixture from the PCR of Inv200 SP1772 was cloned into Topo TA 
(Invitrogen). Successful clones were selected from a plate and colony PCR was 
carried out using plasmid specific primers 7F and 7G.  The reactions gave bands 
of several different sizes, as shown in Figure 6.5a. It is worth noting that PCR of 
all clones resulted in only one clear band. There weren’t multiple bands seen in 
the PCR of any clones from the original PCR. This negated the possibility that the 
heterogenous population of products from the original PCR of SP1772 in Inv200 
was due to enzyme slippage, and not due to the presence of many different sizes 
of SP1772 in Inv200. Selected clones were re-run in approximate size order to 
further evaluate the differences in size present (Figure 6.5b). The clones that 
appeared to be representative of the different sizes present were selected for  
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Figure 6.4 – PCR of In200SP1772 
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(a) Primers 56F and 56G are designed to amplify SP1772 in Inv200. A PCR using 
primers 56F and 56G to amplify Inv200 SP1772. The PCR resulted in many bands, 
the predominant bands being at ~ 0.8, 1.8 and 2.0 kb. 
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Figure 6.5 – PCR of clones resulting from PCR of Inv200SP1772 
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(a) PCR was carried out using primers T7 and 56G to determine the size of 
SP1772 present in each plasmid. (b) Clones were re-ordered approximately 
according to size in order to select representative clones of each size for 
sequencing. 
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sequencing, to identify what the sequences were, if they were in frame and 
could still be functional proteins and identify sites of recombination within the 
gene. Since the amplification of each clone in E.coli resulted in single bands, 
even for large clones, it was deemed that the original amplification from 
S.pneumoniae, which resulted in multiple bands, was due to a heterogenous 
population of SP1772 in Inv200 and not due to enzyme slippage or PCR error. 
6.2.4 Sequence data of all clones 
The 5 clones selected from the PCR of Inv200 SP1772 were sequenced at the 
Sanger centre. The resulting sequences were aligned against the Inv200 genome 
and the sequences were matched to the correct place in the Inv200 genome. 
Data for each clone is shown in Figures 6.6-6.10, and discussed below. Data for 
all clones is shown in Figures 6.11 and 6.12. Figure 6.11 presents the DNA 
sequences of each clone mapped against the full sequence of Inv200 SP1772, and 
Figure 6.12 presents the amino acid sequences encoded by each clone mapped 
against the predicted amino acid sequence of full Inv200 SP1772, annotated with 
features.  
All clones contained part of the N-terminal and part of the C-terminal. In all 
instances the start and stop codons of Inv200 SP1772 were present. All clones 
were also found by sequencing to be in-frame. 
Clone 1 is presented in Figure 6.6. It is 672bp long (additional sequence is coded 
in green and represents the plasmid). It contains 332bp of the N-terminal (shown 
in red) and 340bp of the C-terminal (shown in blue) of full length Inv200 SP1772. 
Recombination appears to have occurred between SRR-1 and SRR-2, as 
demonstrated by sequencing and shown in Figure 6.11 for all clones.  
Recombination has occurred mid-codon, and has caused GCG to change to GCA, 
however an alanine residue is still encoded by this codon. 
Clone 5 is presented in Figure 6.7. It is 642bp long. It contains 362bp of the N-
terminal and 281bp of the C-terminal of full length Inv200 SP1772. 
Recombination appears to have occurred between SRR-1 and SRR-2. 
Recombination has occurred mid-codon, and has caused ACA to change to ACC, 
however a threonine is still encoded by this codon. 
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Figure 6.6 – Analysis of Inv200SP1772 Clone 1 
 
(a) Sequence analysis by BLAST 
 
 
 
 
(b)Annotation of the sequence against the full sequence 
inv200monster c lone1
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(a) The sequence of the clone was BLASTED against the full sequence of Inv200 
in parts to find the homology. The red indicates the N-Terminal portion, blue 
indicates the C-Terminal portion, whilst green indicates TopoTA sequences. 
Therefore the point between red and blue indicates the site of recombination. 
Clone 1 is 672bp long. It contains 332bp of the N-terminal and 340bp of the C-
terminal of full length Inv200 SP1772. Recombination has occurred mid-codon, 
and has caused GCG to change to GCA, however an alanine residue is still 
encoded by this codon. (b) The sequence of the clone is indicated against the 
full sequence, obtained by sequencing of Inv200 at the Sanger Institute. 
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Figure 6.7 – Analysis of Inv200SP1772 Clone 5 
 
(a) Sequence analysis by BLAST 
 
 
(b)Annotation of the sequence against the full sequence 
inv200monsterc lone5
sp1772
5 5  
 
 
 
(a) The sequence of the clone was BLASTED against the full sequence of Inv200 
in parts to find the homology. The red indicates the N-Terminal portion, blue 
indicates the C-Terminal portion, whilst green indicates TopoTA sequences. 
Therefore the point between red and blue indicates the site of recombination. 
Clone 5 is 642bp long. It contains 362bp of the N-terminal and 281bp of the C-
terminal of full length Inv200 SP1772. Recombination has occurred mid-codon, 
and has caused ACA to change to ACC, however a threonine is still encoded by 
this codon. (b) The sequence of the clone is indicated against the full sequence, 
obtained by sequencing of Inv200 at the Sanger Institute. 
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Figure 6.8 – Analysis of Inv200SP1772 Clone 6 
 
(a) Sequence analysis by BLAST 
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(b)Annotation of the sequence against the full sequence 
inv200monsterc lone6
sp1772
6 6
 
 
 
 
(a) The sequence of the clone was BLASTED against the full sequence of Inv200 
in parts to find the homology. The red indicates the N-Terminal portion, blue 
indicates the C-Terminal portion, whilst green indicates TopoTA sequences. 
Therefore the point between red and blue indicates the site of recombination. 
Clone 6 is 1673bp long. It contains 1378bp of the N-terminal and 295bp of the C-
terminal of full length Inv200 SP1772. Recombination has occurred between two 
full codons. (b) The sequence of the clone is indicated against the full sequence, 
obtained by sequencing of Inv200 at the Sanger Institute. 
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Clone 6 is presented in Figure 6.8. It is 1673bp long. It contains 1378bp of the N-
terminal and 295bp of the C-terminal of full length Inv200 SP1772. 
Recombination appears to have occurred within SRR-2. Recombination has 
occurred between two full codons. 
Clone 8 is presented in Figure 6.9. It is 1773bp long. It contains 1607bp of the N-
terminal and 166bp of the C-terminal of full length Inv200 SP1772. 
Recombination appears to have occurred within SRR-2. Recombination has 
occurred mid-codon, but the new codon is still ACA, which encodes alanine. 
Clone 16 is presented in Figure 6.10. It is 1749bp long. It contains 1433bp of the 
N-terminal and 316bp of the C-terminal of full length Inv200 SP1772. 
Recombination appears to have occurred within SRR-2. Recombination has 
occurred mid-codon, and has caused GCA to change to GCG, however an alanine 
is still encoded by this codon.  
It appeared that the resulting truncated clones of SP1772 were either from 
recombination between SRR-1 and SRR-2 or from within SRR-2. It is interesting 
that in all cases, clones remain in frame, and therefore would still encode a SRR. 
The recombination in clone 8 resulted in two full codons from each part of 
SP1772 remaining adjacent to one another. In the case of clones 1, 5, 8 and 16 
recombination has occurred in the middle of a codon, and in the case of clones 
1,5 and 16 a different codon is produced. However in all cases, the same amino 
acid is still encoded at that position.  
This implies that this process is highly regulated in S.pneumoniae, and suggests 
that it may be of importance to strains to be able to produce truncated forms of 
SP1772. 
Interestingly, none of the clones sequenced contained the full predicted 
sequence of Inv200 SP1772. All of the original PCR products were examined, and 
no product was larger than ~2kb. The southern blot also suggests that the 
predominant product is smaller than 3.3kb. Inv200 SP1772 was found to be 3.3kb 
in the strain sequenced at the Sanger Centre. It was possible that due to passage 
of the strain, the 3.3kb full SP1772 was no longer the predominant size of  
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Figure 6.9 – Analysis of Inv200SP1772 Clone 8 
 
(a) Sequence analysis by BLAST 
 
 
 
(b)Annotation of the sequence against the full sequence 
inv200monsterc lone8
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(a) The sequence of the clone was BLASTED against the full sequence of Inv200 
in parts to find the homology. The red indicates the N-Terminal portion, blue 
indicates the C-Terminal portion, whilst green indicates TopoTA sequences. 
Therefore the point between red and blue indicates the site of recombination. 
Clone 8 is 1773bp long. It contains 1607bp of the N-terminal and 166bp of the C-
terminal of full length Inv200 SP1772. Recombination has occurred mid-codon, 
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but the new codon is still ACA, which encodes alanine. (b) The sequence of the 
clone is indicated against the full sequence, obtained by sequencing of Inv200 at 
the Sanger Institute. 
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Figure 6.10 – Analysis of Inv200SP1772 Clone 16 
 
(a) Sequence analysis by BLAST 
 
 
 
(b)Annotation of the sequence against the full sequence 
inv200monsterc lonesanalysis
sp1772
16 16
 
 
 
(a) The sequence of the clone was BLASTED against the full sequence of Inv200 
in parts to find the homology. The red indicates the N-Terminal portion, blue 
indicates the C-Terminal portion, whilst green indicates TopoTA sequences. 
Therefore the point between red and blue indicates the site of recombination. 
Clone 16 is 1749bp long. It contains 1433bp of the N-terminal and 316bp of the 
C-terminal of full length Inv200 SP1772. Recombination has occurred mid-codon, 
and has caused GCA to change to GCG, however an alanine is still encoded by 
16 
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this codon. (b) The sequence of the clone is indicated against the full sequence, 
obtained by sequencing of Inv200 at the Sanger Institute. 
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Figure 6.11 – Alignment of all clones against Inv200 SP1772 DNA 
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The sequence of all analysed clones is indicated against the full sequence of 
Inv200 SP1772, obtained by sequencing of Inv200 at the Sanger Institute. All of 
the gene products sequenced were in frame when translated to protein 
sequence, as shown in Figure 6.12.  
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Figure 6.12 – Alignment of all clones against Inv200 SP1772  
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The sequence of all analysed clones is indicated against the full translated 
protein sequence of Inv200 SP1772, obtained by translation of the Inv200 SP1772 
sequence in Vector NTI (Invitrogen). 
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SP1772 in Inv200. The corresponding area of the DNA gel to 3.3kb was cloned 
into Topo TA, however no clones resulted. This was done in order to establish if 
there was a minor quantity of full SP1772 present, however was not successful. 
This could be due to full SP1772 not being present, being present in too small a 
quantity or alternatively not being able to be amplified by PCR. 
6.3 Discussion 
SP1772, like other serine rich repeat proteins, contains 2 repeat regions: one 
small region at the N-terminal, and a much larger C-Terminal region. In the 
Inv200 genome, the first naturally truncated homologue of TIGR4 SP1772 was 
identified in S.pneumoniae. It was of a size that could be amplified by PCR.  
Amplification of this gene resulted in products of varying size. The results 
presented in this chapter show that, in Inv200, SP1772 is heterogenous in size 
when grown in liquid culture. Different sizes of the gene were detected, ranging 
from 642bp-1773bp. Smaller clones 1 and 5 resulted from recombination 
between SRR-1 and SRR-2 within SP1772, resulting in the complete loss of the 
region encoded between SRR-1 and SRR-2. Larger clones 6, 8 and 16 resulted 
from recombination within SRR-2, resulting in clones truncated only in the size 
of SRR-2. All sequenced clones were found not to have altered their sequence at 
all, and were all in frame. Where recombination had occurred mid-codon, the 
resulting codon still encoded the amino acid that would have occurred at the N-
terminal portion. The differing sizes of clones suggest that recombination could 
be successive. For instance, Clone 6, 8 and 16 could all represent an 
intermediate size that SP1772 recombines to before it goes further to the size of 
clones 1 and 5. However, it is interesting that the site of recombination is 
different for all 5 clones sequenced. Due to the highly repetitive nature of the 
SRRs, it is not surprising that recombination occurs within these regions, nor 
perhaps that the site of recombination is not identical.  
The presence of two different approximate sizes of SP1772 in Inv200 suggests 
that these sizes of SP1772 could be useful to the strain, or that the gene is 
successively getting smaller, either to then increase in size upon immune 
pressure (although the complete absence of the region between SRR-1 and SRR-2 
would presumably the negate the ability for this to be reformed without 
homologous recombination) or else that the strain is attempting to rid itself of 
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the gene entirely. This would also be logical, since the locus is both expensive to 
harbour and to synthesise, and there is possibly no pressure on the strain to 
maintain the locus in liquid culture i.e. the locus is presumably not required for 
pneumococal growth given that it is absent in many pneumococcal strains. Also, 
although not presented here given time constraints in the ability to evaluate the 
mutant, a mutant of SP1754-SP1773 was constructed in the TIGR4 background 
and found to be viable, showing that the locus is not required for viability where 
it is commonly associated with a strain.  
Presumably there is a pressure driving the recombination of SP1772 in Inv200. It 
is not clear what this is, although as speculated above, it could be that the 
growth of the strain in BHI results in this. It would be interesting to analyse the 
behaviour of this gene in blood culture or in vivo models. It would also be 
interesting to grow cultures containing a truncated SP1772 in blood culture or 
passage them to see if their size can increase. 
Since the gene is cell-surface exposed, it may be a form of immune evasion that 
the gene can alter in its size. It may also be that the target that SP1772 
interacts with in the human host can alter from host to host, and the gene 
adapts to this. It is interesting to note that Inv200 contains far fewer 
glycosyltransferases, and therefore this may be a development over time. The 
glycosyltransferases present in TIGR4 may exhibit some functional redundancy, 
and may in the evolution of the bacteria disappear. Alternatively, it could be 
that the size of SP1772 has been increasing, and new glycosyltransferases were 
acquired/copies of existing ones in the genome were copied to make the gene 
even more capable of immune evasion.  Different glycosyltransferases will 
glycosylate in different ways. Different sugar residues are attached to the 
protein backbone and can interact with targets in different ways. The number of 
glycosyltransferases is reflective of the diversity where they are also diverse – 
and perhaps a divergence in this chromosomal region allows a diversity in host 
target interaction. Serotype 14 strains (such as Inv200) might have evolved to 
interact with a different target than Serotype 4 strains (such as TIGR4). Although 
both are involved in invasive disease it may be a subtle indication of the role 
that SP1772 is responsible for being different in these hosts, or that the capsular 
type is variant in its acceptance of the presence of SP1772. The locus appears to 
be always present in serotype 4 strains, but can differ in its presence in 
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serotype14 strains. Serotype 14 ST9 is commonly recovered from invasive disease 
as are serotype 4 strains (Enright and Spratt, 1998; Hausdorff et al., 2000; 
McGee et al., 2001) as evidenced by the fact that both serotypes have been 
included in the pneumococcal vaccine Prevnar (Black et al., 2000).  
The slight difference in the other pneumococcal sequenced strains of SP1772 
also suggests recombination within the gene can occur. The much different ASL 
associated with Inv200 SP1772 is what suggests it is far more divergent than that 
in other sequenced pneumococcal strains. S.pneumoniae has been shown to 
acquire genetic material from other species, the most illustrative example of 
this is the acquisition of the penicillin binding proteins, conferring penicillin 
resistance on the pneumococcus, acquired from S.mitis (Dowson et al., 1993). 
S.pneumoniae has been shown to occupy the same niche as other bacteria and is 
extremely competent at acquiring DNA, not just from other strains of 
pneumococci, but also from other closely related species (Claverys and 
Havarstein, 2007; Johnsborg et al., 2007; Johnsborg et al., 2008). However, 
comparison of the Inv200 ASL with other species harbouring an ASL shows it is 
even more divergent from these, which, based on the evidence we have thus 
far, suggests that the locus was acquired into the pneumococcal population and 
that in Inv200 this locus has subsequently diverged in two particularly able 
regions: the SRR protein and the region downstream from it. The fact that this 
region is also divergent in other species presumably points to the fact that this 
region is able to diverge, as oppose to it having been acquired from elsewhere.  
The variation of the locus in characterised strains of gram positive bacteria is 
shown in Chapter 3, Figure 3.7. S.gordonii and S.aureus both have the region 
SP1771-SP1764 missing and in S.algalactiae it is different, in that it encodes 
fewer glycosyl-transferases, and it encodes transposases. In S.parasanguinis 
SP1772-SP1764 and asp4 and asp5 are missing (Wu et al., 2007), interestingly, 
while these latter two have been shown to be essential for the secretion of GspB 
in S.gordonii (Takamatsu et al., 2005) they have also been shown to be missing 
in S.aureus (Siboo et al., 2005). It could be speculated that the size of SRR 
defines the number of accompanying genes, however, in S.algalactiae the SRR is 
much truncated from that S.gordonii, S.aureus or S.parasanguinis, and yet the 
ASL encodes more genes (Takamatsu et al., 2004). 
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It is worth noting that the southern blot to identify SP1772 in TIGR4 and Inv200 
suggests that there is a heterogenous population of SP1772 in TIGR4, and not in 
Inv200. TIGR4 SP1772 is too big to amplify, and simply results in a smear down 
the gel. This is probably because the gene is so large that the respective 
amounts of each size of SP1772 are not easy to distill into distinct bands. It 
would be interesting to clone the smear and analyse these clones. Perhaps 
Inv200 does not appear heterogeneously on a southern blot because the most 
predominant size is the one that appears on the blot. It would be informative to 
carry out Southern blotting on the SP1772 gene from human isolates to 
determine the extent of the variation in size of SP1772 in the pneumococcal 
population. However, it is worth considering that a southern blot only appears to 
show the diversity where the gene is big enough in the first place. RT-PCR could 
also be informative, from liquid culture and blood culture and from in vivo 
models.  
In results chapter 4, methods to detect the protein expression of SP1772 were 
unsuccessful, and further work in this area should certainly concentrate of 
finding a way to detect the SP1772 protein. Potentially, a method to detect the 
different sizes of the SP1772 protein would be ideal. It would also be interesting 
to identify the genes responsible for this recombination using knockouts of genes 
involved in recombination. 
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7 Final Discussion 
S.pneumoniae is a highly variable bacterial species that can vary in the content 
of its genome by up to 10% between two strains (Hakenbeck et al., 2001). This 
diversity helps to explain the diversity in the outcome of interactions between 
S.pneumoniae and its human host, ranging from harmless asymptomatic 
carriage, to more benign diseases such as otitis media, to fatal pneumonia, 
septicaemia and meningitis (Austrian, 1999). However, it is also true that 
variations in the human host will also influence the outcome of the interaction 
as highlighted by the increased prevalence of invasive pneumococcal disease 
amongst the elderly and immunocomprimised (Black et al., 2000), the apparent 
genetic predisposition of certain populations to pneumococcal disease (Cortese 
et al., 1992), and the different outcomes resulting from the interaction of 
genetically similar strains in different regions of the world. For example, 
serotype 1 strains have been associated with meningitis in developing countries, 
and pneumonia in developed countries (Sjostrom et al., 2006). Nonetheless, it is 
the genetic diversity of the pneumococcus that has been more extensively 
studied, and it has been found that strains which are identical even by the 
sensitive technique of MLST can vary in the content of their genomes, which can 
help to explain the different behaviours of strains of similar genetic background 
(Enright and Spratt, 1998; Hanage et al., 2005). Variation in the sequence of 
important pneumococcal virulence factors is thought to contribute to the 
different behaviour of strains, however the variation in whole regions of the 
genome also contributes. Several whole genome comparative genomic 
hybridisation studies have been carried out to identify regions of diversity in the 
pneumococcus (Hakenbeck et al., 2001; Obert et al., 2006; Silva et al., 2006), 
and the work presented here focuses on one of these regions of diversity in 
S.pneumoniae, encoding a large serine rich repeat protein, SP1772, and 
seventeen genes putatively dedicated to the glycosylation and export of this SRR 
protein. S.pneumoniae is highly competent and can take up DNA not just from 
other pneumococcal strains, but also from closely related bacteria. This locus 
has also been described in other gram positive bacteria, including S.gordonii 
(Bensing and Sullam, 2002; Takahashi et al., 2004), S.aureus (Siboo et al., 2005) 
and S.parasanguinis (Froeliger and Fives-Taylor, 2001). It is likely that 
S.pneumoniae therefore acquired this locus by horizontal gene transfer from a 
closely related species, this has been documented previously in the case of 
Chapter 7  Final Discussion 
168 
acquisition of penicillin resistance genes by S.pneumoniae from S.mitis (Dowson 
et al., 1993). 
This genetic locus was identified originally in S.pneumoniae as a region of 
diversity (Silva et al., 2006), and studies presented in chapter 3, and work by 
Obert et al have confirmed that this locus varies in its presence across the 
pneumococcal population (Obert et al., 2006). Sequencing of pneumococcal 
strains has also revealed that where this locus is present it can vary in the 
sequence of both the SRR and accompanying strains, as presented in chapter 3. 
Until there are a larger number of sequences available of strains of both 
pneumococci and closely related species, the evolution of the locus cannot be 
determined. However, in spite of the sequence divergence of the ASL within the 
pneumococcal population, the ASL in different strains of the pneumococcus 
appears more similar than that in other species. 
Obert and colleagues also made the notable observation that this region can be 
correlated with the ability of an isolate to cause invasive disease, a finding 
which the authors showed by creating a mutant in SP1772 by insertion-
duplication and demonstrating that it was less virulent in a single strain 
pneumonia model of infection (Obert et al., 2006). This finding may be further 
corroborated by the finding that SP1772 is required for the full virulence of 
S.pneumoniae, as demonstrated by a signature tagged mutagenesis screen in a 
competitive model of infection of pneumonia (Hava and Camilli, 2002). 
However, as discussed in chapter 5, a mutant of SP1772 created by clean allelic 
replacement of SP1772 with an erythromycin cassette, was not attenuated in its 
ability to cause pneumonia in a single strain model of infection. It could be 
speculated that this is due to the differing genomic content of the parent strain, 
in spite of the fact that the same strain was used in all cases. One interesting 
difference in the strains used is the expression of SP1773 RNA. In the 
TIGR4∆SP1772 strain used by Obert and colleagues, the RNA of transposase 
SP1772 was found to be expressed (Rose et al., 2008) whilst studies in our 
laboratory show that SP1773 is neither expressed in TIGR4∆SP1772 (Chapter 5), 
or in the parent TIGR4 strain (Chapter 3). The differences in the behaviour of 
the strains could be attributed to the method of mutation of SP1772, since three 
different methods were used across all three studies. It would be desirable to 
carry out further work utilising the two different mutants and their parent 
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strains in the same laboratory and the same experiment to try and understand 
how the variability in results has arisen. It is interesting to note that studies 
utilising the pneumococcus frequently vary in their outcome between 
laboratories, one example was shown in a gene expression study by Oggioni and 
colleagues (Oggioni et al., 2006) the authors note that while their data fit well 
with those described in parts of some other studies, there are also discrepancies 
between other parts of the study (LeMessurier et al., 2006; Orihuela et al., 
2004). In order to examine whether the model of infection and strain of mouse 
used was the variable in the outcome, the conditions described in Obert and 
colleagues work were duplicated. This, however, did not result in the same 
outcome and as such it is presumably either the genetic background of the 
parent strain or the difference in the method of mutagenesis used. 
SRRs in other bacteria have been shown to have differing roles. One SRR, fap1 in 
S.parasanguinis, has been shown to be involved in biofilm formation (Froeliger 
and Fives-Taylor, 2001). The ability of the pneumococcus to form biofilms has 
recently been studied. Studies have noted the contribution of individual genes to 
biofilm formation (Moscoso et al., 2006), the overall increased diversity in the 
expressed proteome of the pneumococcus when forming biofilms (Allegrucci et 
al., 2006) and the differential gene expression pattern of pneumococci in 
biofilms and in stationary growth (Oggioni et al., 2006). As presented in chapter 
5, in the absence of SP1772, TIGR4 was less able to form biofilms. These studies 
also showed that biofilm formation is slightly better in TIGR4 than in an 
unencapsulated derivative, and that TIGR4∆cps∆SP1772 was the most able of all 
four strains to form biofilms. The role of capsule in biofilm formation is 
somewhat disputed in that while it has been shown not to be required for 
biofilm formation (Moscoso et al., 2006), it has also been shown to be expressed 
in biofilms where it is present (Oggioni et al., 2006), and that a capsular protein 
is actually required for optimal biofilm formation (Allegrucci et al., 2006). There 
remains much to be elucidated both about the role of capsule and the ASL in 
biofilm formation, however evidence presented to date suggests that both do 
play a role. It would be interesting to evaluate the mutants generated during 
this study in a variety of biofilm models and assess the outcomes.  
Attempts to visualise SP1772 in TIGR4 by conventional methods were not 
successful. It was also notable that attempts to raise antibodies to a particular 
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region of SP1772, just upstream of SRR-2 were also unsuccessful. It is this region 
of Inv200 SP1772 that was found to be absent completely in some clones 
resulting from the recombination. It is interesting that this region is not 
immunogenic – not just by conventional means but also by fusing this portion of 
the gene to highly immunogenic ply by gateway technology, particularly as the 
region has two predicted regions of immunogenicity (chapter 4). Future work to 
determine whether SP1772 is expressed, in reality as oppose to differential 
judgement of mutants strains, could focus on preparing an antibody specifically 
against SP1772 by adsorption of sera acquired from challenge with TIGR4 against 
a culture of TIGR4∆SP1772, in the manner that serum against GspB was acquired 
(Bensing and Sullam, 2002). Alternatively, antisera could be raised in the manner 
utilised by Rose and colleagues (Rose et al., 2008), and similar to SP1772A as 
presented in chapter 4. However, there is still a limit in visualising the protein 
since it appears not to enter SDS-PAGE gels. 
It is possible that the study of a truncated form of SP1772 would be useful. Many 
studies with GspB have utilised a truncated version of this SRR (Bensing et al., 
2004; Takamatsu et al., 2004, , 2005). It would also be feasible to use naturally 
truncated variants of SP1772, as is present in Inv200. Studies of SP1772 in Inv200 
revealed that it is not only predicted by sequencing to be much truncated from 
TIGR4 SP1772, but also that it is present in different sizes within the strain 
following growth in liquid culture. This recombination has been shown to take 
place either between the two SRRs within the gene, or within the larger SRR 
(Chapter 6). The ability of the pneumococcus to harbour different sizes of 
SP1772, as demonstrated in Chapter 3, is perhaps by virtue of selective pressure 
for the target that the gene is interacting with which could vary between 
strains. It may also be a biochemical or physiochemical property of that 
particular strain. The reasons for a strain containing a heterogenous population 
of SP1772 is less clear, although it could be speculated that growth in liquid 
culture has driven the strain to reduce the burden that harbouring and 
synthesising this large gene has placed on the cell. The mechanism by which 
recombinational variants of SP1772 arise is also unclear. It could be speculated 
that due to the repeat regions that are present in SP1772 it is able to recombine 
by regions within the gene exerting homology and upon annealing when the DNA 
comes into contact homologous recombination can take place. The cells in which 
this takes places may then be more successful in a given environment because 
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there is no selective pressure on the strain to harbour a large, fully functional 
gene product of SP1772. Further study is warranted to identify the behaviour of 
SP1772 in blood culture, biofilm and in vivo models to establish whether this 
phenomenon is also seen here, more relevant models to pneumococcal infection, 
and whether this varies in different models due to differing targets in each 
model. Further work could also focus on more representative models of 
infection. A single strain model of pneumococcal behaviour is fairly definitive in 
defining the attributes of a single strain, however it lacks the contribution of 
other other species which would likely be in contact with the pneumococcus. 
The pneumococcus is known to occupy the human niche with other closely 
related strains with whom it could be constantly interacting. Particularly in the 
case of SP1772 which has homologues in many closely related species, 
elucidation of the role of this gene in the behaviour of the pneumococcus may 
only be found by evaluating SP1772 mutants and their parent strains in multi-
organism models of biofilm formation and infection. 
Given the difficulty in visualising SP1772, as previously discussed, attempts were 
made to utilise an immunogenic FLAG tag to which antibodies are commercially 
available. The FLAG tag was attempted to be inserted at the C-terminal of 
SP1772 upstream of the codons encoding the LPNTG motif. Attempts to do this 
were unsuccessful, and the usefulness of this given that full TIGR4 SP1772 
cannot be visualised easily is limited. However, given the later discovery of a 
naturally truncated form of SP1772 in Inv200, it would be desirable to both 
experiment with visualising this truncated form of SP1772, and also to 
experiment with labelling this form with an immunogenic FLAG tag.  
In addition to further work to the studies already presented, it would also be 
interesting to look at the levels of expression of SP1772 RNA in vivo, in differing 
disease models. However, methods to capture RNA are extremely problematic 
since the RNA is difficult to retrieve at varying timepoints, and is stable for a 
very short period of time when it is retrieved. 
The work presented here shows that SP1772 and its associated genes are present 
in many different serotypes and sequence types of the pneumococcus. The 
sequence of both the SRR protein and the related genes can vary between 
strains, and indeed, the sequence of the SRR has been shown to vary within a 
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strain. Whilst no suitable detection method for the SP1772 protein has yet been 
developed, an interesting role for SP1772 in biofilm formation has been 
elucidated in the absence of capsule.  
Many additional questions regarding the distribution and behaviour of SP1772 in 
pneumococcal strains have arisen from these studies. Further work could focus 
on several areas. It would be desirable to understand more about the prevalence 
of SP1772 in the species by further CGH studies, and to understand more about 
the expression of SP1772 at both the RNA and protein level under different 
conditions. It would also be useful to understand why mutant strains differ 
between different laboratories and to evaluate these mutants in different 
models of infection, colonisation and biofilms. Finally, it would be useful to 
understand the mechanisms by which SP1772 modulates its size in a single strain 
of the pneumococcus and to elucidate the benefit to the pneumococcus of this 
behaviour. 
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1 Appendix I (buffers and recipes) 
All reagents are from Sigma-Aldrich unless otherwise stated 
1.1 Media 
1.1.1 Terrific broth (TB) 
12g bacto-tryptone 
24 g bacto-yeast extract 
4 ml glycerol 
In 900 ml dH2O, autoclave 
Add the following: 
In 90ml H2O 
2.31g KH2PO4 monobasic 
12.54 g K2HPO4 dibasic (for trihydrate 16.45 g) 
Adjust volume to 100 ml with H2O 
 
1.2 SDS-PAGE gels 
1.2.1 Stacking gel 
3.21ml dH2O 
1.25ml 0.5M Tris pH 6.8 
0.05ml 10% SDS 
0.488ml 30% polyacrylamide 
0.025ml 10% ammonium persulphate 
0.005ml TEMED 
 
1.2.2 Resolving gel 
10% - nb to adjust polyacrylamide and dH2O are adjusted) 
4.05ml dH2O 
2.5ml 1.5M Tris pH 6.8 
0.1ml 10% SDS 
3.3ml 30% polyacrylamide 
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0.05ml 10% ammonium persulphate 
0.005ml TEMED 
 
1.2.3 10x Running buffer 
40g SDS 
144g Glycine 
30g Tris base 
In 1L dH2O 
 
1.3 Western blotting 
1.3.1 Transfer buffer 
3.03g Tris base 
14.4g Glycine 
200ml Methanol 
In 1L dH2O, keep at 4˚C 
 
1.3.2 Tris NaCl pH7.4 
1.2g Tris base 
8.7g NaCl 
In 1L dH2O 
Conc. HCL 800µl 
 
1.3.3 Developer 
30mg 4-chloro-1-napthol in 10ml methanol 
Mix with 
30µl H2O2 (30% w/v) in 40ml Tris NaCl pH7.4 
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2 Appendix II (Primers used in this study) 
 
Primer 
name 
Descripti
on 
Sequence 
07F Pet T7 TAATACGACTCACTATAGGG 
07G Pet term GCTAGTTATTGCTCAGCGGTG 
19H Srt1 GAACATCGAACGAATCGC 
19I Srt2 TTCACAAACAGGACGTGC 
19W SrtAsc1 GGCGCGCCCTGCTAGGATATTTGTCAGC 
19X SrtAsc2 GGCGCGCCCTAACAGCTTTCAATCAACC 
48L 5 NT 
START 
SP1772 
ATC GGG ATC CGA TGA CCG AAA CGG TAG AAG 
48M 5 NT NLS 
SP1772 
ATC GGG GAT CCG GTA CCA AAT TAC TGG AAC G 
48N 3 NT NR 
SP1772 
GAC GGA GCT CGA TTA TCC ACC ATT GAA GTA GTT AAT 
TC 
48O 3 NT RR 
SP1772 
GAC GGA GCT CGA TTA TGA AGC TGA GGC GCT TTG AC 
48P pET 
SP1772 A 
513 
GAATATCCAGGACGCATAC 
48Q pET 
SP1772 A 
579 
CGGTTACGTATGGTAATCC 
48R pET 
SP1772 A 
937 
CCACAGTAGATGATGCAG 
48S pET 
SP1772 A 
1060 
GAGTCGGCAAGTACATCTG 
48T pET 
SP1772 C 
351 
GATGTATCCGTTCCAGTAATTG 
48U pET 
SP1772 C 
669 
CGGTTACGTATGTGAATC 
48V pET 
SP1772 C 
864 
GCCAGCAATTGCTCGATGG 
48W pET 
SP1772 C 
1164 
GTTTGTCAGCTTCAGAGTCG 
48X pET 
SP1772 C 
1305 
CCACTTATGACAGCTCCCG 
49V SP1772 P1 AATTAGCTGATTTATACTCATTTGC 
49W SP1772 P2 CCGCCATTCTTTGCTGTTTCGGACCTGAGTAGTATCAACACCA
CC 
49X SP1772 P3 GGAAAGTTACACGTTACTAAAGGCACAAGTTGGAAATACTTCT
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GG 
49Y SP1772 P4 AATTTCCGGACATATTATTCAGACC 
49Z Erm1 CGAAACAGCAAAGAATGGCGG 
50A Erm2 CCCTTTAGTAACGTGTAACTTTCC 
50J 1772P1A CATTAAAGGAGGGCACAGACATGTCG 
50K 1772P4A AGATAAACCACTAGCTTGACCGTTGG 
50V SP1774e CACAAGATGATTGCGCATG 
50W SP1773s GCATAGCTTTATTAGACC 
50X SP1773e GATTCACAAATTAGAGAATG 
50Y SP1772s CTTCTACCGTTTCGGTC 
50Z SP1772e GTGTTACTTGGAGTTCTAGC 
51A SP1771s CCTGAAGCATCCGTAGAACC 
51B SP1771e GAGAGAAATAAGCAAATG 
51C SP1770s CTATAGATTTTGTATTC 
51D SP1770e GTTACGATTTATCCTTG 
51E SP1769s CTAATTAGTTCGTCTGCC 
51F SP1769e GATTACAAAGAGTGATAGC 
51G SP1768s CCCAGTTGACTAGCTATC 
51H SP1768e CTGGAAGAGGTTCATGAG 
51I SP1767s GTTGTTTCTAACTGCCTGGTG 
51J SP1767e CTGCAGAACATAATTTCG 
51K SP1766s GACTATTGTGTCTACAGAG 
51L SP1766e CTTACCAATGTTATTGGAAC 
51M SP1765s CTAATACTATTGATTTTCTC 
51N SP1765e CATAGTAGAATTGATTGGC 
51O SP1764s CAGAATATGCTCGACACAC 
51P SP1764e CCGTTCTGCGTATTCGATTTG 
51Q SP1763s GACGAATAAATCTTAGTC 
51R SP1763e CGATTGGCAATGATTCCAGG 
51S SP1762s CCATGGAGTGATATCTGC 
51T SP1762e GCAGATGTTACAGAATTTTC 
51U SP1761s CTCTGGAATACTGACCATC 
51V SP1761e GCCTATGAACAATTAGTG 
51W SP1760s GTAATAAGATACAGTTGTTC 
51X SP1760e CTTATCCAGAAGATAGTTATAC 
51Y SP1759s GCTACTAATTCTTGATCCG 
51Z SP1759e CAGAAAAATCCAATCGTAG 
52A SP1758s CACCAGCACGATAGGCTTG 
52B SP1758e CTGACCATGTAGAAGACC 
52C SP1757s CGTAACCTAGATAATAGG 
52D SP1757e CAGACGGTGCACAATAGAC 
52E SP1756s GTTTCAACTCTTCCATGCG 
52F SP1756e GATGATTCTGATTGGTTTGC 
52G SP1755s GTTTACCAATATTACTAGTG 
52H SP1755e CTGGCAGAGCAACACCTTGG 
52I SP1754s GAAGCCAAAACCTTCATCC 
52W SP1774 RT 
f 
CCAAGCGAGCCACCATCCTA 
52X SP1774 RT 
r 
GACCTGCCAGATAAGCTTC 
52Y SP1773 RT 
f 
GATGTCGGCGTCAGAACTCT 
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52Z SP1773 RT 
r 
TCCGCTCTAAGTTCCCTTG 
53A SP1772 RT 
f 
AATGAGTCAGCAGTACTTG 
53B SP1772 RT 
r 
TCGCTGAATTACTTGTAG 
53C SP1771 RT 
f 
CTATCTGAGGAAGTGCCTA 
53D SP1771 RT 
r 
CCATCATTAACGACAACA 
53E SP1770 RT 
f 
CTAGATGGTTATGCCTTGG 
53F SP1770 RT 
r 
GGTAGAAGGAACATCACC 
53G SP1769 RT 
f 
GTGTTTGGATAGCATTCAGA 
53H SP1769 RT 
r 
CTCTACAAATTCTTCACAT 
53I SP1768 RT 
f 
GAAATGAATAAGCGTCTGGA 
53J SP1768 RT 
r 
GGTTGGAGACTGAAAGACT 
53K SP1767 RT 
f 
CAATTACACCAGGCAGTTA 
53L SP1767 RT 
r 
TCTGGCATGATATCTTGA 
53M SP1766 RT 
f 
ACATTTGCACGCTATTTTA 
53N SP1766 RT 
r 
CAAATCACCAGTCACAATCA 
53O SP1765 RT 
f 
GCCTATCTTATTCCTTTA 
53P SP1765 RT 
r 
CCATTCAGGAGCTATATCA 
53Q SP1764 RT 
f 
GTGGAGTGTGTCGAGCATA 
53R SP1764 RT 
r 
GAACCGTCATCAACTAAA 
53S SP1763 RT 
f 
GTGTTACTTGCTTTATTA 
53T SP1763 RT 
r 
CAGGAACCAAATAGCGAGCT 
53U SP1762 RT 
f 
GGTGTGTTAGAAATGGATACT 
53V SP1762 RT 
r 
CTTGGGTATGGAGATTATGA 
53W SP1761 RT 
f 
GTCCCCAACAACTAATCAA 
53X SP1761 RT 
r 
CTTGTATCGTCGGAGGAA 
53Y SP1760 RT 
f 
GTTCGTCTGTATAATCCTCTA 
53Z SP1760 RT CTGGTAATTGACACTAGA 
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r 
54A SP1759 RT 
f 
CCATGCCTGTCTATTTGAA 
54B SP1759 RT 
r 
CATTTCCTCGGCATCACGCT 
54C SP1758 RT 
f 
GAACTTTCGCAGATTTATAG 
54D SP1758 RT 
r 
CTGAACCAATAGCTTCCATCAA 
54E SP1757 RT 
f 
GCAGATAGCGAGCCGATTATGA 
54F SP1757 RT 
r 
CAATAAGATATCACCCGTCACA 
54G SP1756 RT 
f 
GTCAGAGGAAGATTTATT 
54H SP1756 RT 
r 
CAACTCTTCCATGCGGCCTT 
54I SP1755 RT 
f 
GATTGAAATACTAATTGTTT 
54J SP1755 RT 
r 
GACGGGGTTGTATAGTTA 
54K SP1754 RT 
f 
GGTTTCAAATTCTTCTCTT 
54L SP1754 RT 
r 
GTCTTCCGGAACCGCAG 
56F INV200 
SP1772 
fwd 
ATGCGTGGTGGTGTTGATAC 
56G INV200 
SP1772 
rev 
GTCTTCATCATCTCTTTTAC 
56L SP1772D-
Ply 
Gateway 
fwd 
GGGGACAAGTTTGTACAAAAAAGCAGGCTTCGTACCAATTACT
GGAACG 
56M SP1772D-
Ply 
Gateway 
rev 
GGGGACCACTTTGTACAAGAAAGCTGGGTCTGA 
AGCTGAGGCGCTTTGAC 
56N SP1772 
Southern 
fwd 
GTGGTAGGTTCACAAACAGCTGCC 
56O SP1772 
Southern 
rev 
CTGAAGCCGAGGCACTGGTTGATG 
57C inv200 
sp1772 1 
rev 
CTCCTGTATTTGGTAATTCC 
57D inv200 
sp1772 1 
fwd 
GTAGAGAAAACGGATGCTTTG 
57E Inv200 
SP1772 6 
GTATGTGAATCCTAAAACAAAG 
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fwd 
57F Inv200 
SP1772 6 
rev 
GAGAATTAGTTGATCCACTTG 
57G Inv200 
SP1772 7 
fwd 
CTGGCAATACGATTGTAAATG 
57H Inv200 
SP1772 7 
rev 
GCTGAGGCACTCGTTGATGCCG 
57I Inv200 
SP1772 8 
rev 
GCCGACGCACTGGTACTTG 
57J Inv200 
SP1772 8 
fwd 
CAAATGTCAATCTCCAATC 
57K Inv200 
SP1772 16 
fwd 
CAAAATTGACCTTTACCTATAC 
57L Inv200 
SP1772 16 
rev 
CTGGTACTTGCTGAAGCTG 
57M inv200 
sp1772 
pET33b-F 
ATCGGGATCCGATGCGTGGTGGTGTTGATAC 
57N inv200 
sp1772 
pET33b-F 
GACGGAGCTCGATTATCATCTCTTTTACGACGTTT 
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